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Abstract 
 
Background 
Cardiovascular disease is the leading cause of death in the developed world. Angiography 
allows the visualisation of arteries through the use of real time X-ray imaging when 
injected with iodinated contrast media (ICM). Due to its excellent temporal resolution and 
real time imaging capability, angiography has been the cornerstone of the diagnosis and 
percutaneous treatment of cardiovascular disease for many years. The number and 
diversity of diagnostic and therapeutic procedures that utilise angiography are increasing 
rapidly but the technology of angiography is not without risk to patients and the staff in 
attendance. ICM used in angiography is excreted by the kidneys and is toxic. The cohort of 
patients being treated for cardiovascular disease are often elderly with pre-existing renal 
disease and more complex angiographic procedures can cause renal failure. There is also 
risk to the patient and the staff working in the room from the stochastic and deterministic 
effects of ionising radiation that is used to produce the images. Currently there is no 
multicentre reference levels for radiation dose to patients undergoing cardiac angiography 
procedures in Australia and globally there is little data on the factors impacting on staff 
dose during these procedures and the potential reductions available with newer X-ray 
systems. As new procedures, such as trans catheter aortic valve impanation (TAVI) 
emerge, there is a need to investigate the radiation doses associated with these, to 
investigate the impact of ICM on renal function and to assess new imaging techniques that 
may be useful for some of these newer procedures. 
 
Methodology 
Radiation benchmarks will be established for diagnostic and interventional procedures for 
Queensland public hospitals, with comparisons to the literature. With a single centre focus, 
radiation dose and procedural data will be collected to investigate the different variables 
that impact on radiation dose to the patient and the staff during diagnostic cardiac 
angiography and structural cardiac intervention. Further, the impact of latest generation X-
ray equipment on radiation dose will be investigated during electrophysiology procedures, 
which are traditionally seen as high dose procedures. The impact of ICM usage and the 
effect on patient’s renal function and mortality will be investigated during trans-catheter 
aortic valve implantation (TAVI). 3D angiography will be investigated to assess its 
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effectiveness, accuracy, ICM use and radiation dose compared to 2D angiography and 
computed tomography (CT) for patients undergoing TAVI. Finally, the degree of X-ray 
beam distortion, inherent in the design of all X-ray systems will be assessed for TAVI 
devices. 
 
Results and conclusions 
Radiation dose 75th percentile reference levels of 5864CGycm2 and 12900CGycm2 for 
diagnostic and interventional angiography procedures across all public hospitals in 
Queensland were established, which are very comparable to other international 
benchmarks. Radiation dose during diagnostic procedures is multifactorial but patient 
obesity was highlighted as the biggest predictor for both a high patient and staff radiation 
dose. During structural cardiac intervention the trans-oesophagel echocardiography 
operator had the highest radiation dose when compared to the rest of the team, but 
additional shielding was shown to reduce radiation dose by 82% and newer X-ray 
technology can dramatically reduce radiation dose, as demonstrated during 
electrophysiology procedures by up to 92%. ICM use was relatively high during TAVI 
procedures when compared to the literature but did not appear to be associated with acute 
kidney injury (AKI). The severity of AKI is important in determining mortality in these 
patients, which was linked to chronic kidney disease, respiratory failure, previous stroke, 
blood transfusion and retrieval or removal of the device, the latter being a new finding in 
this area. 3D rotational X-ray (DynaCT) can accurately determine the calibre and tortuosity 
of the ilio-femoral arteries, for patients selected for TAVI, using less ICM than CT but it 
was inadequate as assessing calcification in this particular study. The TAVI device was 
demonstrated to be significantly affected by X-ray beam distortion, when imaged toward 
the periphery of the image which could affect the implant depth. 
Overall, cardiac angiography is evolving rapidly, with many new procedures utilising this 
technology. Radiation dose to patients and staff is now better understood, with new 
equipment and shielding technologies demonstrating dose reduction. The volume of ICM 
in these new procedures is not associated with AKI but pre-existing conditions are more 
relevant, as well as procedural complications. ICM volume can be reduced for these 
procedures through the use of new imaging technology, though it does have some 
limitations and TAVI devices can be susceptible to the effects of X-ray beam distortion. 
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 Introduction  
In the context of this thesis, cardiac angiography is a generalised term used to describe an 
invasive procedure, using X-ray fluoroscopy, to image the heart chambers and its arteries, 
take measurements of blood pressure, oxygen saturations and electrical activity. As an 
adjunct to cardiac angiography, percutaneous treatments of various pathologies can be 
performed and specialised devices can be implanted to aid such treatment, the term 
cardiac intervention is a generalised term, used in this thesis to describe these 
procedures. 
The first cardiac catheterisation was performed by Werner Forssmann, who in 1929,  
inserted a catheter from the arm into the heart and recorded this on X-ray film. Later he 
injected contrast media to demonstrate that the chambers of the heart could be imaged 
with fluoroscopy.(1) These basic elements of angiography remain today, almost 90 years 
later, but in the modern era, cardiac angiography procedures have matured. Cardiac 
catheterisation laboratories have been designed for the sole purpose of imaging the heart. 
New procedures are being developed at a rapid rate, and the procedures are also 
becoming longer with increasing complexity.(2) Where devices once only consisted of 
internal cardiac pacemakers and coronary stents, now heart valves can be replaced(3) 
and repaired(4), septal defects can be plugged and the left atrial appendage can be 
occluded,(5) all via percutaneous access under fluoroscopic control. These new advances 
mean that procedures are increasing in number and some are associated with higher 
radiation doses.(2) Radiation doses from cardiac angiography and cardiac intervention are 
relatively high.(6) The high radiation doses from the X-rays have risks to the patient and 
the staff working this environment.(7) There is the stochastic risk of malignancy and also 
the deterministic risk of skin injury.(2) The stochastic risk is difficult to quantify but 
increases with radiation dose and the relationship between radiation dose and stochastic 
effect is not known.(7) The deterministic effects by way of skin lesions induced by radiation 
are better understood and reports of skin injury from fluoroscopy X-rays have been 
reported many times in the literature.(2,8-12) In addition, the iodinated contrast media 
(ICM) used for many of these procedures to visualise heart chambers and arteries can 
adversely affect renal function, termed contrast induced nephropathy (CIN),(13) as ICM 
causes cellular injury and death to renal tubular cells (14). 
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Objectives: 
From a radiographer’s perspective, working in this field, there are three main elements to 
cardiac angiography that warrant investigation as part of this thesis. 
 
1. Radiation dose to the patient and the staff present for these procedures; what are 
the dose levels, what impacts on the dose and how can it be reduced? 
2. Given the high-risk cohort of patients undergoing transcatheter aortic valve 
implantation (TAVI), what contrast media volume is used and what are the levels of 
acute kidney injury? What is the impact of this on patient outcome? 
3. Can new advances in fluoroscopic imaging technology, such as rotational 
angiography demonstrate the anatomy and pathology relevant for these newer 
procedures and do the basic principles of fluoroscopic beam distortion have an 
impact on the TAVI device? 
 
The overarching structure of this thesis and how these objectives have been addressed is 
outlined in the following research diagram. 
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Chapter 1 - Background and literature review: 
1.1 Radiation levels in the cardiac catheterisation laboratory 
Establishing acceptable radiation dose levels that X-ray units use to perform procedures is 
an important step in radiation dose management and is recommended by the International 
Committee for Radiation Protection (ICRP)(7). Comparing radiation levels to benchmarked 
levels or diagnostic reference levels (DRLs) is important and they are used a guide as to 
what radiation dose should be achievable for a particular imaging procedure using X-
rays.(7) The recognised radiation values for comparison are the dose area product (DAP) 
(Kerma area product (KAP)), the skin entrance dose (or air Kerma) and fluoroscopy 
time.(7) DAP (KAP) is generally used, as it measures both the radiation exposure and the 
area exposed and is the unit that was used to aid comparison in the large UK 
series.(15,16) In addition, fluoro time has been described as a less reliable indicator of 
patient skin dose than DAP or Kar, as described in one recent study.(17) 
Diagnostic reference levels have been investigated many times by national bodies around 
the world. The UK series was the first, and have been collecting data since 1992. In 2000 
they reported a dose of 25.8 (22.3-36.3) Gycm2 for coronary angiography,(15) which was 
lowered to a dose of 23.5 Gycm2 (18.9-29.0) by 2005 (18) but was similar in 2010 (23 (16-
31) Gycm2).(16) These results demonstrate the importance of DRL studies and that once 
the median and 75th percentiles are established, efforts can then be made to reduce dose. 
Other studies published from Europe, such as the study by Samara et al quoted a DAP of 
45 Gycm2 for CA and 90 Gycm2 for percutaneous coronary interventional procedures (PCI) 
in Swiss academic hospitals.(19) However, one of the largest DRL studies, in terms of 
area covered was that published by Neofotistou et al in 2003, which examined doses from 
six European countries for CA and PCI and established 75th percentile values of 57 and 94 
Gycm2 respectively.(20) D’helft et al published a median value of 31 Gycm2 in 2009 for CA 
procedures across 19 individual X-ray apparatus in Ireland.(21)  The United States 
published median values of 49 Gycm2 for CA and 83 Gycm2 for PCI procedures in the 
publication by Miller et al in 2012 as advisory data sets (22) and Greece performed a large 
DRL study across 26 centres, published in 2013 by Simantirakis et al, suggesting a 
median and 75th percentile DRL of 37.5 Gycm2 and 53 Gycm2 respectively for CA.(23) 
More recently, a study has been published by Ngaile et al in 2018, with a DRL for 
Tanzania, with median values for CA of 37.8 Gycm2 for CA and 86.5 for PCI, though the 
sample sizes from the two major hospitals involved were relatively small.(17) 
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As at 2013, there were no DRL values for CA and PCI in Australia. It is not clear why a 
DRL study has not been performed in Australia before. It is surprising, given that so many 
western countries had achieved this in the early 2000’s. Without measuring radiation 
doses from multiple sites and establishing a benchmark, there is no way of knowing 
whether doses used by cardiac catheter laboratories (CCLs) in Australia are overly high or 
even low when compared to the rest of the world. 
It is clear when reviewing the literature that there is a large variation in median doses for 
these procedures. There would undoubtedly be equipment, protocol and procedural 
differences between the countries and some studies have normalised their doses to a 
median patient weight, such as that by Hart et al in the UK DRL series,(16) which adds a 
further level of confusion, when comparing data. This is in line with a paper by Chapple et 
al who normalized radiation dose to an average of 70Kg(24). Normalising the dose to a 
particular patient weight is advantageous for a comparison between x-ray systems. 
Normalising the dose data to a reference patient weight is difficult with a large number of 
facilities. Many multi-centre studies have not elected to do this. (20,22,25,26) A higher 
DAP value than some of the literature may be the result, due to a higher or lower median 
patient weight. Another method utilised to normalise the DAP data is to exclude patients 
outside a weight range of 80Kg ± 5, with the same aim(18). Normalizing may not be logical 
in establishing a DRL for practical routine use, as the DRL would only be relevant to a 
small portion of patients that fall within a certain weight range. The ICRP published 
guidelines for the creation of DRLs in 2017 and advise that it is difficult to implement DRLs 
for interventional procedures given the wide range of patient size and other factors such as 
procedural complexity but that influence the DAP. However, it does suggest that the DRL 
process should be applied in the same manner as for diagnostic procedures. Dose data 
can be normalized to patient body habitus but similar results can be obtained without 
normalization.(27) 
Given the variation, it is reasonable that DRLs should be established at the local level and 
that each facility dose be audited and compared to the DRL on an annual basis, as 
suggested by the ICRP.(7) Therefore, the first objective for the author of this thesis was to 
establish a benchmark (DRL) for the most commonly formed cardiac angiography 
procedures; diagnostic coronary angiography and precutaneous coronary intervention. 
Once radiation doses are established, efforts can be made to reduce the radiation dose 
required for these procedures, which will undoubtedly lead to a lower risk of the stochastic 
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and deterministic effects of radiation. This is the trend that has been seen in the UK series 
by Hart et al.(28) 
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1.2 Factors that impact on radiation dose in the cardiac catheterisation laboratory. 
X-ray system imaging protocol 
It stands to reason that the dose output of the X-ray system will impact on patient radiation 
dose. One of the most readily achievable methods of dose reduction is that of changing 
the settings of the X-ray system. A lower pulse rate is a simple method that can reduce 
radiation dose in the cardiac cath lab when performing coronary angiography. On this 
topic, Abdelaal et al reduced fluoroscopy pulse rate from 15 pps to 7.5 pps in a 
randomised controlled trial. A DAP reduction of 26% was achieved and an operator dose 
reduction of 40% was also achieved.(29) In a small study of 39 patients, Ebrahimi et al 
demonstrated that lowering the fluoroscopy and cine frame rate from 15 fps to 7.5 fps, 
without any other changes reduced the radiation dose to the patient from 433 to 252 mGy 
for CA procedures, without adversely impacting on image quality.(30) Another study that 
adjusted the fluoroscopy pulse rate and the X-ray system dose protocol was that by 
Wassef et al in 2014. They implemented system changes to the X-ray machine in addition 
to other parameters. They also, in a sub group analysis, reduced the cine frame rate from 
15 to 7.5 frames per second.  A 35% reduction was seen in the system reduction group 
and a 65% reduction was seen in the lower frame rate reduction group.(31) A further study 
by Maccagni et al, published in 2017 investigated the impact of lower pulse rates during 
PCI and reduced radiation dose with their low dose protocol from 115 Gycm2 to 53.3 
Gycm2 .(32) Importantly, in this cohort of patients, where doses are higher than for CA, the 
percentage of patients that exceeded the 5Gy reporting threshold were significantly lower; 
1.8% vs 7.2% with the low dose protocol.(32) These papers demonstrate that traditionally 
used frame rates can be reduced to significantly reduce radiation dose without overtly 
impacting on image quality. Badawy et al reduced their fluoroscopy pulse rates to 3 pulses 
per second in an effort to reduce dose. Their paper also described the changes that were 
made to the X-ray system in an effort to improve image quality at this low pulse rate. Their 
dose reduction was impressive and the 3 pulse per second fluoroscopy is the lowest 
recorded for coronary angiography in the literature. (33)  
X-ray equipment dose reduction technology 
When radiation doses are reduced during fluoroscopy, image quality can suffer and a low 
dose image will appear grainy or noisy.(2) Noise reduction software with new X-ray 
technology, allowing a lower radiation dose to be used has featured for both coronary 
angiography procedures and electrophysiology procedures. Bracken et al demonstrated in 
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268 patients in 2015 how the Philips Allura Clarity (Brest, Netherlands) system reduced 
DAP by 46% when compared to a similar system without the noise reduction 
technology.(34) Eloot et al published a very similar study, also in 2015 on 70 patients, 
comparing the Philips Allura Clarity to the Philips Allura FD10 but this time, found that the 
Allura Clarity system reduced dose by 75%.(35) A further study by Christopoulos et al 
compared four currently available X-ray systems and compared the dose outputs with a 
phantom. There was a significant difference between the four systems, and again the 
Philips Allura Clarity demonstrated the lowest DAP and film dose.(36) There are other 
novel ways to reduce dose: Kuon et al described the use of electrocardiogram (ECG) 
gated fluoroscopy and cine in 2015, with a Siemens X-ray system, as an additional method 
of reducing radiation dose, describing it as ‘feasible in clinical routine’ and it ‘tremendously 
minimises patient radiation exposure’, though it unfortunately was not compared to the 
same system when not utilising the ECG gating as a comparison.(37) Its use does not 
appear to have been investigated further in the literature. Didier et al investigated the 
impact of a dose reduction strategy with a new X-ray system, (GE IGS 520) in a study in 
2016. They demonstrated how a number of new dose reduction features, including 
reducing the fluoroscopy pulse rate, could reduce DAP for CA and PCI procedures. 
However, they did note that patient BMI did have a large impact on DAP during 
procedures. They also noted that radial access was associated with more DAP, longer 
cine time and fluoroscopy time.(38)  
Removal of the stationary grid 
The stationary grid used in X-ray systems reduces scattered photons reaching the detector 
and improves image quality.(39) Removing the stationary grid may reduce image quality 
but it should also reduce patient dose. Removing the stationary grid from the housing of 
the detector/image intensifier was first documented by Partridge et al in 2006, and instead 
used an air gap technique to reduce scatter and image noise. Similar image quality was 
obtained for an approximately 50% dose reduction during CA.(39) Roy et al also removed 
the anti-scatter grid for patients with a BMI of less than 25 kg/m2 in a series of 129 
patients. They too found that removing the grid did not adversely impact on image quality 
in their lower BMI cohort and that radiation dose was reduced by 47%. Also, during 
phantom studies, operator dose was reduced by over 50% in all projections.(40) 
Arterial access route 
Radial artery access is now preferred for CA and PCI as it has lower complication rates 
and is preferred by patients as communicated in a publication by Archbold et al in 2004. 
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(41) Jolly et al also demonstrated lower rates of vascular complications in the RIVAL trial 
in 2011 which enrolled 7021 patients from 158 centres and 32 countries. It also 
demonstrated lower rates of death, myocardial infarction, stroke and bleeding which was 
the composite endpoint.(42)  
These papers highlight the attractiveness of the radial artery access route. Radial access 
has however, been demonstrated many times to be associated with a higher radiation 
dose for the patient than for femoral access. In 2008 Brasselet et al studied radiation dose 
the patient and operator. For the patient, radial access was associated with 65.8% higher 
dose for CA and 28.2% higher for CA with ad hoc PCI. Operator dose was also higher.(43) 
A randomised trial by Brueck et al in 2009 of over 1000 patients for CA and PCI 
demonstrated that longer fluoroscopy times and higher DAP was associated with the radial 
approach. There were however fewer vascular complications in the radial group.(44) In 
2016 Shah et al also studied left vs right radial and femoral approach. Whilst there was not 
a significant difference between left and right radial access, there was a significant 
difference between radial and femoral access for DAP, AK, fluoroscopy time and operator 
dose.(45) A further randomised controlled trial was performed by Michael et al in 2015. It 
included 128 eligible studied patients undergoing angiography who had had previous 
bypass surgery. In that study, fluoroscopy time was higher for radial approach, as was 
contrast media use, though air Kerma was not significantly higher. Operator dose on the 
other hand was significantly higher with the radial access.(46) 
The REVERE trial by Pancholy et al in 2015 randomised patients to left radial, right radial 
and right femoral approach, with almost 500 patients in each arm. They found no 
significant difference in radiation dose between the access routes but did note that 
operator experience was significantly associated with radiation exposure (air Kerma), with 
the least experienced operators delivering the most radiation.(47) In 2016, Singh et al 
demonstrated a significant difference between radial and femoral access in a study 
investigating operators under training. They found radial access was associated with 
higher fluoroscopy times and DAP and also that procedure time reduced during years of 
training, though DAP did not significantly decrease.(48) Also in 2016, Simard et al, 
demonstrated a 15% higher radiation dose associated with radial access in a study with 
data spanning 10 years from 6 countries and 10 different centres. This study concluded 
that as the numbers of radial and femoral access procedures in a centre became 
equivalent, DAP values became equal, demonstrating a learning curve with the 
technique.(49) In addition, Gray et al found no difference in DAP with radial access 
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compared to femoral access in a high volume centre.(50) In 2017, a French national 
multicentre study by Georges et al found lower doses with radial access (RAY’ACT-1) with 
over 55,000 patients in the cohort. It also demonstrated that in centres where both radial 
and femoral access routes were used, doses were lower with femoral access compared to 
radial for CA and PCI and that dose was related to the rate of radial vs femoral access.(51) 
However, one study by Norgaz et al in 2012 found that left radial access was associated 
with less fluoroscopy time than right radial access in a randomised trial of 1000 patients, 
though DAP was not significantly different.(52) 
Patient factors 
Patient obesity was demonstrated to impact on radiation dose in 2007, in an abstract at 
the Cardiac Society of Australia and New Zealand (CSANZ) annual scientific meeting. 
That study found that obese patients had a significantly greater DAP than normal weight 
patients.(53) Shah et al performed a similar study, published in 2015, with 3750 patients 
and demonstrated how obese patients record a DAP 2.5 times greater than normal weight 
patients and patients with a BMI >40 kg/m2 receive a DAP that is four times greater than 
normal weight patients.(54) BMI therefore has a large impact on a patients’ radiation dose. 
Biplane angiography 
The use of biplane angiography and the impact on radiation dose has not been reported 
that many times in the literature. Biplane angiography offers the benefit to the patient of 
taking 2 cine acquisitions for a single contrast media injection, thus reducing contrast load. 
This aspect is of interest because at the authors centre, both cardiac angiography suites 
are of the biplane type. Sadick et al investigated the use of Biplane imaging for PCI 
procedures and demonstrated a 36% higher DAP for biplane procedures than single 
plane. Surprisingly, there was no significant difference in contrast load between biplane 
and single plane procedures. (55) Lin et al investigated radiation doses during diagnostic 
biplane procedures and found that radiation doses were 17% higher for biplane than single 
plane and were significantly higher for all variables studied.(56) Smith et al investigated 
biplane imaging for coronary angiography in 2018, using multivariate analysis in 5176 
patients, the largest cohort to date. Their findings indicated that there was a 28% reduction 
in contrast media, at the expense of a 23% increase in radiation dose.(57) These studies 
suggest that biplane imaging has a significant impact on radiation dose but to the author’s 
knowledge, there is no data on the impact of biplane imaging on operator dose.  
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Operator experience 
Education of staff, particularly the primary catheter operator is another important factor to 
consider. In 2009 Georges et al investigated the effect of a two day education course on 
DAP during CA and PCI procedures in addition to  equipment protocol changes and 
reducing the number of ventriculograms. They reported a 50% reduction in DAP after the 
course and the changes in protocols. Interestingly, the lowest doses were seen in the 
three months immediately after the course, with a rebound effect seen after time that and 
doses increased again.(58) This would indicate that there is possibly a need for ongoing 
education and at least an annual refresher would be necessary, as is the current status in 
Queensland hospitals. 
Staff member operating the equipment 
Some cardiac catheterisation laboratories have the cardiologist operating the X-ray 
equipment and some employ a radiographer to operate this aspect of the angiography 
procedure. There is limited literature as to the most effective method of working, however 
one study by Arthur et al, published in 2002 found that there was no difference in the 
fluoroscopy times and dose whether cardiologists or radiographers controlled the exposure 
but there was less during digital acquisition mode when the cardiologist was controlling its 
operation.(59) 
Multiple factors 
Christakopoulos et al measured a multitude of factors predicting radiation dose in 748 
CTO procedures across 9 US centres in 2017. They found that a higher BMI, prior 
coronary bypass surgery, calcification and long occlusion length were predictors of high 
radiation dose under univariate and multivariate analysis. This is important, as CTO 
procedures are associated with long fluoroscopy times and radiation doses. Median air 
Kerma in this study was high: 3.4 Gy.(60) Understanding which factors predict higher 
doses during cardiac angiography is of utmost importance, and this study highlights some 
of the factors that can impact on this. 
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1.3 Occupational radiation dose for the catheter operator 
Staff who perform cardiac angiography and intervention are also exposed to radiation in 
the cardiac catheter laboratory. This includes the primary operator who inserts and 
manipulates catheters in the heart, their assistant and other staff that are present with the 
procedures. The number of staff required for these procedures may also increase as the 
complexity increases. Considering the length of time that many may work in this 
environment, recording their exposure and reducing their exposure are important 
considerations. In addition their radiation dose needs to be kept within acceptable limits.(7) 
With regard to staff radiation dose; the concerning series of papers by Roguin et al 
investigating brain and neck tumours amongst interventional physicians using 
fluoroscopy(61-63) found that left sided tumours were more likely than right sided 
tumours,(63) which is important as most of the time, the operator’s left side faces the 
radiation and the associated backscatter. Whilst the radiation was not established as the 
source of the malignancy, it is a significant body of work that raises awareness of the risks 
of radiation to personnel working in this field. Attributing the risks of occupational radiation 
to an increased risk in cancer in the modern era is difficult, though the study by Andreassi 
et al in 2016 did demonstrate this. Using a structured questionnaire at a Cardiology 
conference in Italy, delegates answered a series of questions on their health status and 
health history, and they were grouped as either cath lab workers or non cath lab workers, 
which was the control group. The study found that cath lab workers were at a higher risk of 
skin lesions, cataracts, depression, orthopaedic problems and thyroid disease in 
comparison to the control group. There was also an increase in the risk of skin lesions, 
hypertension, hypercholesterolemia and importantly cancer across years of working.(64) 
This important paper highlights the risks to those working with radiation in comparison to 
those who do not. 
Radiation is generally understood to be a linear, no-threshold relationship to cancer, 
meaning that as the amount of exposure increases, the risk of cancer also increases, 
though the severity of the cancer is not related.(7) As a result, it is recommended by the 
ICRP that all personnel that work in a cath lab should be monitored with calibrated 
dosimeters that are read on a regular basis. High radiation dose should then be 
investigated if it occurs.(7) The problem that this type of monitoring has is that it does not 
highlight when the high dose was received, and whether it was an false reading after 
leaving the dosimeter in the cath lab for a period of time instead of in the correct storage 
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location or whether the high dose was genuine and was attributed to when the staff 
member was working in the cath lab. Measuring radiation on a case by case basis has the 
advantage of highlighting where and when higher than usual radiation doses were 
received. However, most of the reported literature relate to small prospective studies 
investigating the effect of only one particular variable. For instance, one of the earliest 
papers investigating access route and operator dose was by Brasselet et al in 2008, when 
they studied radiation dose to the patient and operator during radial and femoral artery 
access routes. In 420 procedures, the patient dose for radial artery access was associated 
with a 65.8% higher dose for CA and 28.2% higher for CA with ad hoc PCI than femoral 
artery access. Operator dose, however, was the primary outcome of this study and was 
determined with two electronic dosimeters. Patients were heavier in the radial group, 80 vs 
76 Kg, which could have contributed to the higher doses. Radial dose for CA was 29 µSv 
for radial and 13 µSv for femoral artery access. They did comment on how operator dose 
was ‘strikingly related’ to patient exposure (r=0.68 for radial and r=0.62 for femoral CA). 
They also commented that there were other variables that were related, such as procedure 
duration and fluoroscopy time and that BMI was related to DAP but surprisingly not 
operator dose.(43) This is one of many studies investigating arterial access location and 
the impact on radiation dose to the operator. 
Effective dose 
Staff dose is measured using calibrated dosimeters. For an interventionalist this should be 
between 2 and 4mSv per year.(7) Effective dose is derived from the calculation of dose to 
each specific organ.(7) Different organs have different tissue weighting factors, meaning 
that certain organs are more sensitive to radiation than others. The breasts, colon, lung, 
stomach and bone marrow are particularly sensitive.(65) However, Brain tumours appear 
to be of particular concern.(63,65) In addition, the lens of the eye is also of concern, 
cataracts can form and are seen in up to 50% of interventional cardiologists.(65) 
Impact of arterial access route 
Dominici et al investigated radiation exposure to the operator in 2013 when comparing left 
versus right radial approach, in a randomised controlled trial of 413 patients. They 
discovered that even though there was no difference in DAP between the two arms, 
operator dose was significantly lower with the left radial approach. Average operator 
radiation dose was 33 and 44 µSv for left and right radial approach respectively.(66) 
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In a further randomised controlled trial, in 2015, Michael et al studied 128 eligible patients 
who underwent angiography and who had had previous bypass surgery. In that study 
contrast media volume was the primary endpoint and radiation dose to the patient and 
operator was a secondary endpoint. Contrast media volume was higher for radial access 
and fluoroscopy time was higher for radial approach, though air Kerma was not 
significantly higher. There were two operators for each procedure, operator one received 
26, mrem for radial access and 1.3 mrem for femoral access. The second operator was 
also significantly higher, 18 vs 0.8 mrem.(46) 
In the REVERE trial, Pancholy et al, randomised patients to left radial, right radial and right 
femoral approach, with almost 500 patients in each arm. They obtained a different result 
for this situation from Dominici et al and found that the left radial approach was associated 
with a significantly higher operator dose than the other access routes. In addition, the less 
experienced operators demonstrated a higher operator dose, highlighting the impact that 
operator experience has on radiation dose to operator. This study used the InstadoseTM 
instantly downloadable dosimeter.(47) 
A sub-arm of the MATRIX trial, (which investigated bleeding in radial vs femoral approach 
PCI during acute myocardial infarction) was the RAD-MATRIX study, published in 2017, 
where operators wore dosimeters when patients were randomised to either radial or 
femoral approach. There were 777 patients, intervened on by 18 operators. DAP was the 
same in both groups but thorax dose was significantly higher in the radial group. 
Calculated effective dose was also higher: 2.3 vs 1.2 uSv. Thorax dose was also 
significantly higher when normalised to DAP. A sub group analysis investigating left vs 
right radial access found that operator effective dose was higher with right radial access 
but was non-significant when normalised to DAP.(67) 
The RAD-MATRIX results are confirmed by the RADIO study (Kallinikou et al 2016) in 
which 830 patients undergoing CA with PCI were performed either radial or femoral. They 
found that right radial and left radial procedures delivered a higher dose to the operator 
when normalised to DAP than the femoral approach. Right radial dose was higher than left 
radial. Interestingly in this study, additional radiation protection was used, by means of a 
lead equivalent drape around the access site.(68)  
Shielding solutions for staff 
Staff that work in the cath lab need to be protected from the occupational backscattered 
radiation dose. Staff should wear a lead or lead equivalent apron that covers the torso and 
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the primary operator should wear a lead thyroid collar and lead glasses.(69) Standard 
shielding solutions in cath labs consist of a lead drape hanging from the table side and a 
ceiling suspended lead acrylic shield.(2) The effectiveness of the ceiling suspended shield 
has been documented recently: In 2017 Jia et al used real time dosimeters, a phantom 
patient and manikins to measure the effectiveness of the radiation shield and concluded 
that the ceiling suspended shield reduces radiation dose to the primary operator by up to 
90%. In addition, they demonstrated that LAO projections produced more radiation dose 
for the operator and that having the ceiling suspended shield close to the operator gave 
the best protection.(70) Even though this study appears simplistic, it is important as it 
demonstrates both the effectiveness of the shield and where best to position it to be as 
effective as possible, with the shield giving the best protection when closest to the 
operator. In 2015, Eder et al demonstrated that changing the design of the lead acrylic 
shield can reduce radiation dose if strips of lead are attached to the lower edge of a 
slightly larger shield. Dose to the operator can be reduced further if lead drapes are placed 
on the patient.(71) 
Given that generally, radial access has been associated with higher radiation doses to the 
operator, additional shielding devices have been developed to counter this trend. In 2010 
Behan et al designed a special radial arm support with inbuilt radiation protection by way 
of a vertical 20cm high piece of polycarbonate, with a sheet of 0.5mm lead rubber glued to 
it. In 106 patients, this simple device reduced radiation dose from 19 to 12 µSv for 
diagnostic CA and 61 to 23 µSv for elective PCI, without changing any other factors and 
with a similar DAP in each group.(72)  
In 2012, Ertel et al investigated different shapes of lead protection that were placed on the 
phantom patient under controlled conditions. All lead drapes gave the same 0.28mm of 
lead equivalency and they found that all shapes of lead drape significantly reduced the 
radiation to the operator. The L shaped device gave the greatest protection to the 
operator, reducing the dose to the operator by 72% in comparison to the other shaped 
drapes that gave 65% and 58% respectively.(73) In addition, Liu et al demonstrated in 
2014 that when optimal radiation protection was in place, radial access gave a lower torso 
radiation dose to the operator than femoral access under a phantom simulation. They did 
find, however, that the hand dose of the operator was higher with radial than with femoral 
access.(74)  
Also in 2012, Lange et al performed a small single centre study on 305 patients and 
demonstrated again that radial access operator dose was higher than femoral access dose 
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when no additional shielding was in place. However, they demonstrated that with shielding 
in place, by way of a pelvic drape, DAP normalised dose was reduced by the same 
amount in each group, concluding that even with shielding in place, radial access gave a 
higher operator dose than femoral access.(75) 
Musallam et al demonstrated a threefold reduction in radiation dose to the operator with 
pelvic shielding on the patient in a randomised controlled trial. The study was published in 
2014 and enrolled 322 patients. They demonstrated that with a sheet of lead rubber placed 
on the patient’s pelvis and thighs, operator dose was reduced significantly. However, 
radiation to the patient, as measured beneath the apron was twice as high. The authors 
concluded that the use of pelvic shielding should be further investigated before being 
adopted widely.(76) 
Other than shielding solutions, the 2014 RadiCure randomised trial by Christopoulos et al 
demonstrated another novel approach to radiation protection. The primary endpoint was 
operator exposure and they used an audible dosimeter that beeped at certain dose 
thresholds. It was worn on the front pocket of the lead apron. The 505 patients were 
randomised for whether the operator wore the dosimeter or not. First and second operator 
exposure was significantly lower (36% and 29% respectively) when the dosimeter was 
worn. The paper suggests that when the dosimeter beeped, it would trigger the operator to 
change their position, optimise the shielding, adjust the C-arm position or adjust the X-ray 
settings. This appears to be a low cost solution that does not impact on everyday practice 
but does reduce dose.(77) 
The use of lead goggles or eye glasses during angiography is recommended by the ICRP 
as the lens of the eye is relatively radiosensitive.(7) Vano et al found that 38% of 
Cardiologists had posterior lens opacification in their 2010 study of 58 interventional 
cardiologists and concluded that there was an urgency in educating interventional staff in 
radiation protection.(78) An early study in 1984 by Dash et al demonstrated a 35% 
reduction in radiation dose to the operators eyes with lead glasses during cardiac 
catheterisation.(79) Additionally, a study by Waddell et al in 2016 demonstrated a 90% 
reduction in eye dose measured during a phantom study with different styles of lead eye 
glasses during spine fluoroscopy.(80) 
Given that radiation to the operator’s brain has received significant attention,(63) lead 
equivalent protection caps have lately become available. A randomised controlled study 
investigated the effectiveness of these protection devices, published in a paper by Uthoff 
et al in 2015. Dosimeters situated inside and outside of the lead caps, which varied in 
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thickness demonstrated a 91.5% reduction in dose for the 0.3mm lead equivalence and 
97.1% for the 0.5mm lead equivalence.(81) This demonstrates the impact of additional 
shielding devices that can cover areas of the body that traditionally are not protected. 
Equipment settings 
In the same way that we have seen equipment settings reduce dose to the patient in CA 
and EP procedures, these settings will also reduce dose to the operator. Abdelaal et al 
performed a randomised controlled trial in 2014, and randomised 385 patients to have 
their radial access procedure performed at either 7.5 pps or the more traditional 15 pps for 
fluoroscopy and cine acquisition was kept at 15 fps in both groups. The results showed 
that for CA, average operator dose was 21 µSv for the 7.5 pps group and 35 µSv for the 
15 pps group. During PCI, these values were 45 and 63 µSv respectively. This 
demonstrates the impact that lower dose settings can have on operator dose, which would 
have a significant impact over many years of work.(29) 
Overall, the literature surrounding patient radiation dose and occupational exposure to 
staff performing cardiac angiography and intervention appears to concentrate on the 
primary operator. Also, they tend to investigate the radiation dose impact of only one 
particular variable, of which arterial access appears to be the most numerous. No study to 
date has investigated the multitude of different factors that would impact on radiation dose 
to the patient and the operator as a holistic all-encompassing approach. This is needed to 
understand radiation dose and which factors drive the higher doses in the cath lab. High 
doses to the patient and the operator need to be highlighted and the factors that led to the 
high dose should be investigated.  
In addition, the literature focuses only on the radiation dose to the primary operator. This 
stands to reason as the operator is the staff member that stands the closest to the X-ray 
source and the patient. Primary operators, usually the cardiologist performing the 
procedure, have tableside and ceiling suspended lead shields in place to protect them 
from the harmful effects of radiation. These are usually only in place on the right side of 
the procedure table, where the primary operator and their assistant stand. However, there 
are other members of staff who are also in the cath lab who are also exposed. Some also 
stand close to the patient, particularly during more complex procedures where anaesthesia 
is required. During percutaneous interventional procedures for structural pathology of the 
heart (including left atrial appendage (LAA) occlusion and MitraClipTM implants) require 
guidance with trans-oesophageal echocardiography (TOE) in addition to fluoroscopy 
(4,82). The echocardiographer or cardiologist who performs the TOE stand relatively close 
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to the patient and the X-ray c-arm, as it is necessary for this form of imaging. This exposes 
the echocardiographer and/or echocardiologist who operate the TOE probe and console to 
the harmful effects of scattered ionising radiation. Whilst the literature has highlighted the 
risks of radiation to the staff performing fluoroscopically guided cardiac procedures 
(63,64,78), none of these studies were inclusive of radiation dose to other staff in 
attendance, and particularly the TOE operators in this environment. There is often no 
specific additional protection installed at the head end or left side of the procedure table 
where the TOE operator would stand. Recent guidelines issued in 2014 by the American 
Society of Echocardiography have highlighted the risks of radiation to TOE operators and 
the lack of evidence surrounding radiation dose to TOE operators (83). As with all staff 
working in the cath lab, they are monitored with optically stimulated luminescent 
dosimeters (OSL) that are interrogated on a monthly basis. While all staff wear these 
dosimeters, they do not demonstrate how much radiation dose each staff member may 
receive on a case by case basis.  
Knowing the close proximity of the TOE operator to the scattered radiation source, the 
authors thought it prudent to measure and monitor radiation doses to TOE operators and 
the other staff in attendance during these complex and lengthy procedures that use 
moderately high levels of fluoroscopy and radiation. Boland et al had demonstrated that 
radiation DAP levels for structural interventional procedures, including TAVI, were 
consistent with those for PCI procedures.(84) This was an important body of work as it had 
not been previously performed.  
Radiation doses to personnel in attendance for surgical access TAVI procedures was 
performed in a small study by Drews et al in 2014. In that study, the anaesthetist 
performed the TOE. As such, the dose to a dedicated TOE operator has not been 
performed to date in a larger study.(85) Doses to other members of staff that are in 
attendance for these kind of procedures should be investigated in this rapidly changing 
environment. 
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1.4 Radiation dose reduction in electrophysiology procedures 
Electrophysiology (EP) procedures, where electrical conductivity of the heart is measured 
and treated, are traditionally seen as high dose procedures, due to the relatively long 
fluoroscopy times. A study by Tsapaki et al demonstrated that with high fluoroscopy times, 
the total dose (KAP/DAP) was highest for radiofrequency ablations (RFA) and higher than 
for PCI procedures.(86) Smith et al investigated this in more detail, breaking down the 
RFA procedures into groups and compared against diagnostic coronary angiography, 
which was higher than most RFA procedures, with the exception of ablation for atrial 
fibrillation, which was higher. A large meta-analysis was performed by Pantos et al in 2009 
who investigated radiation doses from 72 cardiac publications. The findings in that study 
differ somewhat to those above. It found 17 studies related to RFA procedures and quoted 
an average DAP value of 54.6 Gycm2 and a fluoroscopy time of 45.8 minutes, compared to 
4.7 minutes and a DAP of 39.9 Gycm2 for CA. Average fluoroscopy time for PCI 
procedures in this analysis was 15 minutes, yet the DAP was 78.3 Gycm2. One of the main 
findings of this analysis was that there is a large variation in radiation dose values between 
studies. This leads to the comparative differences in the literature when comparing CA and 
PCI doses to RFA. 
Radiation dose reduction for patients undergoing cardiac angiography, intervention and 
electrophysiology can be achieved in many ways. Firstly, establishing whether the patient 
needs the examination performed is essential,(7) and informing the patient of the risks and 
obtaining their consent is also important.(2,7) In a more practical way, during procedures, 
minimising beam on time, using correct X-ray equipment settings and beam geometry is 
crucial. In addition, using modern X-ray equipment, that is well maintained and has good 
radiation dose reduction features are also important.(2)  
Some simple changes can significantly reduce radiation dose during electrophysiology 
procedures. For example; Walters et al demonstrated in 2012 that by simply collimating 
the X-ray beam during procedures, with seemingly no other changes can reduce the 
radiation dose rate by 37% for simple ablation procedures.(87) 
Removing the stationary grid 
There are other ways in which radiation dose can be reduced, such as removing the 
stationary grid, which has been demonstrated previously several times.(39,88,89) The first, 
as previously mentioned in chapter 1.2, was by Partridge et al in 2006, who compared 
radiation doses and image quality during coronary angiography and intervention with the 
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grid in and with the grid out.  For the grid out procedures and air gap was used to minimise 
image noise. Similar image quality was obtained for approximately a 50% dose reduction 
during CA.(39) The second study by Rogers et al removed the stationary grid and a low 
frame rate protocol was used as a combined approach to reduce dose for 
electrophysiology procedures. This study also demonstrated significant decrease in 
radiation dose with this method of dose reduction; up to 65% with phantom measurements 
and a similar reduction under clinical practice.(88) 
X-ray equipment optimisation 
Optimising X-ray equipment settings can have dramatic effects of radiation dose. Primarily, 
this is driven by how much radiation the X-ray machine uses to create an image and the 
number of pulses of radiation that is made per second. The equipment can either be 
configured by the manufacturer and in some cases the end user can adjust these factors 
to optimise the image.  
The routine use of collimation is also advocated in review and consensus 
publications.(2,7,69) Walters et al demonstrated practically what results can be obtained 
through effective collimation during electrophysiology procedures. Their study compared 
the reduction through collimation strategies made by one operator in comparison to three 
other operators that did not routinely use beam collimation. The study demonstrated a 
37% reduction for simple RFA and 12% for complex ablation procedures and advocated its 
routine use.(87) 
Cardiovascular X-ray systems with image intensifiers adjust the image quality using an 
automatic brightness control system within the image intensifier.(2) On the other hand, 
some more modern cardio-vascular X-ray systems can be configured to alter many 
different factors of the x-ray beam. The number of x-ray pulses per second, the number 
and the penetration power of the x-ray photons and even the contrast and edge 
enhancement of the resultant image can all be adjusted mid procedure. Together, these 
beam properties will affect the overall radiation dose as well as the resulting image quality. 
In order to achieve low dose procedures in electrophysiology, an X-ray system’s 
fluoroscopy pulse rate can be substantially lower and the dose per pulse can be lower than 
for coronary imaging. A fluoroscopy dose rate of 2 or 3 pulses per second is advocated by 
Heidbuchel et al in their 2014 practical guide in the European Heart journal. (69)  
Reducing the pulse/frame rate has been reported in multiple publications, though these 
were usually part of a multitude of changes to practice to produce a dose reduction. 
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Schneider et al reduced their frame rate from 7.5 pulses per second (pps) to 4 pps in 
addition to shorter cine times and greater use of the 3 dimensional mapping system. A 
90% dose reduction was obtained with these strategies implemented, though it is not 
certain what proportion is attributed to the lower pulse rate.(90) Rogers et al reduced their 
frame rate from 12.5 pps to 6.25 pps and in addition removed the stationary grid, achieving 
a 65% dose reduction.(88) Using a similar methodology, in 2017, Attanasio et al reduced 
the pulse rate from 4 to 2 pulses per second, lowered the detector dose and removed the 
stationary grid. This resulted in a 73% for cardiac rhythm device implants.(91) The study 
by Nof et al, in a cohort of 212 patients used a lower dose per pulse protocol to 
demonstrate that doses for EP procedures could be lowered by 62% and that other factors 
such as LAO projections and high BMI patients significantly impacted on dose.(92) 
However, one study by Bourier et al in 2015 only changed the X-ray settings, by lowering 
detector input dose used by the X-ray system from 23nGy per pulse to 8nGy per pulse for 
fluoroscopy. They also reduced the cine dose from 120nGy per frame to 36nGy per frame. 
In addition, they used fluoroscopy pulse rates of just 3 pps and cine frame rates of 7.5 fps. 
The result was that for ablation procedures, overall radiation dose was reduced by 77%. 
However, the study did not include other procedures, such as pacemakers and CRT 
device implants but it does demonstrate that radiation dose per frame can be reduced to 
much lower levels that previously used.(93)  
Three-dimensional mapping 
The use of three-dimensional mapping in RFA has demonstrated some significant 
reductions in radiation dose and fluoroscopy time. The NO PARTY randomised controlled 
trial published in 2016 demonstrated the effectiveness of 3D mapping and the impact on 
lowering radiation dose during SVT ablation. This was an important study as it used Monte 
Carlo simulation for calculation of effective doses and lifetime attributable risk of cancer, 
the only study to do so on this topic. It estimated that the lifetime attributable risk of cancer 
was reduced by 96% with the use of 3D mapping.(94) Early et al demonstrated that 3D 
mapping can significantly reduce the radiation dose for ablation procedures as early as 
2006, with the Nax X (St Jude medical, St Paul, MN, USA) system demonstrating the 
greatest reduction in radiation dose when compared to no 3D mapping and to the Carto 
system (Biosense Webster, Diamond Bar, CA, USA). (95) Other studies have 
demonstrated that ablation can be performed without any fluoroscopy at all, such as the 
2010 study by Reddy et al, who demonstrated that ablation of atrial fibrillation can be 
achieved using just intra cardiac ultrasound and 3D mapping, using the Nav X system. 
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(96) Using the UNIVU (fluoro integrated three dimensional electroanatomical mapping 
system) module, as an add on capability to the Carto system and can aid non-fluoroscopic 
imaging during electrophysiology procedures, as it uses pre-recorded fluoroscopy to 
superimpose the 3D map onto. Huo et al demonstrated a 73% reduction in radiation dose 
using the Carto 3 (Biosense Webster, inc, Diamond Bar, CA) system, from 2440cGycm2 to 
652 CGycm2 for AF ablation procedures in a randomised controlled trial.(97) The same 
system, in a separate study by Christoph et al in 2015 demonstrated similar reductions in 
radiation dose across a multitude of different ablation procedures.(98)  
Magnetic guidance systems 
Other non-fluoroscopic magnetic guidance systems, such as the MediguideTM system 
(MediguideTM, St Jude Medical, St Paul, MN, USA) have also recently emerged as 
additional technologies that allows catheters to be displayed in real time. It uses pre-
recorded fluoroscopic loop images and electromagnetic signals, without further use of 
fluoroscopy.(99) The resulting radiation dose reductions resulting from using the 
MediguideTM system are impressive. In 2013 Vallakati et al reported that their dose 
reduced by 62% using MediguideTM for supraventricular tachycardia ablations.(100) 
Sommer et al, also in 2013, saw a greater reduction in fluoroscopy dose, from 996 to 187 
CGycm2 during the same types of ablation procedures for supraventricular 
tachycardia.(101) In 2014 Sommer et al again reported similar radiation dose reductions 
using MediguideTM  for atrial fibrillation ablation procedures in 375 patients.(102)  
For Biventricular cardiac resynchronisation therapy (CRT) devices, Butter et al established 
radiation doses for these procedures. They demonstrated results of 20.3min and 11100 
CGycm2 for conventional fluoroscopy guided implants in their study of radiation dose 
associated with these devices.(103) However, Doring et al implemented the MediguideTM 
technology to reduce radiation dose during CRT device implantation in a small series of 71 
patients. Of those 71, 34 patients were matched against 34 patients that underwent 
conventional CRT device implantation using traditional fluoroscopy. It demonstrated a 
significant reduction in radiation dose (338 vs 603 CGycm2) using the MediguideTM 
system, both of  which are far lower than that of Butter et al.(104)  Again using the 
MediguideTM system, in conjunction with a low dose protocol, Thibault et al demonstrated a 
more impressive 95.9% reduction during CRT device implants.(105) These systems have 
added significantly to radiation dose reduction in these relatively high dose procedures but 
they do, however, change working practices and add additional cost to EP laboratory 
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installations, in addition to the ongoing consumable costs by way of catheter purchase, 
which must also be considered. 
New X-ray system technology 
Using new X-ray technology has seen radiation doses reduced significantly, for a range of 
electrophysiology procedures, without significantly changing working practices.(106,107) 
Dekker et al demonstrated that doses can be reduced by up to 43%, whilst maintaining 
image quality, simply through using image processing technology, introduced by one X-ray 
equipment manufacturer.(107) The same technology was also reported on in 2017 by 
Sharma et al, who also found significant radiation dose reductions(108) and by Van Dijk in 
2016 who saw a 69% reduction in radiation dose with this same type of system. (109) 
Other than these three publications, measuring the radiation dose reduction after 
implementing newer X-ray systems is distinctly lacking in the literature. In addition, the 
radiation doses reported in these studies are not particularly low.   
Given the high fluoroscopy times and high doses reported for electrophysiology 
procedures, they seem an obvious group of procedures to investigate the effectiveness of 
using more modern X-ray equipment, with low radiation dose settings.  
As we can see, reducing radiation dose in EP is complex and multi-factorial. An example 
of a study that has tied all the dose reduction elements together is that by Thibault et al, 
published in 2017.(110) They investigated the reduction in radiation dose to patients and 
staff in their three EP laboratories over a four year period. Changes were implemented in 
training and awareness, reducing fluoroscopy pulse rates, dose per pulse and investing in 
3D mapping and magnetic guidance systems. This was in addition to new X-ray 
equipment. An 85% reduction in overall DAP was seen across all procedures and in 
addition, the operator radiation dose was also significantly reduced over that period.(110) 
This demonstrates what is achievable with a consistent focus on multiple radiation dose 
reduction strategies. 
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1.5 Contrast media and acute kidney injury in TAVI procedures. 
Iodinated contrast media (ICM) is critical to performing angiography. Injecting this liquid 
enables physicians to visualise veins, arteries and structures throughout the body. It is 
generally inert and is excreted by the kidneys. It is, however, toxic to the kidneys.(14) 
McCulough described contrast media and its effect on renal function in a paper published 
in 2008.(14) Chronic kidney disease (CKD) is usually a requirement for the development of 
acute kidney injury (AKI), which is usually identified as a serum creatinine of >1.0 mg/ml in 
women and >1.3 mg/dl in men. There is a release of adenosine, endothelin and other 
vasoconstrictors triggered by ICM, which reduces blood flow and the stasis of ICM in the 
kidney tubules can cause renal tubular cell injury and death. Medullary hypoxia and 
ischemic injury also results. If this is added to by hypotension, showering of artheroembolic 
material, or bleeding, this can amplify the process.(14) This is particularly relevant during 
TAVI procedures, as moderate volumes of ICM are required for device implants. In 
addition, there are periods of hypotension, caused by rapid burst pacing and there may be 
showering of artheroembolic material during the procedure. ICM is needed to accurately 
align the valve plane and position the TAVI device. In addition, the femoral arteries need to 
be imaged with ICM for device access and to ensure that there is no vascular injury after 
the large sheath is removed. Patients are often elderly and present with multiple co-
morbidities, including renal impairment and CKD.  
When reviewing the literature for AKI in TAVI procedures, the majority of studies use the 
RIFLE criteria to define AKI, which is outlined by the publication by Bellomo et al in 
2004.(111) This criterion was created by the Acute Dialysis Quality Initiative group (ADQI). 
It created a five-tier classification system, starting with Risk, followed by Injury, then 
Failure, then Loss and finally End stage renal failure. Serum creatinine levels and urine 
output are used as quantifiable measures to classify the level of AKI against the RIFLE 
criterion.(111)  
In assessing AKI induced by the TAVI procedure, Aregger used the RIFLE 
classification,(112) and Bagur et al also used the RIFLE criteria in their 2010 study. (>25% 
reduction in estimated glomerular filtration rate (eGFR) at 48 hours post procedure). The 
valve academic research consortium (VARC-2) outline classifications and inclusions for all 
TAVI related outcomes and complications. Their criteria outlined in the 2013 publication by 
Kappetain et al include a definition of the stages of AKI, which is also based on the RIFLE 
classification. The AKI definitions outlined by the VARC-2 are stated as an increase in 
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serum creatinine of 150-200% (stage 1), 200-300% (stage 2) or >300% (stage 3).(113) 
Other studies have used different scoring systems to define AKI in relation to contrast 
induced nephropathy (CIN). For example, Madershahian et al used the European Society 
of Urogenital Radiology guidelines in their 2014 study of CIN during TAVI, which used an 
increase in serum creatinine of 25% or greater over three days after exposure to Iodinated 
contrast media, which is the same as the RIFLE classification.(114) It is therefore 
important to use a common classification system or at least have an awareness of any 
differences in classification systems when comparing outcomes of AKI in the literature. 
Because of the relationship between ICM and AKI, accurate documentation of the total 
volume of contrast media used for the TAVI procedure is very important. Total contrast 
media volumes used for TAVI procedures vary greatly in the literature and the impact that 
contrast media has on acute kidney injury for TAVI is not entirely conclusive. One of the 
first studies that reported on acute kidney injury (AKI) was that by Aregger et al in 2009 on 
58 TAVI patients. They reported a 28% incidence of AKI, which under multivariate logistic 
regression was associated with a surgical approach, thrombopaenia and pathalogical 
leucocyte count. Interestingly, iodinated contrast media volume (ICM) was not significantly 
higher in patients that suffered AKI.(112) This finding was similar to that in the study by 
Bagur et al in 2010. In their study of 213 patients, average contrast media volume was 97 
cc and AKI incidence was 11.7%. Again, ICM volume was not significantly different 
between those that had AKI and those that did not. AKI was an independent risk factor for 
mortality and was associated with hypertension, chronic obstructive pulmonary disease 
(COPD) and the requirement for blood transfusions.(115) Kong et al demonstrated a 
higher median volume of 219 cc in their cohort of 52 patients undergoing TAVI in 2012. In 
their population, 15 patients had acute kidney injury (AKI) and AKI was associated with 
procedural technique and blood transfusion. The contrast media volume in the AKI group 
was higher (279 cc vs 216 cc), though it did not reach significance (p=0.50).(116) Vontobel 
et al went a step further in assessing contrast media induced AKI in their 2015 publication. 
In that study, contrast media volumes associated with the pre-operative computed 
tomography (CT) scan and angiography, in addition to the contrast media volume used for 
the TAVI procedure were assessed. In 257 patients, AKI occurred in 31 patients. Median 
ICM volume including that within 5 days prior to TAVI, and the TAVI procedure was 
relatively low at 144cc and again there was no significant difference in contrast media 
volume between those that had AKI and those that did not (154ml vs 139.5 ml, p=0.77). 
(117) Finally, a meta-analysis by Thongprayoon et al in 2016 which specifically analysed 
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four studies that investigated the impact of contrast media volume on AKI found that ICM 
volume was not likely to play a role in TAVI related AKI.(118) 
The use of iso-osmolar contrast media (IOCM) has previously been associated with lower 
rates of contrast induced nephropathy in patients with poor renal function by in a meta-
analysis by McCullough et al in 2006.(119) However, Reed et al performed a meta-
analysis, including 2763 subjects from 16 randomised controlled trials, suggesting that 
ICOM is not associated with contrast induced kidney injury.(120) Heinrich et al also 
performed a meta- analysis in 2009 and also concluded that of 25 trials identified, IOCM 
was not associated with lower rates of contrast induced nephropathy (CIN).(121) In TAVI, 
only one study has compared IOCM with low osmolar contrast media (LOCM). That study, 
by Chatani et al in 2015, compared 203 patients, half with ICOM and half with LOCM. 
Though not randomised, there was equal amounts of contrast media administered (269cc 
vs 288cc p=0.12) and there was no significant difference in the rates of AKI between the 
groups. Only the pre-procedure creatinine level was predictive of AKI in that study.(122) 
  
In an effort to reduce the incidence of AKI, forced diuresis has been assessed in patients 
undergoing TAVI using the Renal-guard system. A publication by Barbanti et al in 2015 
outlined the concept of the Renal-guard system, which is one of inducing diuresis with 
Frusemide (0.25mg/kg) to achieve a urine flow rate of 300ml/hour. This is matched with 
isotonic intravenous hydration.(123) This system was compared in a randomised trial 
(RPOTECT-TAVI) to standard hydration. The Renal-guard group had an AKI rate of 5.4% 
vs 25% in the control group, demonstrating its effectiveness.(123) Visconti et al also 
investigated the Renal-guard system in 2015, in 22 patients versus 26 patients that were 
the control group. The Renal-guard group were those with renal impairment and they 
found that AKI was present in 38.5% of patients in the control group vs 4.5% in the Renal-
guard group. This is particularly interesting because the Renal-guard system was used 
only in patients with renal impairment, whereas the control group did not have renal 
impairment.(124) Chorin et al also investigated the Renal-guard system in their 2017 
publication. Their study investigated the Renal-guard system during 150 CA, PCI and TAVI 
procedures against a patient matched population that did not use the Renal-guard system. 
They found that the Renal-guard system reduced AKI in all procedure groups. 
Interestingly, they also found that the volume of ICM did not correlate to AKI 
incidence.(125) A meta-analysis of the Renal-guard system was performed in 2017 by 
Putzu et al and included 4 randomised studies investigating the effectiveness of the 
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system. The overall finding was that the Renal-guard system reduced contrast-induced 
AKI in patients with renal impairment prior to coronary procedures and all patients 
undergoing TAVI. It noted, however, that further randomised controlled trials should be 
performed.(126) 
Patient gender may also play a part in AKI. In 2014 Madershahian et al investigated the 
relative risk of CIN in females to males with pre-existing renal impairment during trans-
apical access TAVI. Their study found that women received more contrast media than men 
when compared to their body size and that CIN was higher in women than men and was 
associated with a higher 60 day mortality. Their study cohort, however was relatively small 
(n=55) which made extensive univariate and multivariate analysis difficult.(114) 
Rather than focusing on AKI, Faillace et al investigated whether there may actually be an 
improvement in renal function following TAVI. Their 2017 study of 69 patients using the 
VARC 2 criteria found that overall, more patients saw an improvement in renal function 
than renal dysfunction and that 90% of patients left hospital with similar renal function or 
an improvement in real function.(127) There is a lack of evidence of contrast media usage 
and AKI rates in TAVI procedures in Australia and this should be investigated. 
Looking to the future: TAVI has been successfully reported without using any contrast 
media. Eskandari reported in 2016 how they used fluoroscopy and echocardiography 
using the Echonavigator software developed by Philips Healthcare. This software overlays 
the 3 dimensional Trans Oesophageal Echocardiography (TOE) images onto the 
fluoroscopy image, negating the need for visualisation of the aortic anatomy with ICM. In 
their report, two procedures were performed using this technique and both had no change 
in their renal function.(128)  
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1.6 The use of rotational angiography during TAVI procedures 
The iliac and femoral arteries are the access route of choice for trans-catheter aortic valve 
replacement (TAVI), as this percutaneous option is less invasive than the surgical 
alternatives.(129) Assessment of the ilio-femoral arteries is therefore of utmost 
importance, as the size of the original TAVI delivery sheaths were large; 22 to 24 French. 
In the original PARTNER trial, vascular complications occurred in over 30% of procedures, 
(3) which highlights the importance of adequate imaging of these arteries prior to TAVI. As 
described by Delgardo et al in 2010; standard angiography (2D angiography) is a frontline 
tool in evaluating the femoral arteries but it does not provide information on the soft tissue 
structures, such as calcification. Multi-slice computed tomography (MSCT) on the other 
hand has benefits as it can provide information on the vessel size, degree of tortuosity and 
the vessel calcification.(129) In 2010, a guidance paper was published for assessing 
patients for aortic valve implantation by Kaleschke et al. They outlined the use of 2D 
angiography to assess femoral artery calibre and tortuosity and that biplane angiography 
would be superior to single plane angiography, as it may be better in assessing the vessel 
course and eccentricity.(130) With regard to multi-slice computed tomography (MSCT), 
their article suggests that MSCT should be performed if 2D angiography suggests 
suitability or if angiography is not available. It states that MSCT allows for precise 
measurements and an evaluation of the course of the artery and that 3-dimensional (3D) 
reconstruction may be useful. Their summary goes on to describe the usefulness of each 
of the imaging modalities.(130)  
Delgardo et al described echocardiography as the cornerstone of valvular imaging for 
TAVI and that at the time, there was ‘growing interest’ in MSCT. It did however comment 
that MSCT can evaluate the descending aorta and femoral arteries and that MSCT and 
MRI are the gold standard, as they give multi-planar imaging.(129) MSCT is described as 
the most comprehensive modality at assessing all aspects of TAVI imaging, though it does 
have issues with contrast loading in patients with renal impairment.(129) 2D angiography 
is however particularly useful in assessing the arteries post TAVI, as it can assess any 
residual bleeding post TAVI, as described by Lareyre et al in 2017.(131) 
Moving forwards to 2012 and Achenbach et al describe in an expert consensus statement, 
that the main indication for MSCT in TAVI is for evaluation of the access route, whether 
surgical or percutaneous in addition to assessment of the native valve anatomy.(132) In 
2013, Leipsic et al summarised the role of CT for predicting complications in TAVI. Again, 
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this publication highlighted the deficiencies of 2D angiography in imaging calcification and 
tortuosity. This publication highlighted the importance of MSCT in evaluating the ilio-
femoral arteries and that these arteries should be measured in the true cross section of the 
artery and not just in the transverse axial plane. Also, it describes the ability of MSCT to be 
able to adjust the ‘windowing’ of the acquired image to reduce partial volume averaging of 
calcified areas of the artery and that identification of horseshoe circumferential calcification 
as is a major predictor of vascular complications.(133) 
As discussed in the previous section, patients undergoing TAVI procedures are elderly 
with multiple co-morbidities, including renal impairment. Reducing the volume of ICM is as 
important during the patient work-up phase as it is during the TAVI procedure. Nietlispach 
et al demonstrated in 2009 that a direct injection to iliac artery using a pigtail catheter can 
significantly reduce the contrast volume required for imaging the ilio-femoral tree with 
MSCT. This was achieved by inserting a pigtail catheter during the angiogram examination 
and then transferring the patient to a CT scanner. Only 15-20 ml was required for the 
additional MSCT images, yielding additional information on the vessel lumen size and 
calcification.(134) 
At this time, the authors hypothesised using rotational angiography (cone-beam CT) to 
evaluate the ilio-femoral arteries. Rotational angiography can readily be performed as part 
of the femoral angiography examination, if the X-ray system supports it. Because the 
injection of iodinated contrast media (ICM) is direct, much lower volumes may be 
permitted. Rotational angiography, DynaCT, C-arm CT and cone-beam CT are different 
naming conventions for essentially the same imaging modality. It is the description of using 
the angiographic flat detector, found in many interventional suites, to create volumetric 
data sets by rotating it around the patient. Isotropic (multiplanar) reconstructions and 3D 
images can then be created.(135) Binder et al’s 2012 paper used rotational angiography 
(DynaCT) to evaluate the aortic root anatomy and determine an appropriate implant angle 
for TAVI. This was compared to MSCT and both modalities were then compared to the 
actual post implant projection. There was a significant correlation between the DynaCT 
projection and the MSCT projections. There was also a slight but significant difference 
between the modalities in terms of predicted implant angle, though this was deemed not to 
be clinically relevant.(136) 
Using rotational angiography to achieve a suitable implant projection was assessed in 
2012 by Poon et al.(137) That study used rotational angiography in the assessment of the 
aortic root to obtain a perpendicular imaging plane for implant of the TAVI device. In that 
71 
 
Crowhurst Thesis 2020  71 
 
study, patients underwent rotational angiography (DynaCT) as part of the TAVI procedure 
and a 3D image was created. Specialised ‘aortic valve guide’ software was used to 
determine an appropriate C-arm angle for the TAVI implant. The implant angle was also 
determined using MSCT and any differences were recorded. Using the post implant image 
as a guide, the appropriateness of the implant angle was assessed. The study found that 
peri-operative DynaCT was superior to MSCT at predicting an implant angle and it also 
found that those patients whose implant angle was not scored as excellent had a greater 
degree of paravalvular regurgitation. The study determined that DynaCT with the aortic 
valve guide software was more likely to achieve an excellent implant angle, thus 
demonstrating that the use of DynaCT could actually improve clinical outcomes.(137) 
DynaCT has been used in the assessment of arteries in other specialties. Nordon et al 
performed a study in 2010 examining the feasibility of using intra-operative DynaCT for the 
assessment of abdominal aortic aneurysm (AAA) repair. Their study on 20 consecutive 
patients assessed 17 specific morphological variables. They found that DynaCT was 
adequate in assessing the aorta prior to endo-vascular aortic repair (EVAR) and that it’s 
use may be particularly useful in the emergent setting. They did find, however that the 
detector size may be too small and that the image quality/resolution was not as good as 
MSCT. They found that its greatest limitation was in the assessment of the ilio-femoral 
arteries and the underestimation of calcification.(138) 
Wiegerinck et al published a study in 2014 which compared MSCT and angiography for 
the assessment of the ilio-femoral arteries. In 102 patients, 700 measures were taken with 
both MSCT and angiography. They used 3mensio software for the MSCT measurements 
and found that on average, MSCT measures were 1.7 mm smaller than angiography and 
that subsequently, 18 patients arteries were smaller than 6mm in diameter on MSCT. This 
excluded them from TAVI implant but these patients measured greater than 6mm on 
angiography. 15 of these patients went on to have a successful TAVI procedure via the 
femoral artery.(139) 
Okuyama et al demonstrated in 2014 that MSCT with contrast media was better able to 
predict vascular complications than patients who underwent non-contrast MSCT and 2D 
angiography. Their study also found that contrast MSCT and non-contrast MSCT both 
measured vessels slightly larger than on 2D angiography,(140) which is different to the 
findings of Wiegerinck et al (139). It appears that the differences in measurements 
obtained between modalities is still not definitive. 
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Further applications of DynaCT have been reported with regard to TAVI. In 2015, Abu 
Saleh et al described a technique of using co-registration technology to fuse the MSCT 
and non-contrast DynaCT images together. This was used in surgical access TAVI 
procedures. It allows the outline of the aorta and the ideal puncture site to be overlaid onto 
the fluoroscopy image. This aided the direct puncture of the aorta and was found to be 
accurate and its use led to a lower volume of contrast media being used in those 
cases.(141) 
DynaCT has also seen a role in the treatment of paravalvular regurgitation, using the co-
registration of MSCT and DynaCT images. Van Leer-Greenberg et al describe a case 
study in 2014 where the MSCT was used to identify the paravalvular leak location and by 
using DynaCT and co-registration the outline of the aorta and a marker identified the leak 
site. The C-arm was then positioned to ideally visualise the passing of a catheter across 
the leak site. The leak was then successfully closed without further complication.  This is a 
good example of the integration of the different modalities and was particularly useful in 
this case, as there were no radio-opaque anatomic markers on the valve in question. (142) 
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1.7 X-ray beam distortion in TAVI 
X-ray systems use a small focal spot size for a sharp image, which projects a beam of X-
ray photons. This beam is then collimated using lead filters to the desired size to project 
the X-rays photons onto the film plate or digital detector.(143) Objects near the edge of the 
image are projected onto the detector with photons travelling obliquely when compared to 
those at the centre of the beam. Consequently, these objects could appear distorted in 
shape when visualised on the image.(143) This is termed ‘distortion’ (143) or sometimes 
this is called the ‘parallax’ effect. According to Buckle et al, parallax is one of a number of 
illusions in radiology and can be helpful in some situations in radiography but also not 
helpful as it can degrade image quality. One example is the narrowing of disc spacing of 
vertebrae that are at the periphery on spine radiographs. Due to the divergent nature of 
the beam from a point source, the vertebrae size and position appear distorted.(144)  
The effect of distortion/parallax is apparent on plain film radiographs. Wells et al performed 
a study in 1991 investigating the effect of parallax in chest radiographs of children. This 
was performed in the assessment of a short trachea which is evaluated from antero-
posterior chest radiographs. Normally the tracheal bronchial carina on the air bronchogram 
is superimposed on the T4 or T5 thoracic vertebrae, depending on the child’s age. There 
was concern that the angle of the incident X-ray beam in relation to the patient could 
cause a mis-diagnosis of short trachea due to the divergent beam causing 
distotion/parallax. However, their findings using chest x-rays and also post mortem 
bronchograms demonstrated that beam angulations of up to 10 or 15 degrees would not 
cause sufficient parallax to significantly shorten the trachea in relation to the thoracic 
vertebrae. Therefore, the effect of parallax was not enough to cause incorrect 
interpretation of a short trachea in normal clinical practice.(145) 
In 1994, Rutherford et al reported that using the clavicle to position a central venous line 
was prone to error on antero-posterior mobile radiographs due to the parallax effect. 
Instead they proposed using the right main bronchus and trachea as a landmark as it is 
much closer to the superior vena cava than the clavicles. Using this technique they found 
that in 5 of 100 patients assessed, the tip of the central line had moved using the clavicles 
as a landmark on subsequent chest X-rays, though they had not moved using the right 
main bronchus and trachea landmark. They suggest that this change was due to parallax 
between the two radiographs in those patients.(146) 
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In 2008 Petilon et al evaluated the effect of parallax on a spine model and an implanted 
artificial lumbar disc. Their study found that moving the spine from the centre of the image 
or by angling the c-arm even by a small amount can give the impression of a poor implant 
position. Their finding suggested not using the spinous process to determine the midline 
position and instead use the borders of the vertebral body, which apparently was different 
to that laid out in surgical technique guide.(147) 
Matsushita et al proposed using parallax to create a 3 dimensional image for orthopaedic 
surgery in 1998. In their study, they developed a mobile C-arm which had two X-ray tubes 
and each X-ray tube fired separately in an alternate manner at 15 pulses per second onto 
the image intensifier. Using the parallax effect, when visualising the screen with 
specialised polarised glasses, a 3 dimensional image was created and this enabled the 
surgeon to insert inter-medullary nails without needing to move the c-arm. This was 
beneficial as it enhanced the surgeons visualisation of the bone and because the c-arm is 
not moved, it does not compromise the sterile field.(148) 
The effect of X-ray beam distortion on a TAVI device had not previously been described. 
The superimposed appearance of the TAVI device after implant is particularly important in 
confirming that the ascending aorta is perpendicular to the incident X-ray beam. Due to the 
divergent nature of the X-ray beam, the incident beam may be perpendicular at the centre 
of the image and objects in the centre of the image will not be distorted. However, as 
objects are moved further out from the centre, their appearance may be more distorted. 
This is particularly apparent with the TAVI device, as when they are imaged at the 
periphery of the field of view, their appearance may take on an appearance that would 
suggest that the central ray is not perpendicular to the aorta. This is important, as Poon et 
al pointed out in 2012. Their paper demonstrated that not having the beam perpendicular 
(coaxial) to the aorta was more likely to lead to paravalvular leak/regurgitation.(137) This is 
clinically important as the PARTNER trial two-year outcomes demonstrate. The paper by 
Kodali et al demonstrated that even mild paravalvular regurgitation or aortic regurgitation 
was associated with increased mortality at 2 years post procedure.(149)  
Therefore, special attention should be paid when implanting the TAVI device. A coaxial or 
perpendicular X-ray C-arm angle ensures that the three coronary sinuses are aligned in 
one plane under fluoroscopy and the depth of valve implantation in relation to the annulus 
can be accurately assessed.  
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Conclusions 
When considering the literature as a whole, much research has been performed in relation 
to radiation doses in cardiac angiography and intervention. However, the X-ray systems 
we use are evolving continuously and the doses associated with them need continuous 
audit, particularly in countries like Australia where no national benchmark exists. As new 
procedures that use X-ray imaging, like TAVI emerge, there are many things that need to 
be considered, such as the radiation dose to the whole team, in addition to the radiation 
dose and contrast media dose to the patient. Also, the pre-operative imaging assessment 
TAVI with traditional tools like MSCT and echocardiography are now well researched and 
understood but there are still opportunities to explore the imaging capabilities of the 
angiographic C-arm with these new procedures, both pre-operatively and peri-operatively.  
The contents of this thesis are quite unique, as it investigates the aspects of cardiac 
angiography that are relevant to cardiac radiographers; a niche that fits between the 
realms of medical physicists and interventional cardiologists. 
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Chapter 2 –  
J. Crowhurst, M. Whitby, D. Thiele, T. Halligan, A. Westerink, S. Crown, J. Milne. 
Radiation Dose In Coronary Angiography and Intervention: Initial Results From the 
Establishment of a Multi Centre Diagnostic Reference Level In Queensland Public 
Hospitals. J. Med. Radiat. Sci., 2014; 61, (3), 135–141 
 
Details of my contribution to authorship. 
This chapter encompasses the output of a project sponsored by Allied Health Professions 
office of Queensland. I wrote the project proposal prior to enrolment to this candidature. 
Upon approval of the project funding, I took on the role as project officer. I initiated 
meetings with custodians of the relevant data and local experts on the topic (publication 
co-authors) to establish study design. I wrote the research protocol and sought and 
obtained ethical committee approval. I met with relevant stakeholders, met and obtained 
permission for use of data from these stakeholders.  
I performed a literature review of all relevant, previously published material and reviewed 
current guidelines on reporting such studies. I analysed the data obtained, continued 
consultation with local experts in the field (co-authors) and wrote up the findings before 
sending out for critical review by the co-authors. I liaised with the relevant journal for 
publication as corresponding author and made suggested changes in line with peer 
review. 
Prologue 
Before investigating radiation dose and factors that may increase radiation dose or be 
predictors of high dose, it is important to establish acceptable radiation dose levels that X-
ray units use to perform the procedures. This is an important step in radiation dose 
management and is recommended by the International Committee for Radiation Protection 
(ICRP)(7). Radiation dose benchmarks that are established locally can be compared to 
other established benchmark that have been published. Benchmarked levels or diagnostic 
reference levels (DRLs) are important and they are used a guide as to what radiation dose 
should be achievable for a particular imaging procedure using X-rays.(7) This was the 
rationale for the first study of this thesis. No Australian benchmark exists for coronary 
angiography and intervention and as such the first chapter aimed to establish this.  
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Radiation Dose In Coronary Angiography and Intervention: Initial Results From the 
Establishment of a Multi Centre Diagnostic Reference Level In Queensland Public 
Hospitals 
 
Introduction 
Cardiovascular disease (CVD) is the leading cause of death in Australia with coronary 
artery Disease (CAD), the most common form of CVD being the largest single cause of 
death(150,151). Invasive coronary angiography (ICA) has been utilised in the diagnosis 
and treatment of CAD for over 30 years and there is consistent growth in the numbers of 
these procedures being performed each year(152). 
One disadvantage of ICA is the radiation dose to the patient from the fluoroscopy used 
during the procedure. At high X-ray exposures there is a risk of deterministic radiation 
effects to the skin, such as erythema, permanent epilation and at very high doses, dermal 
atrophy and ulceration. There is evidence to suggest that these effects are being 
increasingly reported (9,21). There is also the increased stochastic risk by way of cancer. 
The risk of cancer from medical imaging procedures is largely unknown but is related to 
the cumulative effective dose received from imaging procedures(153). A comparison of the 
effective doses for medical imaging procedures, including coronary angiography and 
intervention is demonstrated in figure 2-1.  
Radiation doses delivered during ICA procedures have not changed significantly over the 
years and remains one of the highest of any x-ray examination in the acute care 
setting(6,154). By way of ensuring patient safety, there are maximum permissible x-ray 
outputs for Cardiac Cath lab (CCL) systems in fluoroscopy mode in Queensland. However 
there is no such limit for digital acquisitions, where radiation dose can be up to 15 times 
that of fluoroscopy for the same beam on time(153). Operator dose from scattered 
radiation from the patient is also a consideration as procedures become more lengthy and 
complicated. The long term effects by way of cancer to operators from long term exposure 
to low energy ionising radiation is being increasingly recognised(61,62,155). 
Unsurprisingly, radiation protection and advisory bodies suggest that radiation dose for 
radiological procedures should be monitored closely at a local, regional and national 
level(7). In order to keep doses low, whilst also maintaining adequate image quality, 
physicians and their support staff require established, evidence based data to benchmark 
against and to date in Queensland and Australia, there is no benchmark. The publication 
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of a benchmark or diagnostic reference level (DRL) has been performed numerous times 
by radiation regulatory bodies around the world. It is most commonly used in providing a 
benchmark for diagnostic radiological imaging but can equally be utilised for interventional 
procedures.(7) They are a guide to good practice, 
but are neither dose limits nor thresholds that define competent performance of 
the operator or the equipment(7). The DRL provides physicians with a guide for which the 
median dose of a particular procedure type should fall below and should be used as a tool 
for optimising patient dose. The DRL is most commonly derived from the dose area 
product (DAP or PKA) value for fluoroscopy procedures and is a product of the dose 
output and the area exposed.(7) 
The purpose of this study is to establish Queensland Public Facility (Queensland Health) 
radiation diagnostic reference levels for cardiac catheter procedures, for the purpose of 
providing benchmarks for ongoing quality assurance and audit. 
Methods 
Site participation: 
All seven public hospitals in the state of Queensland, Australia with a cardiac 
catheterisation laboratory (CCL) were invited to participate in the study.  
Procedures Included: 
The study included patients undergoing ICA procedures from January 2013 through to 
April 2013 inclusive. Procedures were separated into two groups:  
 Diagnostic coronary angiography only group (CA) 
 Adult patients undergoing Coronary Angiography +/- Left Heart Catheterisation 
and/or Left Ventriculography. 
 Diagnostic coronary angiography in conjunction with single vessel percutaneous 
coronary intervention (PCI).  
 Adult patients undergoing Coronary Angiography +/- Left Heart Catheterisation 
and/or Left Ventriculography + Percutaneous Coronary Intervention. 
 The study included all adult patients that fitted the above criteria. All other 
procedures, including graft studies and complex multi-vessel PCI were eliminated 
from the study. 
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Figure 2. 1 Relative patient effective dose for medical imaging procedures 
Legend: Relative patient effective dose for medical imaging procedures. Typical doses for 
medical imaging procedures. Adapted from data from Mettler et al (6). (mSv = Millisievert, 
CT = Computed Tomography). 
 
Data Collection: 
Radiation data, automatically stored by each X-Ray machine was prospectively entered 
into an electronic image and reporting system (Impax CV, Agfa Healthcare) at the time of 
procedure for all cases.  Data were extracted from the cardiac catheter laboratory image 
and reporting system (Oracle database) using structured query language (SQL) and 
exported into SPSS version 20 for analysis.  Radiation data collected were as follows: 
 Examination type 
 Patient Height/weight/BMI 
 Fluoroscopy time 
 Dose Area Product (DAP or PKA) 
 System calculated skin surface entrance dose (KAR) 
Data Analysis 
In line with the ICRP recommendations, the DRL was set from the entire population for 
each procedure and is determined by the 75th percentile of the PKA(7).  
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Patient size is known to affect dose(21). Therefore patient height, weight and body mass 
index (BMI) were additional measures for comparison. Fluoroscopy time was collected as 
it demonstrates ‘beam on’ time. KAR was measured because in Queensland, the trigger 
value for a reportable dose and subsequent patient follow-up is determined by exceeding 
an entrance surface dose of 5Gy. Individual centres were de-identified and allocated a 
number for analysis. 
 
Additional Measures: 
The Dose Area Product meter (DAP meter) housed within the x-ray tube was calibrated on 
all systems within the 12 months prior to the data collection for each CCL. A variation of ± 
25% was deemed acceptable and was in line with similar studies(19,22). CCL X-ray 
equipment in Queensland Health facilities (QH) is serviced by equipment vendors on a 
regular basis and the x-ray output of the systems is measured annually by QH radiation 
physicists to ensure compliance and quality assurance. Ethics approval was granted for 
this study by the Prince Charles Hospital human research ethics committee, Queensland 
Health. 
 
Results 
All seven QH facilities identified as performing ICA participated in the study, a total of 12 
individual x-ray suites. Eleven of the twelve X-ray units were supplied by one 
manufacturer, with only one from a different manufacturer. All were less than 10 years old 
and incorporated flat detector technology.  
3535 procedures fitted the criteria of the two groups and were included in the study. Of 
those, 2590 were CA and 947 were PCI.  Overall data collection rates for the specified 
fields were 97.95% in the CA group and 98.33% in the PCI group. 
The dose results and patient related data for CA and PCI procedures are demonstrated in 
table 2.1. Distribution curves are demonstrated in figure 2.2 for the overall populations. 
How the different facilities/sites contributed to the data is outlined in table 2.2. The DRL, 
as determined by the 75th percentile of the PKA value for the study population was 5865 
uGym2 for CA, and 12900 uGym2 for single vessel PCI procedures. How these results 
compare to the literature is demonstrated in table 2.3 and table 2.4. 
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Table 2. 1 – Baseline results in this study for the two identified groups, 
demonstrating the various dose measures collected in this study. Numbers in 
brackets indicate the inter quartile range. 
Measure  Coronary 
Angoigraphy 
Percutaneous Coronary 
Intervention 
Number of Patients 2590 947 
Median Patient Age 62.71 (54 – 72) 61.73 (53 – 71) 
Median Patient Height 
(centimetres) 
170 (177 - 162) 172 (165 - 178) 
Median Patient Weight 
(Kilograms) 
83 (71.0 - 96.0) 82  (73 - 94) 
Median Patient BMI 28.7 (24.9 - 32.9) 27.8 (24.8 – 31.9) 
Median Fluoro Time (Minutes) 3.5 (2.3 – 6.1) 11.2  (7.7 - 17.4) 
Median PKA (uGym2) 3908 (2489 - 5865) 8736 (5449 - 12900) 
Median KAR (mGy) 581 (374 - 876) 1501 (928 - 2224) 
Calculated DRL (uGym2) 5865 12900 
 
Abbreviations: Numbers in parenthesis indicate the interquartile range. BMI = body mass 
index, KAR =  patient skin surface entrance dose, PKA = dose area product, DRL = 
diagnostic reference level CA = coronary angiography, PCI = percutaneous coronary 
intervention, 
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Legend :Distribution charts demonstrating how the distribution of PKA is non normal in both 
CA and PCI groups. The y axis demonstrates the fraction of procedures that fell within a 
particular PKA range. (CA = diagnostic coronary angiography, PCI = percutaneous 
coronary intervention, PKA = dose area product) 
Figure 2. 2 - Distribution plots for CA and PCI procedures 
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Table 2. 2 – How each site enrolled in the study contributed to the data for PKA  and 
the DRL. The values given are all in uGym2.  
 
Abbreviations: DRL = diagnostic reference level, PKA = dose area product, Std. Dev. = 
one standard deviation, 25th% = 25th percentile, 75th% = 75th percentile 
Diagnostic Coronary Angiography (CA)  
 
n= 
Site 1 
(n=193) 
Site 2 
(n=230) 
Site 3 
(n=542) 
Site 4 
(n=331) 
Site 5 
(n=261) 
Site 6 
(n=571) 
Site 7 
(n=462) 
All 
(2590) 
 
Mean 
 
3263 
 
4301 
 
4909 
 
4701 
 
3620 
 
4740 
 
5601 
 
4448 
Median 2774 3826 4235 4197 2899 3886 4641 3908 
Std. Dev. 2033 2386 3168 2769 2617 3630 4057 2952 
25th % 1798 2594 2893 2827 1955 2531 2605 2489 
75th % 4178 5472 6288 5788 4461 5779 7176 5865 
         
Percutaneous Coronary Intervention (PCI)  
 
n= 
Site 1 
(n=76) 
Site 2 
(n=127) 
Site 3 
(n=186) 
Site 4 
(n=119) 
Site 5 
(n=68) 
Site 6 
(n=215) 
Site 7 
(n=156) 
All 
947 
 
Mean 
 
8303 
 
10023 
 
10615 
 
10034 
 
6912 
 
12350 
 
8655 
 
9566 
Median 7071 8445 9283 8710 6528 10801 7291 8736 
Std. Dev. 5111 6177 6986 6401 3483 7580 5690 5918 
25th % 4707 5424 5917 5463 4525 6753 4853 5449 
75th % 9471 12403 12900 11089 6528 15973 11789 12900 
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Table 2. 3 – Demonstration of how the results from this study compare to those 
previously published and the country where the data originates. - Diagnostic 
coronary angiography 
CA Group    
Country Author 
Median PKA  
(uGym2) 
75th 
Percentile 
Switzerland (Non-
Academic Centres) 
Samara et al 201114 5800 10200 
USA Miller et al 200915 4900 8300 
Turkey Bor et al 200823 4910 - 
Switzerland 
(Academic Centres) 
Samara et al 201114 4500 9000 
Italy Neofotistou et al 200328 4240 - 
Australia  This study 3908 5864 
Finland Neofotistou et al 200328 3960 - 
Greece Neofotistou et al 200328 3800 - 
Ireland Neofotistou et al 200328 3330 - 
Ireland D’Helft et al 20095 3100 4200 
Italy Neofotistou et al 200328 2820 - 
Spain Neofotistou et al 200328 2780 - 
United Kingdom Hart et al 200516 2350 2900 
England Neofotistou et al 200328 1910 - 
 
Abbreviations: CA = coronary angiogram, PKA = Dose Area Product 
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Table 2. 4 – Demonstration of how the results from this study compare to those 
previously published and the country where the data originates. - Percutaneous 
coronary intervention. 
PCI Group    
Country Author 
Median PKA 
(uGym2) 
75th 
Percentile 
USA Miller et al 200915 11700 19300 
Turkey Bor et al 200823 10690 - 
Switzerland 
(Academic Centres) 
Samara et al 201114 9000 17000 
Australia  This study 8736 12900 
Italy Neofotistou et al 200328 8200  
Switzerland (Non-
Academic Centres) 
Samara et al 201114 6700 12000 
Finland Neofotistou et al 200328 6690 - 
Ireland Neofotistou et al 200328 4850 - 
Italy Neofotistou et al 200328 4240 - 
Ireland D’Helft et al 20095 4200 8400 
United Kingdom Hart et al 200516 3600 5000 
Greece Neofotistou et al 200328 3900  
Spain Neofotistou et al 200328 3900 - 
England Neofotistou et al 200328 2710 - 
 
Abbreviations: PCI = percutaneous coronary intervention, PKA = dose area product 
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Discussion 
The investigation and publication of a DRL for coronary angiography has been performed 
in the UK every 5 years since 1992(18). This has subsequently been followed by studies in 
Europe(156) and the United States(22). The studies in the UK have found an incremental 
drop in radiation dose since they started investigating and reporting radiation dose16.  
Many different factors affect radiation dose in ICA procedures and these factors have been 
evaluated before(157-160). Factors such as x-ray system set-up, operator technique and 
clinical practice all play a part and it may well be beneficial to locally investigate these 
factors on a site by site basis in the future. Complexity of procedure has also been 
demonstrated to significantly affect radiation dose(161,162) but again was not measured 
as part of this initial study. 
It is advantageous to collect the height and weight of patients for these studies. Previous 
studies have normalised their PKA results to patient weight(163). This is in line with a paper 
by Chapple et al to an average of 70Kg(24). Normalising the dose to a particular patient 
weight is advantageous for a comparison between x-ray systems. Normalising the dose 
data to a reference patient weight is difficult with a large number of facilities. Most multi-
centre studies have not elected to do this(20,22,25,26) and this was not performed as part 
of this study. A higher PKA value than some of the literature may be the result, due to the 
higher median patient weight of 83Kg seen in this study. Another method utilised to 
normalise the PKA data is to exclude patients outside a weight range of 80Kg ± 5, with the 
same aim(18). Normalizing may not be logical in establishing a DRL for practical routine 
use, as the DRL would only relevant to a small portion of patients that fall within a certain 
weight range. 
The results obtained from this study are comparable with those from other studies in the 
literature. Tables three and four show how this study compares to similar studies. It is 
evident that there is a great variation between these multi-centre studies. As an example, 
reference levels for CA range from between 2900 ųGym2 to 10200 ųGym2 , with this study 
sitting just below the average of 6744 ųGym2 at  5865 ųGym2. Neofotistou et al attributed 
higher doses to teaching hospitals in its study,(20) as it is known that in their first year of 
training operators use higher levels of radiation due to extended fluoroscopy(164). It is 
noteworthy therefore that all seven facilities involved in this study are teaching hospitals, 
training registrars and fellows in ICA and this has the potential to make some impact on 
the results. Neofotistou et al also attributed the possible difference in dose between the 
highest and lowest centres in its study to the dose rate under fluoroscopy28.  Although 
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dose rates of individual x-ray units were not measured in this study, all units are measured 
annually in terms of fluoroscopy dose, which is governed by state regulations. Sample size 
may also be important. There are differences in study population size within the literature, 
with sample sizes for CA examinations ranging from 311 patients(19)   to 34236 
patients(18). It has been proposed that only 50 examinations will produce sufficient 
statistical power in these kind of studies(165).  With that in mind, the sample sizes of 2590 
CA examinations and 947 PCI examinations seen in this study should make one confident 
that the DRLs calculated here are based on a sufficiently sound sample size. 
This study would indicate that Queensland public facilities are delivering appropriate levels 
of radiation to patients during ICA procedures. However, there is always work that can be 
done to reduce dose and audits such as this are a good starting point in raising 
awareness. They are a fundamental foundation for ongoing audits as part of a quality 
assurance program for radiation dose(7).  
In line with recommendations(7), it is planned that doses for cardiac angiography and 
intervention be measured against benchmarks on an annual basis and for a study such as 
this to be repeated in 3-5 years.  The DRL should be seen a guideline only, as it is well 
recognised that fluoroscopy procedures are difficult to benchmark and that each individual 
procedure may deviate from the DRL for many legitimate reasons(7). DRLs are intended 
to provide guidance on what is achievable with current good practice rather than optimum 
performance(7). However, to date there is no DRL for these procedures in Australia and 
this study could be used as an interim yardstick for other cardiac catheter laboratories in 
Queensland and Australia, until a larger national study can be performed. 
Conclusion 
This study allowed for the calculation of a DRL for diagnostic and interventional coronary 
angiography procedures in Queensland Health facilities. The establishment of a 
benchmark means that these DRLs can be used for ongoing audit in these and new 
facilities across Queensland and potentially other similar facilities in Australia. 
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Limitations 
This was a retrospective analysis of a state-wide database and not prospective in nature. 
The number of procedures from each centre are not equal, which would have been more 
ideal. 
Current implications 
More recently, in 2017 the ICRP published guidelines for the calculation of DRLs, which 
included both diagnostic and interventional fluoroscopically guided procedures. They 
suggested using the PKA or the Kar as measures to determine the DRL and that dose data 
can be normalized to patient body habitus but similar results can be obtained without 
normalization. They suggest that using both PKA and the Kar would be useful in determining 
why the dose may not be optimized.(27) In addition, other similar studies have emerged: A 
study has been published by Ngaile et al in 2018, with a DRL for Tanzania, with median 
values for CA of 37.8 Gycm2 for CA and 86.5 for PCI, which are relatively similar to those 
seen in this chapter.(17) As at April 2020, there are other DRL or data sets published in 
Australia with regard to coronary angiography and coronary intervention. 
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Chapter 3 –  
J. Crowhurst, M.Whitby, M.Savage, D.Murdoch, B.Robinson, E. Shaw, N. Gaikwad, R. 
Saireddy, Hay, K, Walters, D. Factors Contributing to Patient and Operator Dose During 
Diagnostic Cardiac Angiography. J Med Radiat Sci. 2019 66 1: 20-29 doi: 
10.1002/jmrs.315 
 
Details of my contribution to authorship: 
This chapter was assisted with a research scholarship from the Australian Society of 
Medical Imaging and Radiation Therapy. For the research scholarship, I wrote a research 
study outline and protocol after reviewing current literature. I designed the study in 
consultation with local experts (co-authors). I wrote the research protocol and sought and 
obtained ethical committee approval.  
I performed a literature review of all relevant, previously published material and reviewed 
current guidelines. I led the collection of the data, analysed the data obtained, performed 
calculations and statistical analysis, following advice from a statistician. I continued 
consultation with local experts in the field (co-authors) and as lead author, wrote up the 
findings before sending out the manuscript for critical review by the co-authors. I liaised 
with the relevant journal for publication as corresponding author and made suggested 
changes in line with peer review. 
 
Prologue 
Now that local reference levels for coronary angiography and intervention have been 
established, it is important that efforts are made to investigate what factors during 
angiography could push doses above the reference level. The study in chapter 2 
established the reference level at the 75th percentile of the dose area product.(166) 
Therefore, the next step in this thesis was to investigate which of the multitude of factors 
are most likely to lead to a high (above the 75th percentile) radiation dose. In addition, 
given some recent high profile publications on operator radiation dose,(63,64) it was 
deemed important to investigate the primary operator’s dose and factors that would lead to 
them having a high (above the 75th percentile) dose. The following body of work 
investigates this in detail and demonstrates how some factors are predictors of both a high 
patient and operator dose. 
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Factors Contributing to Radiation Dose for Patients and Operators During 
Diagnostic Cardiac Angiography. 
 
Introduction 
Cardiovascular disease is Australia’s most common chronic disease and coronary artery 
disease is the leading cause of mortality.(167) Coronary artery disease can be diagnosed 
and treated in the same setting with invasive cardiac angiography (CA). CA uses X-ray 
fluoroscopy and carries risks to the patient undergoing these procedures(2). The side 
effects of radiation are both stochastic (neoplasm and heritable abnormalities) and tissue 
injury (deterministic).(2) The associated radiation dose and relative risk of malignancy may 
not be conclusive(168) but the deterministic effects of fluoroscopy procedures, presenting 
as skin injury have been reported many times(10,12,169) and have been compiled into 
case review reports and recommendation documents.(2,9) The cardiologist who is closest 
to the X-ray source and patient is exposed to the harmful effects of low energy scattered 
radiation during CA which has been highlighted in numerous studies and 
reports.(63,64,78) 
The International Commission on Radiological Protection recommends that dosimeters 
should be available for all staff working in fluoroscopic laboratories. In addition, a quality 
assurance (QA) program should ensure the use of dosimeters with a review of abnormal 
dose values.(7) Dosimeters, using thermo-luminescent or more recently optically 
stimulated luminescent dosimetry techniques are required to be worn by catheter 
laboratory personnel. These are submitted for evaluation on a monthly basis. However, 
these monthly readings do not demonstrate how radiation dose is received on a case by 
case basis and which factors increase a staff members’ radiation exposure more than 
others. 
Patient and operator dose have been investigated before, such as the REVERE trial(170) 
and the RAD-MATRIX trial,(67) which investigated the impact of vascular access site on 
radiation dose. However, there is a paucity of data on this subject where all variables that 
may impact on operator dose are assessed together, and which variables are predictive of 
high doses. 
This study aimed to supplement the QA program and perform a more detailed 
investigation of radiation exposure to both patients and operators during contemporary 
diagnostic cardiac angiography procedures. This study sought to identify patient and 
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procedural factors that may impact on patient and operator dose in addition to identifying 
which variables are predictive of a high patient and operator radiation dose.  
 
Method: 
The study was a retrospective analysis of consecutive patients presenting to the cardiac 
catheterisation laboratories in this single, tertiary, teaching hospital that had diagnostic 
procedures performed. Data were collected from mid-August 2014 through to mid 
December 2015. Approval for this study was granted by the facility human research ethics 
committee. 
 
Radiation protection for operators 
The examination table had lead drapes fitted to the tableside. Operators also had a lead 
acrylic, ceiling suspended shield. Operators all wore a protective apron of at least 0.5 mm 
lead equivalent at the front, thyroid shields, lead shin guards, lead eye glasses and some 
wore lead equivalent protective hats. 
 
Workflow and equipment protocols 
All procedures were performed in one of two identical biplane cardiac catheterisation 
laboratories (Siemens Axiom Artis dBc, Siemens Healthcare, Erlangen, Germany). 
Operators positioned (panned) the patient on the floating top tables and activated the 
fluoroscopy and digital acquisition. Radiographers operated the C-arm, controlled pulse 
rate, dose per pulse, collimation and wedge filtration from an adjacent control room. 
Fluoroscopy was typically set to 7.5 pulses per second and the digital acquisition (DA) 
frame rate was set to 15 frames per second. A standard fluoroscopy and acquisition 
protocol was typically used for procedures in which the X-ray system automatically 
adjusted copper filtration, kV and mA to achieve a detector dose that would produce an 
acceptable image.  
Radiation data collected were: 
Fluoroscopy time (FT), Kerma area product (PKA), skin entrance dose (air kerma - mGy) at 
the reference point (KAR) and number of DA. These were entered into an oracle database 
at the end of each procedure (Impax CV, Agfa Healthcare, Netherlands). PKA was the 
primary measure for patient dose and was calculated using the PKA meter in the X-ray tube 
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housing and is given in Gycm2. Both X-ray systems were checked for accuracy of the PKA 
meter readings as part of their annual compliance tests.  
Individual elements for each procedure were entered into the database using a series of 
tick boxes and procedures were then grouped into 10 categories: 
 Abdominal/femoral angiogram only (AFA). 
 Coronary angiography only (CORS). 
 Coronary angiography + aortogram/ left ventriculogram (CORS-LV/AO). 
 Coronary angiography + left heart catheterisation + Right heart catheterisation 
(CORS-LHC/RHC). 
 Coronary angiography + additional coronary artery lesion assessment with 
intravascular ultrasound (IVUS), optical coherence tomography (OCT) of fractional flow 
reserve (FFR) - (CORS-OCT/IVUS/FFR). 
 Coronary angiography + pulmonary angiography (CORS-PA) 
 Coronary angiography + coronary artery bypass graft angiography (CORS-
GRAFTS). 
 Pulmonary angiography alone (PA). 
 Right heart catheterisation +/- venography (RHC) 
 Work-up for transcatheter aortic valve implant: Includes coronary angiography, 
aortography, ilio-femoral angiography (TAVI-WU). 
The CORS group was used as the reference group for statistical analysis. Other 
procedural variables that could impact on radiation dose, such as catheter access route 
and whether biplane angiography was used were also recorded. Patient variables, 
including age and body mass index (BMI) were collected. BMI was grouped into three 
categories: <25, 25-30, and >30 kg/m2. 
 
Operator dose analysis 
The primary and secondary operators (where a second operator was present) were 
monitored using instantly downloadable personal dosimeters (IDD) (InstadoseTM, Mirion 
technologies, Georgia, USA) in addition to their usual TLD monitors. The IDD was worn on 
the thyroid collar, on the outside of the protective apron for the procedure duration and 
downloaded at the end of each procedure. The methodology for using these dosimeters 
has been previously described(171). The dosimeter is plugged into a personal computer 
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(PC) to be read using the InstadoseTM software. The readout from the PC demonstrates 
the air kerma incident on the dosimeter with a conversion calculation to give the personal 
dose equivalent Hp(10). Hp(10) (the dose equivalent in soft tissue measured  at a depth of 
10mm) is an accepted surrogate measurement of effective dose (E). This is inaccurate in 
this setting, as the operator wears a lead apron so this value was divided by 21 - in line 
with the methodology outlined in the NCRP 168 document(172) to give an effective dose 
(E) whilst wearing a lead apron. 
Operators were all cardiologists with varying experience. For analysis, they were grouped 
into three experience categories: Group1 = Registrar, Group 2 = Interventional fellow, 
Group 3 = Consultant. 
 
Data integrity and statistical analysis: 
Data for procedures where an IDD was worn were compared to those procedures where 
the IDD was not worn to ensure a comparable data set. The continuous outcome 
measures (OD and PKA) were categorised to form binary measures for use in analysis. For 
each variable, values below the 75th percentile were included in the reference category 
and values at or above the 75th percentile were included in the high dose comparison 
category.  
The distributions of variables were assessed. Means and standard deviations (SD) or 
medians and inter-quartile ranges were used to describe continuous variables, with Mann-
Whitney U tests or Kruskal Wallis tests used to compare groups. Categorical variables 
were compared using a Chi squared test. Significant categorical variables from the Chi – 
square analysis with a p-value of <0.1 with univariate analysis were included in 
multivariate logistic regression modelling. Stepwise removal of variables with the highest 
p-value was performed. In the final model all variables remained significantly associated 
with the outcome at the 0.05 level.   
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Results 
The study population comprised 3860 patients. The mean age for patients was 66 (SD 13) 
years. PKA measurements were available for all 3860 procedures and the IDD was worn 
during 2591 (67.1%) of these procedures. Primary operator dose (OD) was measured in 
this subset.  The cut point for the 75th percentile value for PKA was 61.4 Gycm2 (table 3.1). 
Procedures above this were considered High PKA. The cut point for the 75th percentile for 
Operator 1 dose (OD) was 1.90 µSv, with dosimeter readings above this value categorised 
as high. 
All patient and radiation parameters did not differ significantly between procedures where 
the IDD was and was not worn. Overall and procedure group comparisons for each of the 
10 examination categories are given in table 3.1. The CORS –LV/AO category was the 
most numerous, accounting for 1745 (45%) of the procedures performed. The medians of 
all variables differed significantly across procedural categories. Patients in the TAVI-WU 
category were the eldest (median 82 years) but the CORS-PA category demonstrated the 
highest FT (13 (10.4-17.9) mins), KAR (1327 (885-1796) mGy), PKA (99.69 (67.66-160.07)) 
Gycm2) and DA (19 (17-22). However, this category accounted for only 0.3% of 
procedures performed. Median OD was 0.95µSv (Inter quartile range (IQR) 0.00-1.90) and 
varied significantly across procedure categories (p=0.002) and is demonstrated graphically 
in figure 3.1. Median patient and operator dose for each category within each variable that 
may impact on radiation dose is given in table 3.2. 
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Table 3. 1 - Overall patient and radiation data and comparisons across procedure categories 
     Procedure category     
 
 
Overall AFA CORS 
CORS-
LV/AO 
CORS-
LHC/RHC 
CORS-
OCT/IVUS
/FFR 
CORS-PA 
CORS-
GRAFTS 
PA RHC TAVI -WU p-value 
N= 3680 11 1019 1745 200 268 10 413 18 55 121 - 
Patient measures          
Age (Years) 66 ±13 77 (72-82) 67 (57-75) 65 (56-72) 69 (54-77) 68 (61-75) 64 (59-67) 72 (66-79) 52 (36-67) 59 (41-72) 82 (78-86) <0.001 
BMI kg/m2 
29.3 
(25.5-
33.6) 
30.5 
(25.7-
34.8) 
29.3 
(25.4-
33.8) 
29.6 
(25.7-
33.9) 
27.9 
(24.1-
33.3) 
29.4 
(26.0-
33.2) 
29.8 
(28.3-
35.3) 
28.9 
(25.9-
32.9) 
25.6 
(22.2-
30.0) 
27.6 
(21.2-
31.6) 
27.7 
(24.9-
31.4) 
<0.001 
Radiation measures          
FT (mins) 4.7 (2.9-8.3) 
4.5 (1.3-
7.7) 
3.9 (2.5-
6.4) 
3.7 (2.6-
5.6) 
8.1 (5.1-
11.9) 
9.1 (6.5-
12.9) 
13.0 
(10.4-
17.9) 
9.8 (6.7-
14.4) 
10.5 (8.5-
14.3) 
4.7 (2.0-
9.5) 
7.5 (4.5-
9.7) <0.001 
KAR (mGy) 
646 
(399-
980) 
139.0 
(32.6-
451) 
626.0 
(398-934) 
593.0 
(374-872) 
613.0 
(372-
900.5) 
841.5 
(493.5-
1242.5) 
1327.0 
(885-
1796) 
1018.0 
(665-
1476) 
391.5 
(200-610) 
53.8 (19-
105) 
721.0 
(449.0-
1124) 
<0.001 
PKA 
(Gycm2) 
40.0 
(24.8-
61.4) 
12.93 
(3.13-
42.70) 
37.37 
(23.96-
56.41) 
35.76 
(22.89-
53.49) 
43.25 
(26.69-
65.28) 
49.37 
(30.44-
72.72) 
99.69 
(67.66-
160.07) 
67.11 
(43.75-
95.58) 
34.30 
(17.13-
57.43) 
5.72 
(2.24-
13.97) 
47.86 
(32.09-
78.38) 
<0.001 
DA 10 (9-13) 4 (2-9) 9 (8-11) 10 (10-12) 10 (8-12) 12 (9-14) 19 (17-22) 17 (14-20) 8 (5-9) 0 (0-1) 14 (12-16) <0.001 
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Footnote: Table shows how the different patient characteristics and radiation measures 
compare across procedure category. Median and inter-quartile ranges are shown with p- 
values calculated using Kruskal-Wallis tests. (BMI = body mass index, CORS=coronary 
angiogram, DA= digital acquisitions, FT=fluoroscopy time, KAR = air Kerma at the 
interventional reference point, PKA = Kerma area product, TAVI = transcatheter aortic valve 
implant. AFA = Abdominal/Femoral angiogram only, CORS = Coronary angiography only, 
CORS-LV/AO = Coronary angiography + aortogram/ left ventriculogram, CORS-LHC/RHC 
= Coronary angiography + left heart catheterisation + Right heart catheterisation, CORS-
OCT/IVUS/FFR = coronary angiography + additional coronary artery lesion assessment 
with intravascular ultrasound (IVUS), optical coherence tomography (OCT) of fractional 
flow reserve (FFR), CORS-PA = Coronary angiography + pulmonary angiography CORS-
GRAFTS = Coronary angiography + coronary artery bypass graft angiography, PA = 
Pulmonary angiography alone, RHC = Right heart catheterisation +/- venography , TAVI-
WU = Work-up for transcatheter aortic valve implant). 
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Table 3. 2 - Median radiation dose for patients and operators within variable 
categories. 
Item PKA (Gycm2) p-value OD (µSv) p-value 
N= 3860  2591  
Access  <0.001  0.002 
Radial access 38.37 (24.55-57.24)  0.95 (0.00-1.90)  
Femoral access 46.04 (26.17- 72.57)  0.95 (0.00-1.90)  
Jugular access 2.86 (1.43-6.06)  0.72 (0.24-1.19)  
Gender  <0.001  <0.001 
Female 27.52 (16.65-44.57)  0.95 (0.00-1.43)  
Male  47.45 (32.22-70.71)  0.95 (0.00-2.38)  
Imaging technique  <0.001  <0.001 
Biplane Imaging 58.16 (35.55-89.74)  1.43 (0.00-2.38)  
Single plane 36.44 (22.88-55.27)  0.95 (0.00-1.90)  
Cath lab used  <0.001  0.372 
Cath lab 1  37.40 (23.29-59.83)  0.95 (0.00-1.90)  
Cath lab 2 42.49 (26.40-63.97)  0.95 (0.00-1.90)  
BMI category  <0.001  <0.001 
BMI >30 53.63 (37.52-76.01)  1.43 (0.00-2.38)  
BMI 25-30 35.96 (24.29-53.02)  0.95 (0.00-1.90)  
BMI <25 21.73 (13.43-33.83)  0.48 (0.00-1.43)  
     
Operator 1 experience  0.001  0.380 
OP1 exp. (Consultant) 38.06 (23.91-60.40)  0.95 (0.00-1.90)  
OP1 exp. (Fellow) 41.11 (25.07-61.37)  0.95 (0.00-1.90)  
OP1 exp. (Registrar) 44.60 (28.38-65.41)  0.95 (0.00-1.90)  
Operator 2 experience  0.825  0.056 
OP2 exp. (Consultant) 46.74 (30.65-71.07)  0.95 (0.00-2.38)  
OP2 exp. (Fellow) 45.68 (26.77-67.13)  0.95 (0.00-1.90)  
OP2 exp. (Registrar) 44.76 (29.50-69.86)  1.43 (0.48-2.86)  
     
 
Footnote: This table demonstrates the differences in median (IQR) radiation dose values 
for the patient (Gycm2) and operator (uSv) between categories within each variable 
measured. (BMI = Body mass index, OD = primary operator dose, OP1= operator 1 OP2 = 
operator 2). 
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Figure 3. 1 - Median radiation dose to operators by procedure category. 
 
Legend: This graph demonstrates the differences in operator dose accross procedure 
categories. (AFA = Abdominal/Femoral angiogram only, BMI = body mass index, CORS = 
Coronary angiography only, CORS-LV/AO = Coronary angiography + aortogram/ left 
ventriculogram, CORS-LHC/RHC = Coronary angiography + left heart catheterisation + 
Right heart catheterisation, CORS-OCT/IVUS/FFR = coronary angiography + additional 
coronary artery lesion assessment with intravascular ultrasound (IVUS), optical coherence 
tomography (OCT) of fractional flow reserve (FFR), CORS-PA = Coronary angiography + 
pulmonary angiography CORS-GRAFTS = Coronary angiography + coronary artery 
bypass graft angiography, OP1 = operator 1, OP2 = operator 2, PA = Pulmonary 
angiography alone, RHC = Right heart catheterisation +/- venography , TAVI-WU = Work-
up for transcatheter aortic valve implant: Includes coronary angiography, aortography, ilio-
femoral angiography). 
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Factors contributing to a high PKA 
Overall, 64% of patients were male, 33% of patients were overweight (BMI 25-30) and 
45% were obese (BMI>30). Under univariate analysis, the CORS-PA procedure category 
demonstrated the highest odds ratio (OR), with these patients having a 16 fold greater 
chance of receiving a high dose in comparison to the CORS baseline category. 
Under multivariate analysis, a BMI>30 was the strongest predictor for a high PKA, 
demonstrating that after correcting for all other variables in the model, these patients were 
19.1 times more likely to receive a high dose. Males were more likely to be in the highest 
quartile of radiation dose (OR: 5.3, 95% CI: 4.3 - 6.7), compared to females and Biplane 
imaging was also more likely to be associated with a high PKA (OR=5.2 (95%CI: 4.2 - 6.5)) 
(table 3.3). 
 
Factors contributing to a high operator 1 dose (OD) 
In the subset of 2591 patients where the IDD was worn by operators, patients were 
predominantly male (64%), 33% were overweight and 46% were obese. Biplane imaging 
was used in 21% of cases and radial access was used in 69% of procedures. Under 
univariate analysis, a BMI >30 was demonstrated to be the strongest predictor of a high 
OD, with an OR of 3.3 (95%CI: 2.5 - 4.4). This effect persisted in the multivariate model, 
where after correcting for all other variables in the model, a BMI >30 was the strongest 
predictor of a high OD, (OR = 3.3 (95%CI: 2.4 - 4.4)). Of the 10 procedural categories, 
TAVI-WU demonstrated the highest OR for predicting a high OD, (OR = 2.7 (95%CI: 1.5 – 
4.8)). Males, biplane imaging and radial access were also associated with a high OD 
(table 3.4). 
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Table 3. 3 - Regression analysis for variables that impact on PKA for diagnostic 
cardiac angiography procedures. 
 Univariate Multivariate 
 OR 95% CI P value OR 95% CI P value 
Gender     <0.001     <0.001 
Female Ref.Cat.     Ref.Cat.    
Male  4.39 3.61-5.32 <0.001 5.34 4.26-6.68 <0.001 
 Access     <0.001       
Femoral Ref.Cat.          
Jugular 0.13 0.02-1.00 0.05       
Radial 0.53 0.46-0.62 <0.001       
 Cath lab used     <0.001     <0.001 
Cath lab 1 used Ref.Cat.     Ref.Cat.    
Cath lab 2 used 1.20 1.04-1.39 0.01 1.37 1.14-1.64 0.002 
Imaging technique     <0.001     <0.001 
Single plane Ref.Cat.     Ref.Cat     
Bi-plane 3.93 3.34-4.62 <0.001 5.17 4.14-6.47 <0.001 
 BMI     <0.001     <0.001 
BMI <25 Ref.Cat.     Ref.Cat     
BMI 25-30 3.58 2.61-4.90 <0.001 3.88 2.74-5.50 <0.001 
BMI >30 9.59 7.13-12.90 <0.001 19.08 13.52-26.94 <0.001 
 Procedure type     <0.001     <0.001 
CORS Ref.Cat.     Ref.Cat     
AFA 0.40 0.05-3.12 0.386 0.25 0.03-2.26 0.215 
CORS-LV/AO 0.85 0.70-1.03 0.102 0.88 0.70-1.10 0.254 
CORS-OCT/IVUS/FFR 2.55 1.91-3.41 <0.001 3.47 2.46-4.89 <0.001 
CORS-PA 16.08 3.39-76.29 <0.001 10.36 1.96-54.77 0.006 
CORS-RHC 1.64 1.17-2.31 0.004 2.51 1.66-3.79 <0.001 
CORS-GRAFTS 5.15 4.02-6.60 <0.001 3.66 2.70-4.96 <0.001 
PA 1.15 0.37-3.53 0.809 1.51 0.40-5.67 0.542 
RHC 0.32 0.11-0.88 0.028 0.45 0.15-1.37 0.157 
TAVI-WU 2.55 1.72-3.80 <0.001 1.85 1.13-3.01 0.014 
 Operator 1 Experience     0.077     0.010 
Consultant Ref.Cat.     Ref.Cat.    
Registrar 1.29 1.04-1.61 0.024 1.51 1.15-1.98 0.003 
Fellow 1.06 0.90-1.24 0.480 1.06 0.87-1.28 0.588 
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Table 3.3 cont.. 
Operator 2 Experience     0.72       
Consultant Ref.Cat.         
Registrar 0.81 0.46-1.42 0.455       
Fellow 0.97 0.55-1.73 0.923       
 
Footnote: This table demonstrates the odds ratio and significance for all variables that 
impact on a high PKA in the study under univariate and multivariate logistic regression. 
(AFA = Abdominal/Femoral angiogram only, BMI = body mass index, CORS = Coronary 
angiography only, CORS-LV/AO = Coronary angiography + aortogram/ left ventriculogram, 
CORS-LHC/RHC = Coronary angiography + left heart catheterisation + Right heart 
catheterisation, CORS-OCT/IVUS/FFR = coronary angiography + additional coronary 
artery lesion assessment with intravascular ultrasound (IVUS), optical coherence 
tomography (OCT) of fractional flow reserve (FFR), CORS-PA = Coronary angiography + 
pulmonary angiography CORS-GRAFTS = Coronary angiography + coronary artery 
bypass graft angiography, OP1 = operator 1, OP2 = operator 2, OR = odds ratio PA = 
Pulmonary angiography alone, Ref.Cat. = reference category, RHC = Right heart 
catheterisation +/- venography, TAVI-WU = Work-up for transcatheter aortic valve implant: 
Includes coronary angiography, aortography, ilio-femoral angiography) 
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Table 3. 4 - Regression analysis for variables that impact on operator dose for 
diagnostic cardiac angiography procedures. 
 Univariate Multivariate 
 OR 95% CI P value OR 95% CI P value 
Gender     <0.001     <0.001 
Female Ref.Cat.     Ref.Cat.   
Male  1.77 1.44-2.17 <0.001 1.66 1.33-2.06 <0.001 
 Access     0.053     <0.001 
Femoral Ref.Cat.     Ref.Cat.   
Jugular 0.83 0.18-3.84 0.815 1.79 0.26-12.16 0.565 
Radial 1.29 1.05-1.58 0.017 2.34 1.69-3.17 <0.001 
 Cath lab used     0.793       
Cath lab 1 used Ref.Cat           
Cath lab 2 used 0.98 0.81-1.17 0.793       
Imaging technique     <0.001     <0.001 
Single plane Ref.Cat.     Ref.Cat.   
Bi-plane 1.73 1.40-2.14 <0.001 2.18 1.68-2.84 <0.001 
 BMI     <0.001     <0.001 
BMI <25 Ref.Cat.     Ref.Cat.   
BMI 25-30 1.66 1.22-2.27 0.001 1.51 1.09-2.08 0.011 
BMI >30 3.31 2.49-4.41 <0.001 3.25 2.42-4.37 <0.001 
 Procedure type     0.011     0.014 
CORS Ref.Cat.     Ref.Cat.   
AFA 1.94 0.35-10.68 0.448 3.13 0.50-19.57 0.223 
CORS-LV/AO 1.03 0.82-1.30 0.793 0.97 0.77-1.24 0.818 
CORS-OCT/IVUS/FFR 1.41 0.97-2.05 0.069 1.44 0.98-2.12 0.067 
CORS-PA 1.94 0.48-7.84 0.354 1.87 0.43-8.03 0.404 
CORS-RHC 0.83 0.50-1.36 0.454 1.28 0.74-2.20 0.376 
CORS-GRAFTS 1.53 1.11-2.12 0.010 1.86 1.24-2.79 0.003 
PA 0.86 0.18-4.03 0.849 1.49 0.28-7.88 0.641 
RHC 0.52 0.18-1.49 0.222 0.91 0.24-3.36 0.882 
TAVI-WU 2.05 1.24-3.39 0.005 2.68 1.50-4.76 0.001 
 Operator 1 Experience     0.094      
Consultant Ref.Cat         
Registrar 1.00 0.74-1.34 1.000    
Fellow 1.23 0.92-1.65 0.168    
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Table 3.4 cont.. 
Operator 2 Experience     0.190       
Consultant Ref.Cat         
Registrar 0.76 0.41-1.42 0.391       
Fellow 1.35 0.76-2.40 0.310       
 
Footnote: This table demonstrates the odds ratio and significance for all variables that 
impact on a high OD in the study under univariate and multivariate logistic regression. 
(AFA = Abdominal/Femoral angiogram only, BMI = body mass index, CORS = Coronary 
angiography only, CORS-LV/AO = Coronary angiography + aortogram/ left ventriculogram, 
CORS-LHC/RHC = Coronary angiography + left heart catheterisation + Right heart 
catheterisation, CORS-OCT/IVUS/FFR = coronary angiography + additional coronary 
artery lesion assessment with intravascular ultrasound (IVUS), optical coherence 
tomography (OCT) of fractional flow reserve (FFR), CORS-PA = Coronary angiography + 
pulmonary angiography CORS-GRAFTS = Coronary angiography + coronary artery 
bypass graft angiography, OP1 = operator 1, OP2 = operator 2, OR = odds ratio PA = 
Pulmonary angiography alone, Ref.Cat. = reference category, RHC = Right heart 
catheterisation +/- venography , TAVI-WU = Work-up for transcatheter aortic valve implant: 
Includes coronary angiography, aortography, ilio-femoral angiography). 
 
Discussion 
This study is a large and comprehensive analysis of factors that can impact on patient and 
operator radiation dose during 10 different diagnostic cardiac procedures performed in a 
tertiary cardiac catheter laboratory over 16 month period. There was no significant 
difference between the radiation dose variables when an IDD was or was not worn and 
this is important when establishing results for operator dose and whether they are relevant 
across the entire cohort. 
A local, multicentre diagnostic reference level (DRL) for CA was developed in 2013 and 
published in 2014.(166) The 75th percentile of 61.4 Gycm2 in this study appears to be 
similar to that studies’ DRL for CA of 58.65 Gycm2 and importantly, the median PKA value 
appears to be lower than that studies’ 75th percentile DRL.(166) This demonstrates 
ongoing compliance with the local DRL, even with the addition of more complex 
procedures that were not included in the DRL study of 2014.  
Obesity 
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The multivariate analysis demonstrates that after correcting for all other variables in the 
model, risk of exposure to high PKA and OD values was highest in obese patients. This is 
consistent with previous research where obesity was demonstrated to significantly 
increase the radiation dose used during coronary angiography.(54) However, the present 
study supplements these findings with the additional information that a high patient BMI is 
the strongest predictor for both a high patient and operator dose across a range of 
diagnostic procedures. A high patient BMI means a greater patient thickness which requires 
more X-ray tube output. The X-ray system boosts exposure automatically but increases patient 
dose from the increased absorption and scatter of X-rays from the additional thickness. The 
additional scatter in turn increases OD. 
 
Catheter access route 
Radial arterial access has previously been demonstrated to be a procedural factor that 
increases PKA(173-175) and operator dose.(43,75) However, in the present study, under 
multivariate analysis, access route did not remain significantly associated with a high PKA 
at the 5% level. However, radial artery access was associated with a high OD. This is 
important as radial artery access is now the access route of choice, with lower vascular 
complication rates(41,42) and a higher patient preference.(41) This study shows a 
predominantly radial approach and operators are familiar with the technique. The reason 
for a higher OD with radial access is likely due to the operator standing closer to the 
radiation source and this observation has previously been highlighted as a possible reason 
for a higher OD.(47,173) 
 
Biplane imaging 
Unsurprisingly, biplane imaging was demonstrated to significantly increase high PKA and 
OD rates. Biplane imaging uses an additional C-arm and X-ray source to acquire images 
and it has previously been demonstrated to increase FT, DA(176) and PKA.(56) The study 
by Lin et al also demonstrated that imaging of saphenous vein grafts and patient gender 
impact on PKA,(56) a finding that is has been replicated in this study, where the CORS-
GRAFTS procedure category was demonstrated to be associated with a high PKA and OD 
under univariate and multivariate analysis. Biplane imaging takes more images and may 
increase magnification, as it requires the anatomy to be placed in the isocentre of the 
image in both planes, positioning the patient closer to the X-ray source, which will increase 
skin dose. In addition, biplane imaging may increase the air-gap between the patient and 
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the detector, increasing the incident air Kerma. These factors will also impact on OD and 
the ceiling suspended lead shield may be more difficult to position in order to protect the 
operator from the additional radiation from the two C-arms.  
 
X-ray system used 
It is interesting that one X-ray system delivered more PKA than the other and that this was 
a significant predictor under multivariate analysis for a high PKA. This did not, however, 
equate to a high OD. Both systems were identical models of the same age and used the 
same imaging protocols and exposure parameters. One explanation for this finding may be 
a difference in dose area product meter (DAP meter) readings between the two systems. 
Median PKA varied only slightly between the systems. Both systems were tested on a 
regular basis for dose outputs and the accuracy of the DAP meter, and there are 
acceptable error ranges for DAP meters. Others studies suggest that an error of ±25% is 
usually deemed acceptable,(19,22) which is far greater than the difference seen here. 
 
Procedural Categories 
Coronary angiography (CORS) was used as the baseline/reference procedure category for 
this study and the other categories were compared against this. CORS is seen as the 
baseline procedure of cardiac angiography, with most other procedure categories building 
on it. CORS and CORS-AO/LV account for 71.6% of procedures in this study. Only AFA, 
PA and RHC procedures did not include coronary angiography.  
It is unsurprising therefore that those procedure categories that built on the CORS 
reference procedure, demonstrated a higher PKA. Of the procedure categories, CORS with 
pulmonary angiography (CORS-PA) was the strongest procedural predictor for a high PKA. 
CORS-PA had the highest median PKA and DA count. CORS-PA routinely uses bi-plane 
angiography, in which the planes are used in the posterior-anterior projection and lateral 
projection for the PA component. The lateral projection is very steep and steep or more 
extreme angles have been shown to increase PKA.(177)  
Intra coronary assessment of coronary artery disease with the use of pressure wires (FFR) 
and intra-vascular imaging with OCT or IVUS is also shown to impact on PKA, although it 
did not reach significance for a high OD. The results here show that these additional 
assessment tools increase the FT, PKA and DA for diagnostic procedures. FFR is 
recommended in the assessment of intermediate lesions prior to revascularisation(178) 
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and the use of these additional tools may increase over time so it is therefore important to 
measure their impact on radiation dose. 
 
Operator Experience 
Operator experience is shown to impact on PKA during CA under multivariate analysis. 
After correcting for other variables, the least experienced operators (registrars) were 
statistically more likely to deliver high PKA values and these findings complement those of 
the REVERE trial where less experienced radial access operators delivered a higher 
PKA.(170) The higher PKA seen is possibly due to increased fluoroscopy times when 
manipulating guide wires and catheters, and possibly a higher number of repeat DA from 
catheters disengaging mid-acquisition. A higher number of DA and FT for inexperienced 
operators was also noted in the REVERE trial.(170) Other studies have demonstrated a 
difference between individual operators in terms of FT, KAR and PKA delivered, though this 
was not attributed to experience level.(175,179) Operator experience did not appear to 
impact on OD in this study. All operators had training in the use of radiation and the 
effective use of protection measures, supplemented through annual refresher training. 
 
Limitations: 
While not measured in this study, the effective use of the ceiling suspended shield would 
make a significant impact on OD and this should be analysed in future studies. Beam kV, 
mAs and beam geometry were not collected for each procedure, given the cohort size and 
this could have impacted on dose for different procedures. 
 
Conclusions 
This study demonstrates that radiation dose to patients and the operator performing the 
procedure is multifactorial and is affected by both patient and procedure related variables. 
Some variables impact on radiation dose more than others and some variables are 
predictive of a high PKA, some predictive of a high OD, and some both. Overall, a high 
patient BMI is the strongest predictor for both a high patient and operator radiation dose. 
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Current implications 
This study was published in 2019. As such it is very current and contemporary. 
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Prologue 
In the previous chapter factors that contribute to high doses for the patient and the primary 
operator were investigated. Percutaneous intervention for structural pathology of the heart 
requires a larger team than for angiography. During these newer, more contemporary and 
complex procedures, occupational radiation dose is not just a concern for the primary 
operator. The additional staff members may stand close to the patient during these 
procedures, particularly the anaesthetist and the trans-oesophageal  echocardiogram 
(TOE) operator. The radiation dose to the team for these procedures has had little 
investigation and chapter 4 set out to fill this void in the literature.
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Radiation Exposure of Operators Performing Trans-oesophageal Echocardiography 
During Percutaneous Structural Cardiac Intervention 
 
Introduction 
Percutaneous interventional procedures, guided by fluoroscopy for structural pathology of 
the heart are now commonplace and procedures such as trans-catheter aortic valve 
implantation (TAVI) offer an alternative treatment option to open heart surgery (180). 
These procedures and many others, including left atrial appendage (LAA) occlusion and 
MitraClipTM implants require guidance with trans-oesophageal echocardiography (TOE) in 
addition to fluoroscopy (4,82). This exposes the echocardiographer and/or 
echocardiologist who operate the TOE probe and console to the harmful effects of 
scattered ionising radiation. Whilst recent publications have highlighted the risks of 
radiation to the staff performing fluoroscopically guided cardiac procedures (63,64,78), 
none of these studies were inclusive of radiation dose to TOE operators in this 
environment. 
Primary operators, usually the cardiologist performing the procedure, have tableside and 
ceiling suspended lead shields in place to protect them from the harmful effects of 
radiation. These are usually only in place on the right side of the procedure table, where 
the primary operator and their assistant stand. There is often no specific additional 
protection installed at the head end or left side of the procedure table where the TOE 
operator would stand. Recent guidelines have highlighted the risks of radiation to TOE 
operators and the lack of evidence surrounding radiation dose to TOE operators (83). All 
staff working in this environment are monitored with optically stimulated luminescent 
dosimeters (OSL) that are interrogated on a monthly basis. While all staff wear these 
dosimeters, they do not demonstrate how much radiation dose each staff member may 
receive on a case by case basis. 
With the lack of evidence surrounding this issue, this study sought to measure the 
radiation dose to TOE operators during percutaneous interventional procedures that 
require TOE guidance and compare their dose to other members of the multidisciplinary 
heart team. Secondly, we sought to investigate procedural factors that would impact on 
total radiation dose and the TOE operator dose. Additional lead shielding was also 
implemented for the TOE operator and the effectiveness of the shielding solution was 
measured. 
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Methodology 
This single, tertiary centre, observational study, conducted between September 2014 and 
November 2015 included all x-ray guided procedures requiring TOE guidance in a single 
hybrid operating theatre, equipped with a contemporary cardiovascular X-ray system 
(Siemens Artis Zee ceiling, Siemens Healthcare, Erlangen, Germany).  
Four key roles (Primary catheter operator (OP1), secondary catheter operator (OP2), 
anaesthetist (ANA) and the TOE operator (TOEOP)) who were in attendance wore an 
instantly downloadable dosimeter (IDD) (InstadoseTM Mirion technologies USA) for the 
duration of each procedure. The IDD was worn on the outside of the lead thyroid 
protection collar by all key staff, except for the TOEOP, who attached the IDD to the 
posterior aspect of their left shoulder, so that the dosimeter faced the radiation source. 
The IDD is a direct ion storage dosimeter, the basic principles of which are well described 
in the literature (181-183). The dosimeter is based upon the storage of charge in a non-
volatile analogue (MOSFET) memory cell, surrounded by a small volume of air, essentially 
acting as an ion chamber.  When scattered radiation emanating from the patient is incident 
on the detector, ionisation occurs within the ion chamber, altering the stored charge.  This 
change in charge provides a measure of the air kerma (mGy) incident on the detector.  
The exposure can then be downloaded by connecting the dosimeter to a computer.  The 
personal dose equivalent Hp(10) (mSv) is then calculated by the application of an 
appropriate algorithm, by the computer, which takes into consideration the typical photon 
energy incident on the dosimeter.  The IDD has a broad dose and energy response of 
0.01mSv – 5 Sv and 5 KeV – 6 MeV respectively (NVLAP lab code 100555-0 for ANSI 
N13.11-2009 categories IA, IIA, and IIC).  
The personal dose equivalent Hp(d) is defined as the dose equivalent in soft tissue below a 
specified point on the body at an appropriate depth. For penetrating x-rays this depth is 
10mm and therefore denoted as Hp(10). Hp(10) is normally considered to provide a 
conservative or close approximation to effective dose (E)(184). However as the IDD was 
located outside the protective apron, Hp(10) in this case would significantly overestimate 
effective dose. The results in Hp(10) were therefore converted to effective dose, by dividing 
the value by 21, in line with the methodology outlined in the NCRP 168 document (172).  
This conversion allows for the dose across key staff to be compared along and with other 
studies. 
 
Radiation protection 
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All personnel working in the hybrid theatre wore a lead apron or apron and skirt with a 
minimum of 0.25mm of lead equivalent properties at the back and 0.5 mm at the front. A 
collar for thyroid protection was also worn. In addition, there was the option for staff to 
wear a lead lined theatre hat and lead goggles with lead equivalent properties of 0.5 mm. 
OP1 and OP2 stood on the patient’s right side for all procedures, with the exception of 
surgical access TAVI procedures, where OP1 stood either on the patients’ left side (trans 
apical access TAVI) or at the head of the procedure table (trans aortic TAVI procedures). 
OP1 and OP2 were protected by a table mounted lower body radiation lead shield (skirt), 
with 1mm lead equivalent properties and when standing on the patient’s right side, a 
ceiling mounted “drop down” lead Perspex shield with 0.5mm lead equivalent properties. 
The ANA was positioned at the head of the patient and was provided with a lead Perspex 
shield on wheels with 1mm lead equivalent properties. The TOEOP was positioned at the 
head of the patient, toward the patients left side and stood obliquely, predominantly with 
their back to the x-ray source. The TOEOP had access to use the Perspex shield on 
wheels but had no other specific additional protection. A plan view of approximate staff 
and shielding positions is demonstrated in Figure 4.1.  
 
Procedural radiation measures collected were: 
 Procedure type. 
 Fluoroscopy time (FT). 
 Total radiation dose (Kerma area product (KAP)). 
 Patient body mass index (BMI). 
 Patient gender. 
 C-arm projection most used during each procedure. 
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Figure 4. 1 - Graphical representation of approximate positions of key staff 
members and lead protection apparel. 
Legend: This diagram shows the approximate location of the key personnel monitored 
during structural cardiac intervention procedures and their position relative to the c-arm (X-
ray source). It shows the position of lead shield on wheels which was available for the ANA 
and TOEOP and the position of the table and ceiling suspended shielding for OP1 and 
OP2. In addition, the position of the additional ceiling suspended shielding is shown, which 
was implemented for a further 50 procedures (dotted line). (ANA = anaesthetist, OP1 = 
primary operator, OP2 = secondary operator, TOEOP = Trans-oesophageal 
echocardiography operator). 
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Procedures  
To aid analysis, procedures were grouped into the following categories: 
 Trans-femoral transcatheter aortic valve implant or intervention (TAVITF). 
 Transcatheter aortic valve implant or intervention using open surgical access, either 
trans-aortic or trans-apical (TAVIS). 
 Mitral valve intervention (MVI). 
 Left atrial device implant (LADI). 
 Ventricular or atrial septum intervention/implants (VASI). 
 
Additional protection measures for TOEOP 
After reviewing data from the initial procedures, steps were taken to reduce TOEOP dose 
and an additional ceiling suspended lead Perspex shield with 0.5mm lead equivalent 
properties (Mavig GmbH, Munich, Germany), identical to that available to OP1 was 
mounted to the ceiling of the hybrid theatre, such that the TOEOP could use it for 
additional protection (Figure  4.2). With this solution in place, dosimeters were worn for a 
further 50 procedures and the results from the IDD, worn by the four key roles, compared 
for procedures before and after the additional protection was installed. Facility human 
research ethics committee approval was granted for this study. 
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Figure 4. 2 - Image of the angiography suite with additional ceiling suspended lead 
shield. 
Legend: This image shows the position of the additional ceiling suspended lead shield 
(arrow) used by the TOE operator for additional protection in the final 50 procedures. It is 
of the same style as that used by OP1, which is also shown. The authors advocate this 
typeof shielding to be used for procedures where TOE operators are required on a regular 
basis. 
 
Analysis 
In line with other studies investigating radiation dose levels (166), and international 
guidelines (7), the Kerma –air –product (KAP) was used as the primary measure for 
overall radiation dose and patient dose. Effective doses were compared across procedure 
type and TOEOP individuals. The c-arm projection most used during each procedure were 
divided into five categories and each key operator effective dose per unit of KAP (E/KAP) 
was analysed across these categories. C-arm projection categories were defined as: 
Steep RAO ( > -20o (STRAO)), RAO (-6 o to -20 o RAO), PA (-5 o to +5 o), LAO (6 o - 20 o 
LAO), Steep LAO (>20o (STLAO)). A Pearson correlation coefficient was used for 
correlation of TOEOP E against the different radiation measures. Categorical data was 
compared across groups with a Chi – squared or Fishers exact test. Continuous variables 
were tested for normality and groups were compared using a Mann-Whitney U test or 
Student’s T test as appropriate. Statistical significance across multiple groups was 
performed using a Kruskal Wallis or ANOVA test as appropriate. Multivariate linear 
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regression was performed to investigate independent predictors for TOEOP dose from the 
variables collected. A small constant was added to all TOEOP dose values and natural 
logarithmic transformations were applied. Scatter plots of continuous predictors by the log-
transformed outcomes were examined and KAP was also log-transformed for use in 
regression modelling.  Variables with p-values <0.2 in univariable linear regression models 
were entered into a multivariable linear regression model. Variables with p-values <0.05 
remained in the final model. Regression coefficients were exponentiated to obtain the 
relative effects of predictors on the outcome variable measured in the original units. SPSS 
v22 (IBM) was used for analysis. 
 
Results 
There were 98 procedures performed prior to the installation of the additional ceiling 
mounted lead Perspex shield and a further 50 procedures after installation. Overall, 
patients were 54.7% male with a median BMI of 28.70 (IQR = 24.09-32.64). There was no 
significant difference in gender for procedures before and after the additional lead 
protection was installed; (58.2% male vs 48.0% male p=0.240), though there was a 
difference in patient BMI (29.73 (24.39-33.96) before, 26.26 (23.66-30.84) (p=0.012) after). 
 
Procedures without additional TOE operator protection 
Before the additional protection was present, a significant difference in radiation dose 
across the key roles was demonstrated (p<0.001). Median TOEOP E was the highest of 
the key roles, though not statistically higher than OP1 E- 2.62 (IQR = 0.95-4.76) vs 1.91 
(0.48-3.81) µSv (p=0.101), but was significantly higher than OP2 E- 0.48 (0.00-1.91) µSv 
(p<0.001)) and ANA E- 0.48 (0.00-1.43) µSv (p<0.001)) (figure 4.3).  
Many of the patient and radiation measures were significantly different across the 
procedural categories. Median TOEOP E was significantly different across procedure 
groups, with LADI procedures demonstrating the highest Eat 4.76 (IQR 3.81 -11.91) )  µSv 
and TAVIS the lowest E at 0.95 (0.00 -1.91) µSv (p<0.001). A predominantly steep right 
anterior oblique (STRAO) projection was more likely in LADI procedures (100%) and not 
used in other procedures, including TAVIS (0%) and TAVITF (0%), (p<0.001) (Table 4.1). 
TOEOP E had the strongest correlation with KAP (r=0.547, p<0.001).  
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Table 4. 1 – Patient, procedural and radiation dose related data for each procedural 
group for procedures before the additional lead protection for the TOE operator was 
installed. 
Measure All 
(N=98) 
TAVIS 
(N=19) 
TAVITF 
(N=33) 
LADI 
(N=14) 
MVI 
(N=24) 
VASI 
(N=8) 
p= 
Male 
Gender (N) 57 (58.2%) 
11 
(57.9%) 
18 
(54.5%) 10 (71.4%) 
15 
(62.5%) 3 (37.5%) 0.595 
BMI 
(Kg/m2 ) 
29.73 
(24.39-
33.96) 
27.89 
(23.44-
33.54) 
29.71 
(24.44-
35.49) 
33.55 
(30.49-
37.04) 
24.89 
(21.87-
29.19) 
35.49 
(32.90-
43.16) 
<0.001 
FT 
(minute) 
15.6  
(10.2-21.1) 
9.1  
(7.6-
10.5) 
17.4  
(14.2-
20.2) 
11.2 
(9.4-14.8) 
22.3 
(17.6-
35.45) 
13.3 
(9.3-15.2) <0.001 
KAP 
(Gy.cm2) 
88.26 
(59.63-
154.72) 
69.66 
(46.65-
95.70) 
143.04 
(73.46-
200.85) 
123.23 
(74.51-
154.72) 
62.89 
(38.79-
103.99) 
113.16 
(53.77-
172.43) 
0.002 
STRAO 
Projection 
21 (21.4%) 0 (0%) 0 (0%) 14(100%) 6 (25.0%) 1 (4.8%) <0.001 
 
Footnote: This table demonstrates the medians (inter-quartile range) for patient and 
radiation related variables across the different procedure categories prior to the installation 
of the additional protection shield. (BMI = body mass index, FT = fluoroscopy time, KAP = 
Kerma air product, STRAO = Steep right anterior oblique,). LADI Left atrial device implant, 
MVI Mitral valve intervention, TAVITF = Trans-femoral transcatheter aortic valve implant or 
intervention, TAVIS = Transcatheter aortic valve implant or intervention using open 
surgical access, either trans-aortic or trans-apical, VASI = Ventricular or atrial septum 
intervention/implant. 
 
The TOEOP effective dose/KAP (E/KAP)composite value, when grouped by predominant 
c-arm angle demonstrated that doses were higher in procedures where more RAO and 
steep RAO projections were used (p=0.041)  OP1 E/KAP was also significantly different 
across C-arm projections, with the PA projection demonstrating the highest value 
(p=0.045). E/KAP for the other team members E/KAP did not differ significantly across c-
arm projection categories, OP2 – p=0.856, ANA – p=0.366) (Figure 4.4).  
 
There was a large difference in the number of procedures that individual TOE operators 
performed, ranging from 1 procedure for one operator to 39 procedures for another. 
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However, there was no statistically significant difference in any patient, procedural or 
radiation related variable across the individual operators. There was no significant 
difference in radiation dose to the other key personnel across TOEOP categories. 
 
Impact of additional TOE operator protection 
After the additional protection was installed, median TOEOP E was reduced by 81.7% -
2.62 (IQR = 0.95-4.76) vs 0.48 (IQR 0.00-1.43) µSv (p<0.001)) (Figure 3.3). Radiation 
dose to the other key personnel did not change significantly with the installation of the 
additional protection. All other variables were not significantly different, other than patient 
BMI and KAP. The procedure numbers across procedure categories were not significantly 
different after the installation of the additional shielding (p=0.173). The TOEOP E/KAP 
value was significantly lower with the additional protection in place; 28.42 (13.47-52.64) vs 
8.40 (0.00-18.53 µSv) p<0.001) (Table 4.2). 
 
Univariate and multivariate linear regression demonstrated that the use of the shield was 
significantly associated with TOEOP radiation dose. A 76% (95% CI 59-86%) (p<0.001) 
reduction in TOEOP dose is demonstrated in procedures where the shield was in place, 
compared to those without the shield after correcting for the other variables in the 
multivariate model. The procedure type was also demonstrated as a significant predictor 
for TOEOP dose, with LADI procedures demonstrating an 8.7 times greater dose than the 
reference group: TAVIS (p<0.001). KAP was also demonstrated as a significant predictor 
(p<0.001). 
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Table 4. 2 - Impact of the implementation of additional lead shielding for the TOE 
operator 
 No Shield (N = 98) Shield (N = 50) p= 
Male Gender (N) 57 (58.2%) 24 (48.0%) 0.240 
BMI (Kg/m2 ) 29.73 (24.39-33.96) 26.26 (23.66-30.84) 0.012 
FT (minute) 15.6 (10.2-21.1) 15.9 (10.3-20.8) 0.971 
KAP (Gy.cm2) 88.26 (59.63-154.72) 64.14 (42.68-123.20) 0.048 
TOEOP E/ KAP ratio) 
(µSv/Gy.m2) 28.42 (13.47-52.64) 8.40 (0.00-18.53) <0.001 
STRAO Projection 35 (21.4%) 8 (16%) 0.648 
TOEOP E (µSv) 2.62 (0.95-4.76) 0.48 (0.00-1.43) <0.001 
OP1 E (µSv) 1.90 (0.48-3.81) 2.86 (0.95-4.76) 0.129 
OP2 E (µSv) 0.48 (0.00-1.90) 0.95 (0.00-2.86) 0.176 
ANA E (µSv) 0.48 (0.00-1.43) 0.00 (0.00-1.43) 0.559 
Procedure type   0.173 
TAVIS (N)% 19 (19.4%) 9 (18%)  
TAVITF (N)% 33 (33.7%) 25 (50%)  
LADI (N)% 14 (14.3%) 2 (4%)  
MVI (N)% 24 (24.5%) 12 (24%)  
VASI (N)% 8 (8.2%) 2 (4%)  
 
Footnote: This table compares the different patient and radiation measures before and 
after the installation of additional radiation shielding for the TOEOP. All values are median 
(inter-quartile range). (ANA = anaesthetist, BMI = body mass index, FT = fluoroscopy time, 
KAP = Kerma air product, LAO = left anterior oblique , OP1 = primary operator, OP2 = 
secondary operator, STRAO = steep right anterior oblique, TOEOP = trans-oesophageal 
echocardiography operator, LADI Left atrial device implant, MVI Mitral valve intervention, 
TAVITF = Trans-femoral transcatheter aortic valve implant or intervention, TAVIS = 
Transcatheter aortic valve implant or intervention using open surgical access, either trans-
aortic or trans-apical, VASI = Ventricular or atrial septum intervention/implant). 
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Figure 4. 3 - Radiation dose to TOE operators compared to the rest of the team and 
the impact of additional radiation protection. 
 
Legend: Radiation dose to the TOE operator is relatively high per procedure when 
compared to the rest of the attending team (a) but can be reduced by 82% by installing 
additional ceiling suspended lead protection (b). (ANA = anaesthetist, OP1 = primary 
operator, OP2 = secondary operator, TOEOP = Trans-oesophageal echocardiography 
operator). 
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Figure 4. 4 - Operator effective dose /KAP composite measure grouped by C-arm 
projection. 
 
Legend: This box plot maps the significant incremental increase in TOE operator 
radiation effective dose per unit of KAP (E/KAP) from the steep LAO projection 
through to the steep RAO projection (p=0.041), before the additional shielding was 
in place. OP1 also demonstrated a significant difference in effective dose (0.045). 
The other key personnel monitored did not demonstrate a significant difference 
across c-arm categories. It highlights the need for TOE operators to be vigilant with 
their position relative to the c-arm in procedures with predominantly RAO 
projections. (ANA = anaesthetist, KAP= Kerma area product, OP1 = primary 
operator, OP2 = secondary operator, LAO = left anterior oblique, PA = posterior 
anterior, RAO = right anterior oblique, STLAO = steep left anterior oblique, STRAO = 
steep right anterior oblique, TOEOP = Trans-oesophageal echocardiography 
operator). 
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Discussion 
These results demonstrate that before the additional ceiling suspended protection was in 
place, there was a significant radiation dose to the TOE operator for structural intervention 
procedures requiring TOE support. The dose is at least as high as the dose to the primary 
operator, with the associated risks from radiation. Radiation dose to primary operators 
performing percutaneous cardiac procedures have been associated with cataracts (78) 
and higher rates of orthopaedic illness and cancer (64). Other studies have also found a 
higher incidence in left sided brain tumours in physicians performing cardiac procedures 
(63). The American Society of Echocardiography issued guidelines in 2014 in an effort to 
highlight the radiation risks associated with percutaneous structural intervention 
procedures and ways to reduce that risk, including additional shielding. It too highlighted 
the paucity of data on this important topic (83). There is good data for radiation dose to 
operators during coronary angiography and intervention (43,67) and additional protection 
measures have proved to be effective in reducing radiation exposure (185). However, to 
date there is no data with regard to radiation dose to TOE operators assisting with these 
procedures. 
Drews et al investigated radiation dose to key personnel during surgical TAVI procedures 
with a mean KAP of 86.61 Gycm2, similar to the 88.26 Gycm2 median overall KAP in this 
study. They reported a mean E of 17.5µSv for the anaesthetist/TOE operator, compared to 
a median E of 2.62µSv for the TOEOP in the present study. However, in that study, the 
anaesthetist performed the echocardiography, which is a different model to the dedicated 
TOE operator seen in the present study. In addition, their methodology in calculating 
effective dose also differed (85). 
The dose to the primary operator can also be compared. The median OP1 E of 1.9 µSv in 
the present study appears similar to the 2.3 µSv and 1.2 µSv of the radial and femoral 
access arms, respectively, of another study investigating operator radiation dose during 
acute myocardial infarction intervention (67). Again, however, a slightly different method to 
calculate E was used, as E cannot be directly measured. 
At this centre, the TOEOP face their back to the radiation source, thereby potentially 
lowering the effectiveness of the lead garment. As such, TOE operators should take care 
to ensure that there is adequate lead equivalent protection in the rear of the lead apron 
and ‘backless’ style lead aprons should be avoided completely. TOEOP dose was not 
significantly different between operators, indicating that the high doses seen were not 
attributed to the working practices of one or two individuals but more likely related to the 
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close proximity of the TOEOP to the radiation source. Increasing their distance from the 
source would reduce the dose but this is difficult to achieve whilst operating the TOE probe 
and the utilization of the lead shield on wheels is ergonomically challenging. 
Procedures with increasing steepness of RAO c-arm projections are demonstrated in this 
study to deliver higher doses to the TOEOP. In comparison, the lowest E/KAP to the 
primary operator is seen in procedures with steep RAO projections. This is in agreement 
with a previous study that demonstrated the lowest operator dose with RAO projections 
and considerably higher doses from backscatter when LAO projections were used (177). 
In a similar manner, highest TOEOP E/KAP is seen in the present study with increasing 
steepness of RAO projections, as they are stood on the left side of the patient and are 
more exposed to the higher backscattered radiation. TOE operators should be mindful of 
this when performing left atrial and mitral valve procedures, where RAO projections are 
predominantly used. If it is possible to stand on the patient’s right side for these 
procedures, then this should be considered. Radiation doses to the TOEOP were 
significantly  lower after the implementation of the ceiling suspended shield, however 
doses to OP1 did not significantly decrease and were higher than the TOEOP when both 
had ceiling suspended shields present. The higher dose to OP1 is likely due to the shorter 
distance between the patient and OP1 during procedures and the fact that the shield may 
have been difficult to use for certain procedures, such as TAVIS, where the PA projection 
is commonly used and in this study, higher doses are demonstrated. 
Normalising the operator’s dose to KAP is advantageous as it then accounts for 
confounding factors that impact on operator dose. KAP is the primary measure for the 
amount of radiation used for the procedure. It is a measure of the dose output from the X-
ray system and the area exposed. KAP was lower for procedures after the installation of 
the additional protection and is possibly due to the lower patient BMI in that group; 
however, E/KAP was demonstrated to be significantly lower after the installation of the 
additional protection, indicating that the lower KAP was not the reason for the lower 
TOEOP doses.  
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Conclusion 
This study highlights a comparatively significant scattered radiation dose to TOE operators 
during percutaneous structural intervention, with the associated risks involved. The 
radiation dose is at least as high as that to primary operator and doses are higher for 
procedures with predominantly RAO c-arm projections. With the additional ceiling-mounted 
lead protection in place, radiation dose to TOE operators was reduced dramatically. Based 
on these results, the authors advocate that similar shielding devices should be 
implemented in cardiac catheterisation theatres and hybrid operating theatres where TOE 
operators are utilised to facilitate these procedures on a regular basis. 
 
Perspectives 
Competency in medical knowledge: TOE operator radiation dose during percutaneous 
structural intervention is relatively high when compared to other attending staff. 
Translational Outlook 1:  Radiation dose to TOE operators can be significantly reduced 
with additional lead shielding. Specifically, the installation of a ceiling mounted lead shield 
for TOE operators is recommended for all cath labs and hybrid operating rooms where 
TOE support is required on a regular basis. 
 
Limitations 
This was a single centre observational study and the work practices could be unique to 
this centre and the results could have been affected by this. However, the findings are 
relevant to all centres performing structural interventions 
 
Current implications 
This study was published in 2018 and is very contemporary literature. It has been recently 
cited (April 2020) by the Society of cardiovascular angiography and intervention (SCAI) in 
their multi-society position statement. This document outlines the risks of radiation 
exposure in the cath labs and advocates a culture of increased safety, education and 
adoption of new technologies.(186) 
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Chapter 5  -  
Incorporated as Chapter 5: 
J. Crowhurst, M. Whitby. Lowering fluoroscopy pulse rates to reduce radiation dose during 
cardiac procedures. J Med Radiat Sci. 65 (2018) 247–249. 
 
Details of my contribution to authorship: 
I was contacted by the relevant journal for this editorial. I performed a literature review of 
all relevant, previously published material and reviewed current guidelines. I analysed the 
relevant publication content. As lead author, wrote the manuscript before sending out for 
critical review by the co-author. I liaised with the relevant journal for publication as 
corresponding author and made suggested changes in line with editorial review. 
 
Prologue 
In the previous chapter, radiation dose to the team performing structural intervention was 
investigated, with the finding that the TOE operator received the highest dose of the team. 
Additional shielding was used to reduce the dose but there are other ways to reduce 
radiation dose during these procedures. The previous chapter, discussed the relationship 
between radiation dose output from the X-ray system and staff dose. The next chapter is 
an editorial written on request for the Journal of Medical Radiation science that discusses 
radiation dose reduction, with a particular focus on fluoroscopy pulse rate reduction.  
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Lowering Fluoroscopy pulse rates to reduce radiation dose during cardiac 
procedures. 
 
Radiation dose to patients undergoing cardiac imaging procedures in cardiac 
catheterization laboratories (cath labs) can be relatively high so implementing strategies to 
reduce dose should be a priority for radiation practitioners and catheter operators when 
working in this environment. Radiation dose to patients should be kept as low as 
reasonably achievable (ALARA principle) and during cardiac procedures utilizing 
fluoroscopy, radiation dose parameters including fluoroscopy time, accumulated air kerma 
(at the reference point, Ka,r ) and air kerma area product (Pk,a) should be monitored 
throughout the procedure and recorded in the patient record.(7) The air kerma area 
product or dose area product (DAP) is an important measure in estimating radiation dose 
to the patient, as it is a measure of both the incident air kerma and the area of the patient 
exposed. In addition, the incident air kerma at a reference point from the radiation source 
is a useful measure in estimating the peak skin dose. Fluoroscopy time (FT) is less 
indicative of the radiation exposure as it does not capture information regarding the 
fluoroscopy pulse rate, the dose per pulse and the number of digital acquisitions although 
it may give an indication of the complexity of the procedure. 
There are many ways in which patient dose can be reduced during cardiac procedures, 
even before optimising the exposure settings of the equipment.  These include, using good 
beam geometry, maintaining a minimal patient to detector distance and keeping the patient 
as far away from the X-ray tube as possible. Collimating tightly to the area of interest and 
not overusing electronic magnification is also important.  In addition, the inherent 
advantage of newer systems allow for far greater functionality to adapt default post 
processing parameters, helping to find the correct balance between image quality and 
radiation dose for an individual department/ cath lab. 
   126 
Crowhurst Thesis 2018  126 
 
 
However, one of the easiest ways to reduce dose is to reduce the fluoroscopy pulse rate 
and/or the digital acquisition frame rate. The advantage of this strategy being that it can be 
easily adjusted mid-procedure, without interrupting workflow on most modern X-ray 
systems. Normally, fluoroscopy pulse rates of between 7.5 and 15 pulses per second 
(PPS) are used for coronary angiography and the choice of pulse rate is dependent on the 
operator’s preference. The publication by Badawy et al in JMRS explores the possibility of 
using a new image processing protocol and fluoroscopy pulse rates as low as 3 PPS.(33) 
Their well written retrospective study investigates the impact of reducing the fluoroscopy 
pulse rate on the total dose area product (DAP) for the procedure. To our knowledge, this 
is the first study to report pulse rates as low as 3 PPS for coronary angiography. The study 
reported that a significant reduction in DAP (up to 58%) and Ka,r could be achieved by 
operating as low as 3 PPS, with no significant increase in fluoroscopy time. The authors 
highlighted the inevitable image quality changes with this approach, such as a reduction in 
temporal and spatial resolution as well as a degradation of low contrast detectability.  
However, after a period of adjustment, with appropriate changes made to post processing 
parameters, such as noise reduction, edge enhancement and temporal filtering, 
acceptable image quality could be maintained. Though all procedures were successfully 
completed in the 3 PPS protocol without protocol deviation, only one operator utilized the 
3PPS technique. This paper demonstrates that the 3 PPS technique is feasible but future 
studies investigating this technique should investigate multiple operators using this 
technique and procedural complication data should be included. This would demonstrate 
that this technique is safe when being implemented more widely. 
Other studies have also investigated reducing fluoroscopy pulse rates for coronary 
angiography: Abdelaal et al investigated this in a randomized controlled trial in 2014.(29) 
The study cohort was 363 patients undergoing coronary angiography, with or without ad-
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hoc percutaneous coronary intervention (PCI). In their trial, patients were randomised, at a 
ratio of 1:1 using sealed envelopes to indicate whether their procedure was to be 
undertaken at either 15 PPS or 7.5 PPS. All X-ray system parameters other than the pulse 
rate were the same. During diagnostic coronary angiograms, fluoroscopy time was non-
significantly different between the groups but DAP was 26% lower in the 7.5 PPS group 
and interestingly, operator dose saw a 40% relative reduction in the 7.5 PPS group. These 
results indicate how lower pulse rates can significantly reduce radiation dose to patients 
and in addition, to the staff performing the procedure.(29) A natural progression of this 
work is in the optimisation of the digital acquisition (DA) parameters, as DA is used to 
document the vascular anatomy and is of a higher dose than fluoroscopy. Adjusting DA 
parameters would also have the potential to contribute to a large reduction in patient and 
operator dose. 
Implications for staff radiation dose 
The study by Badawy et al(33) also has implications for the radiation dose to the staff 
present, particularly the primary operator, who stands closest to the patient during these 
procedures. Radiation exposure to staff working in cath labs can be significant. Staff that 
work in this environment have been reported to be at a higher risk of developing certain 
pathologies, such as skin lesions, cataracts, depression, orthopaedic problems and thyroid 
disease in comparison to staff that do not work in cath labs(64).  Further to these findings, 
an increase in the risk of skin lesions, hypertension, hypercholesterolemia and cancer 
across years of working in cath labs was also reported(64). As such, it is important that 
every effort should be made to reduce radiation exposure during cardiac fluoroscopy 
procedures. This is especially relevant to those that may spend their entire career working 
in this environment. 
Electrophysiology Procedures 
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Lowering fluoroscopy pulse rates are also a particularly important dose reduction tool 
during electrophysiology procedures as electrophysiology procedures perform few digital 
acquisitions so the majority of the radiation exposure comes from fluoroscopy. Using a 
modern X-ray system, with low fluoroscopy pulse rates and a low dose per pulse has 
previously been demonstrated to reduce DAP by over 90%, when compared to an older 
generation system.(187) That study also tailored the image processing to this low pulse 
rate and low dose rate protocol. Using a pulse rate of 3 PPS for most electrophysiology 
procedures has been advocated by the European Heart Rhythm Association (EHRA).(69)  
Radiation Safety implications 
The paper by Badawy et al(33) in JMRS demonstrates the impact that proactive staff 
working in the cath lab can have on the radiation exposure of the patient. Using an X-ray 
system ‘straight out of the box’ without some form of customization to the local 
environment is ill advised. The team using the equipment, including the treating physician, 
radiographer, medical physicist and equipment manufacturer should optimize the 
equipment for procedures, depending on its use, which may be different from other sites 
using the same model. Furthermore, ideally, the X-ray system should be optimized for 
individual operators, as each will have preferences in terms of image quality (e.g. can 
tolerate more noise, prefers more edge enhancement).   
Fluoroscopy pulse rates, acquisition frame rates and the radiation dose for each pulse can 
be readily changed on most modern fluoroscopy systems. Further software changes that 
will enhance the image can also be optimised. In addition, it is important for the team to 
have multiple options for radiation protocols to suit the needs of the procedure. These 
protocols should be adjusted during the procedure as required and this should be 
performed in conjunction with the continuation of good radiation practice, such as optimal 
beam geometry and adjusting collimation and filtration as necessary. This paper is an 
excellent example of how exploring imaging options beyond those traditionally used can 
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reduce radiation exposure to low levels, which is of benefit to the care of the patient and 
the staff working in this environment. Sensible, iterative changes, where minor, 
progressive adjustments are made to the imaging protocol can lead to significant patient 
and staff radiation dose reductions. 
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Chapter 6 –  
J. Crowhurst, H. Haqqani, D. Wright, M. Whitby, A. Lee, J. Betts, R. Denman. Ultra-low 
radiation dose during electrophysiology procedures using optimized new generation 
fluoroscopy technology. Pacing Clin Electrophysiol. 2017 Aug;40(8):947-954 
 
Details of my contribution to authorship: 
I wrote a research study outline and protocol after reviewing current literature. I designed 
the study in consultation with local experts (co-authors). I performed a literature review of 
all relevant, previously published material and reviewed current guidelines. I wrote the 
research protocol and sought and obtained ethical committee approval. I liaised with 
relevant experts in the field and obtained permission for use of data from relevant 
stakeholders. I collected the relevant data. 
I analysed the data obtained, performed calculations and statistical analysis. I continued 
consultation with local experts in the field (co-authors) and as lead author, wrote up the 
findings before sending out the manuscript for critical review by the co-authors. I liaised 
with the relevant journals for publication as corresponding author and made suggested 
changes in line with peer review. 
 
Prologue 
Chapter 5 discusses radiation dose reduction for cardiac procedures, with a particular 
focus on fluoroscopy pulse rate reduction in order to reduce dose. With that in mind, 
chapter 6 focusses on radiation dose reduction during electrophysiology procedures, 
where particularly long fluoroscopy times may be seen and which have previously been 
associated with high radiation doses.(86) This chapter describes features of newer 
generation X-ray systems that allow them to be configured to reduce dose and the dose 
reductions that can be made. It also puts the magnitude of dose reduction in perspective, 
with some comparisons to other studies in the literature. 
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Ultra Low Radiation Dose During Electrophysiology Procedures Using Optimised 
New Generation Fluoroscopy Technology 
 
Introduction: 
Electrophysiology (EP) procedures require catheters to be manipulated accurately inside 
the heart. Fluoroscopic imaging uses ionising radiation to enable visualisation of the 
various catheters which are used for recording, pacing, mapping and ablation. Procedures 
have become increasingly complex in recent years and this is associated with longer 
fluoroscopy times, resulting in the potential for greater radiation exposure for the 
patient.(2) Inserting permanent pacemakers (PPM) and internal cardiac defibrillators (ICD) 
generally require less fluoroscopy than for radiofrequency ablation (RFA) but bi-ventricular 
devices have been associated with four times the dose of conventional rhythm 
devices.(188) A recent publication has highlighted the risks of low energy radiation over 
long periods of time to the operator(64) and the side effects of high radiation doses to the 
patient, in terms of radiation-induced dermatitis are well recognised.(2)  
Cardiovascular fluoroscopy systems have seen considerable advances over the years and 
can be more readily configured peri-procedurally to tailor the imaging to the needs of the 
procedure. The number of pulses per second and the dose per pulse can be adjusted mid 
procedure. Together, these beam properties will affect the overall radiation dose as well as 
the resulting image quality. 
Electroanatomic 3D mapping systems (Carto3 (Biosense Webster, Diamond Bar, CA, 
USA) and NavX (St Jude Medical MN USA)) and nonfluoroscopic magnetic guidance 
systems (MediguideTM, St Jude Medical, St Paul, MN, USA) have recently emerged as 
additional technologies that allows catheters to be displayed in real time. The latter uses 
pre-recorded fluoroscopic loop images and electromagnetic signals, without further use of 
fluoroscopy.(99) These systems do, however, add additional cost to EP laboratory 
installations, and ongoing consumable costs by way of catheter purchase. 
This study aimed to investigate what radiation dose reductions can be achieved by 
upgrading from an older image intensifier unit to the latest generation digital fluoroscopy 
system, optimised to reduce radiation dose but without changing clinical practice. 
Secondly, we aimed to compare the radiation dose levels obtained with the new system to 
previously published studies that focused on radiation dose reduction in electrophysiology 
procedures. 
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Methods 
Radiation dose parameters were prospectively collected for all EP procedures in a single 
EP laboratory, in a tertiary level institute. The parameters collected were: Patient age, sex, 
height and weight, the procedure type, fluoroscopy time (FT), dose area product (DAP), 
the number of digital acquisitions (DA), procedural time (from patient on table to patient off 
table) (PT) and procedural success (PS). These data were collected between February 
2013 and February 2014 when an image intensifier based single plane cardiovascular 
imaging system (Philips Integris Allura H5000, Philips Healthcare, Einhoven, Netherlands) 
was used for EP procedures. These same parameters were also prospectively collected 
between March 2014 and March 2015, when the older system was replaced with the latest 
generation single plane cardiovascular fluoroscopy system, using a flat panel detector 
(Siemens Artis Q ceiling, Siemens Healthcare, Erlangen, Germany).  
Procedures were separated into seven groups:  
 Devices: Permanent pacemaker (PPM) and Internal cardiac defibrillator devices 
(ICD) (including both dual and single chamber). 
 BIV: Bi ventricular cardiac resynchronisation devices (BIV PPM and BIV ICD). 
 EPS: Diagnostic electrophysiology studies without ablation  
 RFA: Radiofrequency ablation (RFA) for supraventricular tachycardia (SVT), atrial 
flutter (AFL) and AV node/HIS bundle ablation. 
 VAA: Ventricular arrhythmia (VA) ablation, including focal ablation of premature 
ventricular ectopics (PVCs), as well as idiopathic and scar related ventricular 
tachycardia (VT). 
 CAA: Complex atrial arrhythmia ablation (excluding atrial fibrillation). 
 PVI: Pulmonary vein isolation for atrial fibrillation. 
 
Equipment settings 
All procedures were performed by one of six experienced electrophysiologists, with or 
without the assistance of a fellow in training. These physicians were all trained and 
licensed by state authorities in the safe and appropriate use of fluoroscopic equipment and 
were assisted by a qualified, licensed cardiac radiographer. This team worked together to 
optimise both radiation dose and image quality throughout the procedures.  
With the older system, the fluoroscopy pulse rate was set to 6.25 pulses per second 
(PPS). Three dose rates were available: low, normal and high, with the system defaulting 
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to the lowest. This system was used without the stationary grid in place. With the new 
system, the pulse rate defaulted to 4 PPS and rates could be increased from 4 to 6 to 7.5, 
10 or 15 PPS and detector input dose for fluoroscopy could be increased from 6 nGy/ 
pulse to 12 or 23 nGy/ pulse. This system was used with the stationary grid in place for all 
procedures. The imaging field was used at 23cm and 25cm field of view respectively and 
the beam was optimally collimated with both systems to the area of interest, for each 
phase of each procedure as necessary.  
Both imaging systems were checked for image quality and radiation dose compliance on 
an annual basis by a medical physicist. DAP readings were taken using a calibrated DAP 
meter housed in the X-ray tube housing. Nominal x-ray dose rates were measured using a 
calibrated solid state detector (Unfors Xi by RaysafeTM, Billdal, Sweden) on both systems 
with a 200mm Perspex phantom placed in the beam and a source to detector distance of 
700mm.  
In addition, the results for each procedure type from this study with the new system were 
compared to other studies in the literature that focused on radiation dose reduction in 
electrophysiology procedures. 
This study was approved by our institutions Human Research Ethics Committee. 
Statistical analysis 
Data were assessed for normality with a Shapiro-Wilk (or KS test) and reported as means, 
standard deviations or medians and interquartile ranges. Student’s T test and Mann-
Whitney U tests were used for inferential testing as appropriate. Fisher’s exact test was 
used to compare categorical variables. Statistical significance was defined as p <0.05. 
SPSS V.20 (IBM) was used for analysis of data. 
 
Results: 
Typical default fluoroscopy settings and the results of annual testing for both systems are 
summarised in Table 6.1. There are various technical differences between the two 
systems and dose rate under testing was 87% lower (1.76 vs 0.23 mGy/minute) with the 
new system. 
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Table 6. 1 - Default x-ray system fluoroscopy settings- as measured using a 200mm 
Perspex phantom. 
 
 Old System New system 
Image Field size (cm) 23 25 
Fluoro dose rate 
(mGy/minute) 1.76 0.23 
Frame rate (PPS) 6.25  4 
X-ray tube voltage (kV) 61 77 
X-ray tube current (mA) 7.9 95.1 
Pulse width (ms) 10 3.8 
Copper filtration (mm) 0 0.9 
Stationary Grid used in 
testing Yes Yes 
 
Footnote: This table demonstrates the differences in the default fluoroscopy settings of 
the 2 x-rays systems used in this study when measured by a solid state detector, with a 
200mm perspex phantom. (cm = centimetre, mGy = milliGray, PPS = pulses per second, 
kV = Kilovolt, mA = milliamp, ms = milliseconds, mm = millimetre) 
 
1537 clinical procedures were included in the study, 776 with the old system and 761 with 
the new system. Comparisons of patient demographics and radiation dose metrics for 
each procedure group are given in table 6.2. Patient weight was not significantly different 
between the old and new system cohorts for any of the procedure types. Procedure times 
were not significantly different between these cohorts, with the exception of the devices 
group where procedure times were longer with the old system. Fluoroscopy times were 
similar in all groups with the exception of the devices, BIV and EPS groups, where the 
times were lower with the new system. Overall, DAP was 91% lower with the new system 
(from 5.0 (2.0-17.0) to 0.45 (0.16-2.61) Gycm2 (p>0.001)) and was significantly lower 
across all procedure groups with the new system (figure 1). The greatest reduction (93%) 
was seen in the EPS group (2.0 (1.0-4.5) to 0.14 (0.05-0.41) Gycm2 (p>0.001)). 
Procedural success was not significantly different between the two systems in any of the 
procedure groups. A comparison of the radiation dose levels from the new system to 
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previously published studies focusing on radiation dose reduction are presented in table 
6.3. These results demonstrate that radiation doses with the new system in this study are 
consistently some of the lowest published in the literature across all procedure groups. 
 
 
Figure 6. 1 - Box plot graph graphically demonstrating the difference in DAP 
between the old system and the new system for each procedure type. 
 
Legend: This figure graphically demonstrates the dose reduction between the old system 
and the new system. (AF = atrial fibrillation, BIV = bi ventricular devices, CAA = complex 
atrial arrhythmia, DAP = dose area product, Devices = permanent pacemakers and 
internal cardiac defibrillators, EPS = diagnostic electrophysiology studies, RFA = radio-
frequency ablation for simple atrial pathology, VAA = Ventricular arrhythmia ablation). 
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Table 6. 2 - Patient demographics and procedural comparisons of the two X-Ray systems analysed. 
Procedure  N= Age (years) Male% Height (cm) Weight (Kg) FT (min) DAP (Gycm2) DA PT (hr: min) PS% 
Devices  
 
Old 385 74.2 (62.1-81.6) 63.6% 169 (159–177) 80 (65 - 97) 5.3 (3.3 - 8.5) 3.0 (2.0-5.0) 0 (0-0) 1:20 (1:05-1:35) 100% 
New 340 71.4 (61.2-81.2) 62.9% 170 (160–176) 80 (69 – 95) 3.6 (2.4 – 5.9) 0.22 (0.10-0.41) 0 (0-0) 1:12 (1:00-1:30) 100% 
P=  0.094 0.877 0.780 0.458 <0.001 <0.001 0.941 <0.001 1.000 
BIV 
Old 59 64 (56-73) 81.4% 173(167–178) 94 (77-104) 20.3 (14.8-36.1) 26.0 (13.0-43.0) 4 (2-6) 2:15 (1:50-3:00) 100% 
New 56 63 (57-76) 73.2% 175 (169–180) 87 (75-100) 15.2 (9.9-28.0) 4.1 (2.3–7.4) 2 (1-5) 2:05 (1:40-2:30) 100% 
P=  0.771 0.374 0.302 0.219 0.261 <0.001 0.043 0.388 1.000 
EPS 
Old 72 51.3 (31.2-67.0) 62.5% 170 (163-177) 83 (70-95) 4.2 (2.0-7.8) 2.0 (1.0-4.5) 0 (0-0) 1:40 (1:20-2:00) 100% 
New 99 41.0 (27.7-56.2) 47.5% 170 (163-179) 78 (66-94) 2.3 (1.3-5.4) 0.14 (0.05-0.41) 0 (0-0) 1:35 (1:20-2:00) 100% 
P=  0.022 0.063 0.961 0.211 0.042 <0.001 0.991 0.956 1.000 
RFA 
Old 150 52.9 (36.1-64.5) 46.7% 169 (163-177) 81 (67-95) 22.2 (13.2-34.4) 11.0 (5.0-20) 0 (0-2) 2:20 (1:55-2:55) 98.7% 
New 137 52.9 (33.7-66.9) 47.4% 169 (163-176) 80 (65-97) 17.4 (10.5-34.1) 1.34 (0.60-2.71) 0 (0-0) 2:07 (1:45-2:43) 94.2% 
P=  0.767 0.906 0.844 0.896 0.260 <0.001 0.012 0.054 0.052 
VAA 
Old 46 60.1 (53.2 69.7) 47.7% 169(162-178) 89 (74-102) 39.4 (28.0-48.2) 26 (15-40) 1 (0-3) 4:20 (3.40-4:55) 89.1% 
New 52 58.7 (43.0-69.2) 52.3% 172 (165-177) 86 (74-97) 37.1 (23.5-54.8) 4.85 (2.46-7.59) 0 (0-2) 4:10 (3:15-4:45) 82.7% 
P=  0.840 0.834 0.467 0.492 0.544 <0.001 0.275 0.107 0.271 
PVI 
Old 45 56.7 (49.4-64.3) 57.8% 173 (165-177) 90 (81-103) 39.7 (34.2-52.1) 31.0 (22.0-43.0) 1 (0-2) 4:35 (4:10-5:10) 88.9% 
New 54 56.1 (44.0-66.5) 77.8% 176 (167-185) 89 (77-108) 42.1 (36.2-52.0) 7.10 (3.83-15.78) 1 (0-2) 4:35 (3:50-5:10) 88.9% 
P=  0.927 0.049 0.148 0.836 0.618 <0.001 0.884 0.983 0.517 
CAA 
Old 19 40.5 (26.3-66.3) 47.4% 169 (161-174) 70 (59-98) 45.4 (32.4-60.9) 25.0 (12.0-46.0) 0 (0-1) 4:18 (3:50-5:00) 78.9% 
New 23 38.7 (29.9-53.5) 56.5% 173 (164-178) 87 (73-95) 38.7 (29.9-53.5) 3.76 (2.25-7.28) 0 (0-2) 4:00 (3:30-4:30) 87.0% 
P=  1.000 0.757 0.151 0.860 1.000 <0.001 0.243 0.920 0.682 
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Table 6.2 Footnote: All data are expressed as medians and inter-quartile ranges. (BIV = bi-ventricular devices, CAA = complex atrial 
ablation. DA= Digital Acquisition, EPS = electrophysiology study, FT= Fluoroscopy time, PVI = pulmonary vein isolation, RFA = 
radiofrequency ablation, PT=Procedural Time, PS= Procedure Success, VAA = ventricular arrhythmia ablation).
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Table 6. 3 - Comparison of this study to the literature for different categories of 
procedures. 
Study Procedure type Guidance system used 
Fluoroscopy Time 
(Minutes) 
Dose Area Product 
(Gycm2) 
PPM and ICD implants 
Perisinakis at al 
2005(188) PPM /ICD N/A 8.2 ± 3.7 11.06 ± 2.80 
Perisinakis et al 
2005(188) Bi-V PPM/ ICD N/A 35.2 ± 21.7 47.65 ± 9.65 
Tsapaki et al 
2008(86) PPM N/A 87 (55-225) 6.7 (1.1–167) 
Richter et al 
2013(189) Bi-V  Mediguide
TM 5.2 (3.0-8.4) 10.7 (6.9 -17.4) 
Thibault et al 
2015(190) Bi-V Mediguide
TM 6.5 (4.3, 10.7) 7.69 (4.91- 21.82) 
Attanasio et al 
2016(91) PPM/ICD/BIV N/A 13 ± 15 13.72 ± 26.59 
Thibault et al 
2016(105) BIV Mediguide
TM 5.1 (2.8-9.1) 1.08 (62-229) 
This study (New 
system) PPM /ICD N/A 3.6 (2.4 – 5.9) 0.22 (0.10-0.41) 
This study (New 
system) BIV  N/A 15.2 (9.9-28.0) 4.1 (2.3–7.4) 
Simple RFA procedures 
Earley et al 2006(95) 
(conventional) 
RFA (AVNRT, 
AVRT, flutter) N/A 13 (2-46) 12 (1-106) 
Earley et al 2006(95) 
(Carto) 
RFA (AVNRT, 
AVRT, flutter) Carto 6 (1-55) 5 (1-89) 
Earley et al 2006(95) 
(NavX) 
RFA (AVNRT, 
AVRT, flutter) NavX 4 (0-50) 2 (0-54) 
Tsapaki et al 
2008(86) Various RFA NS 110 (44-420) 83.5 (3-259) 
Rogers et al 
2010(88) 
Simple RFA 
(AP, AVNRT, 
Flutter, AVN) 
N/A 21.3 ±18.5 8 ±10.3 
Vallakati et al  
2013(100) 
RFA (flutter, 
AVNRT, WPW, 
EPS) 
MediguideTM 8.25 ±4.9 70.79 ±70.72 
Sommer et al 
2013(101) SVT Mediguide
TM 0.5 ±1.4 1.87 ±5.54 
Lee et al 2014(191) RFA (AVNRT, WPW, CBT) N/A 8.8 ±6.9 2.7 ±4.2 
Malliet et al 
2015(192) Atrial Flutter Mediguide
TM 0.8 (0.4-2.5) 1.61 (0.65-5.37) 
This study (New 
system) RFA N/A 17.4 (10.5-34.1) 1.34 (0.60-2.71) 
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Table 6-3 cont... 
 
AF ablation and VT ablation 
Rogers et al 2010(88) Complex (AF,VT, CHD) Carto/NavX 52. 7 ± 23.3 32.8 ±31.7 
Dekker et al 
2013(107) 
AF/atrial/VT 
ablation Carto/NavX 24 (IQR=±13) 8.8 (IQR=±8.2) 
Sommer et al 
2014(193) (last 50 
patients in cohort) 
AF MediguideTM 1.1 (0.7–1.5) 4.90 (2.30–6.54) 
Malliet et al 2015(192) AF MediguideTM 12.5 (7.6-17.4) 11.07 (9.06-20.33) 
Schneider et al 
2015(90) AF Carto /NavX 13.3 ± 8.3 8.37 ± 6.47 
Knecht et al 
2015(194) PVI Carto 3 4.2 (2.6-5.6) 13.2 (6.2-22.2) 
Attanasio et al 
2017(91) PVI  13.62 ± 7.11 2.26 ± 2.77 
This study (New 
System) PVI Carto 3/ NavX 42.1 (36.2-52.0) 7.10 (3.83-15.78) 
This study (New 
system) VAA Carto 3/ NavX 37.1 (23.5-54.8) 4.85 (2.46-7.59) 
 
Footnote: This table demonstrates how the fluoroscopy time and dose area product from 
the new system in this study compares to other studies in the literature. There are many 
differences in study methodologies and endpoints with the studies cited. The lowest dose 
group or the overall dose from each study has been cited as deemed appropriate. DAP 
data have been converted to Gycm2 for standardisation where necessary. (3rd Q = third 
quartile, Bi V = bi- ventricular device, AF = atrial fibrillation, AP = accessory pathway, AVN 
= artioventricular nodal ablation, AVNRT = Atrioventricular nodal re-entry tachycardia, 
AVRT = Atrioventricular re-entry tachycardia, CBT = concealed bypass tract ablation, CHD 
= Congenital heart disease, EPS = Electrophysiology study, ICD = Internal cardiac 
defibrillator, IQR = Inter quartile range, N/A = not applicable, NS = not stated, PPM = 
Permanent pace maker, PVI= Pulmonary vein isolation, RFA = Radio frequency ablation, 
VT = Ventricular tachycardia, VAA = ventricular arrhythmia ablation, WPW = Wolf 
Parkinson White). 
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Discussion 
These results demonstrate that very low radiation doses can be achieved with this newer 
digital imaging system, even with prolonged fluoroscopy times. For example, PPM or ICD 
device insertions can be performed with a median DAP value of 0.21 Gycm2. This appears 
comparable to that quoted for a lateral chest x-ray (0.24 Gycm2) in one national audit.(18) 
Though it is unsurprising that the newer system achieves a lower dose than the older 
model, it is the magnitude of reduction (over 90%) that is impressive. The new system 
used in the study is the vendor’s latest model. In order to achieve the low dose rates, the 
new system’s x-ray tube allows greater pre-filtration and shorter pulse widths. This should 
equate to sharper images and less patient dose. The system was configured by hospital 
electrophysiologists, technical staff and a medical physicist, in conjunction with the 
manufacturers’ staff in an effort to optimise the image quality during low dose fluoroscopy. 
There are also image processing options which were optimised at the time of installation. 
Image processing software is not unique to this vendor. Other vendors have invested in 
image processing technologies with significant reductions in dose, whilst maintaining 
image quality, verified in a randomised, controlled trial.(107) 
A lower dose per pulse can be used for fluoroscopy, which lowers overall radiation dose 
but this will reduce image quality. Image quality is not the primary focus for EP procedures. 
EP catheters are of quite large diameter (4-8mm) and are highly radio-opaque. In most 
cases, the primary purpose of fluoroscopy is to guide catheters into position, rather than to 
accurately document anatomy. Lower image quality is therefore acceptable for the majority 
of procedures. Because of the low dose per pulse and low pulse rate used in this study, 
long fluoroscopy times are demonstrated in the VAA and PVI ablation groups, when 
compared to the literature, without this translating to high radiation doses. Figure 6.2 
demonstrates a typical image from the new system used in the study, with the detector 
input dose set to 6nGy/pulse.  
 
The fluoroscopy pulse rate was also reduced with the new system to a default setting of 4 
PPS. This default setting is higher than the 3 PPS advocated by Heidbuchel at al(69) and 
the 2 PPS in other studies(91,191), indicating that there are further dose savings that 
could be made. 
The systems’ settings were consciously optimised peri-procedurally for each procedure 
and when higher image quality was necessary, such as during transeptal and epicardial 
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punctures or during placement of left ventricular leads for BIV implants, a higher dose per 
pulse and/or pulse rate was used but this was reduced again when high image quality was 
no longer required.   
 
 
Figure 6. 2 - Example image from the new x-ray system at low dose settings. 
Legend: This image shows is a typical example of a still frame produced at the low dose 
fluoroscopy setting with the new (Siemens Artis Q) x-ray system. The patient was an 87kg 
female presenting for an AVNRT ablation procedure. It also demonstrates appropriate 
collimation of the x-ray beam to the area of interest. 
 
Beam collimation was also consciously optimised for both systems in this study, which can 
also reduce DAP as it reduces the area imaged. These combined strategies for dose 
reduction are not new and have been clearly outlined as dose reduction strategies in the 
literature.(2,69) It would seem that the ability to lower fluoroscopy dose and pulse rates to 
these levels is an important factor for dose reduction.  
The dose reduction strategies described here with the new system were relatively easy to 
achieve. The dose per pulse and pulse rates are low but an acceptable image was still 
produced and procedural success was not compromised as a result. All 
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electrophysiologists were comfortable with the image quality as a result of the reduced 
dose and pulse rates. Whilst these strategies have reduced the radiation dose to new 
levels with this new system, these strategies could be implemented on other contemporary 
fluoroscopy systems and similar results should be possible. 
Removal of the X-ray systems’ stationary grid has also been demonstrated to significantly 
reduce dose(88) and the grid was removed for all procedures with the older unit in this 
study. The newer system in this study was operated with the stationary grid in place, again 
demonstrating that there may be further dose savings to be made with this system by 
removing the stationary grid. 
Local, multicentre radiation dose benchmarking for coronary angiography and intervention 
was performed in 2014, demonstrating a median dose of 39.08 Gycm2 for coronary 
angiography and 87.36 Gycm2 for coronary intervention.(166) This is 29.2 and 65.2 times 
higher respectively than that of the RFA group in this study with the new system and is 3.6 
times and 7.9 times higher than the RFA group with the older system used in this study. 
However, another study found that DAP for RF ablation procedures were shown to be 
higher than both coronary angiography and coronary intervention. Although that study did 
not state whether a lower dose protocol was used for the RF ablation group, or whether 
the same dose setting and frame rates were used for all procedure groups.(86) 
Comparisons have been made to the literature in terms of radiation dose in table 3. Whilst 
there may be some differences in study methodologies and endpoints between the various 
studies, the present study demonstrates very low radiation doses across all procedure 
categories. The results for pulmonary vein isolation (PVI) in this study are comparable to 
those studies using magnetic guidance systems for AF ablation.(192,193) These systems 
remove the requirement of fluoroscopy once the initial images are taken. Meticulous dose 
optimization of fluoroscopy equipment may result in similar radiation dose reduction than 
that conferred by magnetic guidance systems, which serve primarily to reduce fluoroscopy 
but also add additional cost. However, magnetic guidance systems have also been shown 
to reduce procedure duration,(100,105) which is an important factor in a busy institute. 
Other 3D mapping systems (Carto and NavX) have also been demonstrated to 
significantly reduce radiation dose and fluoroscopy time.(95) Both these systems were 
employed for catheter ablation procedures in this study. Studies have also demonstrated 
that catheter ablation procedures can even be performed without the need for fluoroscopy 
at all.(96) 
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The use of magnetic guidance system technologies, in conjunction with optimal imaging 
equipment and low dose configuration has the potential to reduce radiation doses to very 
low levels.  However, due to its simplicity and ubiquitous availability, fluoroscopy will 
continue to remain for many EP procedures, particularly if it can be used at the dose levels 
seen here. 
 
Limitations 
This was a retrospective observational study over two years in a single EP laboratory and 
not a randomised controlled study so there may be confounding factors over the two time 
periods that were not accounted for. The doses obtained with the older system compare 
favourably with prior published experience, however, ‘fluoro image store’ was not available 
on the old system so comparative fluoroscopy images could not be supplied. 
 
Conclusion 
In the EP laboratory, implementation of a contemporary cardiovascular digital imaging 
system, with meticulous optimization of low dose fluoroscopy settings and continued 
adherence to good radiation practice principles can result in marked reductions in radiation 
doses without prolonging procedural time or compromising procedural success. Doses can 
be reduced to levels comparable to those achieved by magnetic guidance systems, 
without limiting the use of fluoroscopy. 
 
Conflicts of interest: 
None declared. 
 
Current implications 
This publication dates back to 2017. The X-ray equipment studied is the latest generation 
and there are no other publications since that have demonstrated lower doses using a 
similar strategy. One 2019 publication used a slightly older X-ray system, but still 
contemporary and investigated dose saving strategies in cardiac device implantations. 
They used a dose per pulse of 10nGy per pulse as opposed to the 6nGy per pulse in the 
present study and a pulse rate to 2 PPS, lower than that used in the present study. This 
resulted in a median dose of 30 CGycm2 for single chamber devices and 326 CGycm2 for 
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CRT devices.(195) By comparison, the doses in the present study are reported as 22 and 
410 CGycm2 , which appear to be similar. A further study in 2019 established a multi-
centre DRL for device implants. In that study, median doses obtained were 115 CGycm2 
for single chamber devices and 1410 CGycm2 for CRT devices. This was not specifically 
an investigation into low doses but none the less, demonstrates the current situation with 
median doses across multiple centres.(196) 
A further 2019 paper investigated ultra-low dose with a similar X-ray system with a slightly 
different detector (Siemens Artis Q.Zen). They reported SVT ablation doses of at 429 
CGycm2 and 1890 CGycm2 for AF ablation.(197) This compares to 134 and 710 CGycm2 
in the present study which appears to be favourable for the author’s institution’s continued 
efforts for radiation reduction and ongoing radiation safety. 
 
  
 145 
 
Crowhurst Thesis 2018  145 
 
Chapter 7 –  
J. Crowhurst, M. Savage, V. Subban, A. Incani, O. C. Raffel, K. Poon, D. Murdoch, R. 
Saireddy, A. Clarke, C. Aroney, N. Bett, D.L. Walters.  Factors Contributing to Acute 
Kidney Injury and the Impact on Mortality in Patients Undergoing Trans-catheter Aortic 
Valve Replacement. Heart Lung Circ. 2016 Mar; 25(3):282-9 
 
Details of my contribution to authorship: 
I wrote a research study outline and protocol after reviewing current literature. I designed 
the study in consultation with local experts (co-authors). I performed a literature review of 
all relevant, previously published material and reviewed current guidelines. I wrote the 
research protocol and sought and obtained ethical committee approval. I liaised with 
relevant experts in the field and obtained permission for use of data from relevant 
stakeholders. I collected a significant portion of the relevant data. 
I analysed the data obtained, performed calculations and statistical analysis. I continued 
consultation with local experts in the field (co-authors) and as lead author, wrote up the 
findings before sending out the manuscript for critical review by the co-authors. I liaised 
with the relevant journals for publication as corresponding author. Peer review required no 
further changes. 
 
Prologue 
Moving on from the risks associated with fluoroscopy and radiation dose, this thesis now 
investigates the risks of one of the other key requirements for angiography – that being 
Iodinated contrast media (ICM). ICM is essential for angiography to demonstrate the 
anatomy and new, contemporary structural heart procedures such as trans-catheter aortic 
valve replacements (TAVI) require modest volumes of contrast media. Contrast media is 
known to be toxic to the kidneys(14) and previous studies have shown moderately high 
rates of acute kidney injury (AKI) following TAVI.(198) This next chapter investigates AKI 
following TAVI procedures and the relationship with contrast media. It also investigates 
other predictors of AKI and the impact on hospital stay and mortality. 
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Factors Contributing to Acute Kidney Injury and the Impact on Mortality in Patients 
Undergoing Trans-catheter Aortic Valve Replacement 
 
Introduction 
Elderly patients with significant aortic stenosis have a poor prognosis without surgery to 
replace the valve (199). However, they are often deemed too high risk for an operation 
because of frailty or significant comorbidities (3,199,200). Transcatheter aortic valve 
replacement (TAVI) is an alternative to conventional open heart surgery in the treatment of 
severe symptomatic aortic stenosis in this patient group (149,201,202). These patients are 
at an increased risk of complications, particularly acute kidney injury (AKI). The incidence 
of AKI in patients undergoing TAVI is reported to be as high as 41.7% (198) and post TAVI 
renal failure was listed as the most common complication at 30 days in the local SOURCE 
ANZ registry (203). AKI has been associated with increased length of hospital stay 
(112,116), 30 day (115) and one year mortality (204).  
Iodinated contrast media (ICM) may adversely affect renal function, termed contrast 
induced nephropathy (CIN) (13). ICM causes cellular injury and death to renal tubular cells 
(14). In patients undergoing TAVI, the relationship between AKI and ICM is not conclusive, 
with some studies indicating that ICM use impacts on AKI (205) and others reporting that 
there is no relationship(115,204,206-210). It is suggested that the high incidence of AKI in 
this elderly group of patients is multi-factorial, with comorbidities such as age, 
hypertension (207), peripheral vascular disease (PVD) (198,204) and chronic obstructive 
pulmonary disease (COPD) (115) being associated with a higher incidence of AKI. To date 
there are limited local data for AKI incidence and outcomes in patients undergoing TAVI in 
Australia. This study aimed to investigate AKI in an Australian TAVI centre and investigate 
how AKI is related to ICM usage, baseline patient characteristics and TAVI procedural 
data.  This study had four aims: 
Determine the relationship between ICM volume and AKI in this cohort. 
Determine what risk factors or baseline characteristics are related to patients that suffer 
AKI during TAVI in this cohort. 
Determine any procedural factors that have not been previously reported that may predict 
AKI. 
Investigate the impact of AKI on hospital length of stay and early, mid and long term 
mortality in this cohort. 
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Material and Method 
209 consecutive patients who underwent TAVI procedures between August 2008 and July 
2013 were included. The study encompassed TAVI patients in whom either the Corevalve 
(Medtronic), Edwards Sapien valve (Edwards Lifesciences) or the Lotus Valve (Boston 
Scientific) were implanted. It excluded those who had a TAVI device implanted in pre 
existing prosthetic aortic valves and those who had presented for repeat TAVI. It included 
patients who had TAVI devices implanted from the femoral artery, via the trans-apical 
approach and via the trans-aortic approach. 
All patients were imaged with Iopromide Ultravist 370 mg/cc (Schering AG, Berlin, 
Germany) contrast media, using a Siemens Artis Zee (Siemens AG, Erlangen, Germany) 
cardiovascular imaging suite in a hybrid operating theatre. All patients were pre-hydrated 
with 0.9% sodium chloride saline at a rate of 20 cc/hour unless otherwise indicated. 
Baseline patient characteristic data and procedural data were collected prospectively and 
entered into a database. Other measures were collected post-procedure, including post-
procedural complications, blood results, hospital length of stay and mortality at 72 hours, 
30 days and 1 year. 
AKI was defined in each group by the modified RIFLE classification, as published by the 
updated Valve Academic Research Consortium definitions (VARC 2) (113). This group 
defines AKI as an increase in serum creatinine of 150-200% (stage 1), 200-300% (stage 2) 
or >300% (stage 3). Comparisons were made between patients who did and did not suffer 
AKI, in terms of baseline patient characteristics, procedural data and outcomes. Approval 
for this study was granted by the facilities’ human research ethics committee. 
 
Statistical Analysis: 
Univariate analysis was carried out on all baseline, procedural and follow-up patient 
characteristics. Categorical variables were compared with a Fisher’s exact test and 
continuous variables with a 2-tailed Students t-test. Multivariate logistic regression was 
utilised to compare the variables that demonstrated a p-valve >0.1 and that also had >5 
events in either group in the univariate analysis. ANOVA calculations were performed to 
determine significance between AKI stages and mortality. Kaplan Meier curves were 
created to demonstrate mortality between AKI groups. Significance was determined where 
probability (P-value) was determined to be < 0.05. SPSS version 20 was utilised for the 
statistical analysis. 
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Results 
Of the 209 patients in this cohort, 82 developed AKI (39%). Of these 82 patients, 65 had 
stage 1, 9 had stage 2 and 8 had stage 3 AKI (figure 7.1). 
  
 
Figure 7. 1  - Numbers of patients who developed AKI. 
Legend: Figure 1 demonstrates the number of patients that developed AKI in this study 
and what severity category they fall into with reference to the criteria laid out by VARC 2 
(113). (AKI = Acute kidney injury) 
 
Predictions of AKI from baseline characteristics 
Univariate analysis of patient baseline characteristics is demonstrated in table 7.1. Of the 
27 variables, four reached significance: New York Heart Association (NYHA) class 4, 
those patients with chronic kidney disease, those with pre-existing anaemia and those with 
a higher Society of Thoracic Surgeons (STS) (211) score. 
Analysis of Blood samples taken 
Univariate analysis of the results from blood tests obtained before and after the TAVI 
procedures indicated that 39% of patients had an increase in their serum creatinine levels 
consistent with the VARC 2 criteria for AKI (table 7.2). This was reflected by a 
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corresponding fall in their eGFR. Patients who suffered AKI demonstrated lower 
haemoglobin levels prior to their TAVI procedure and haemoglobin levels were lower in 
patients who developed AKI post TAVI. Patients with AKI were also more likely to require 
blood transfusion. 
Procedural variables and Mortality 
Of the procedural variables (table 7.3), AKI was associated with those patients who 
suffered a procedural stroke (CVA), those that required the valve to be repositioned and 
those that suffered respiratory failure. Multivariate analysis highlighted CKD and 
respiratory failure as key predictors of AKI (table 7.4). 
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Table 7. 1 – Baseline Characteristics of patients 
 
Footnote: Baseline statistics for the patients involved in this study. All were patients being 
worked up for re-valving procedures. Median values are given. Numbers in brackets 
indicate the 95% confidence interval or percentage of the population that exhibits that 
factor. (AVA = aortic valve area, BMI = body mass index, MI = myocardial infarction, 
CABG = coronary artery bypass grafts, CAD = Coronary Artery Disease, PPM = 
Item Overall No AKI AKI P-value 
Number of Patients 209 127  (61%) 82    (39%)  
Age (years) 83.1 (82.2-84.0) 83.6 (82.6-84.7) 82.3 (80.7-83.8) 0.143 
BMI 27.5 (26.8-28.3) 27.3 (26.3-28.2) 27.9 (26.8-29.1) 0.384 
Male sex (n) 101   (48%) 58  (46%) 43    (52%) 0.395 
Previous MI (n) 21     (10%) 11  (9%) 10    (12%) 0.482 
Previous CABG (n) 67     (32%) 38  (31%) 29    (34%) 0.650 
Previous PCI (n) 67     (32%) 41  (32%) 26    (32%) 1.000 
CAD (n) 129   (61%) 79  (62%) 50    (61%) 0.885 
Previous PPM (n) 30     (14%) 16  (13%) 14    (17%) 0.425 
Diabetes (n) 69     (33%) 37  (29%) 32    (39%) 0.175 
Hypertension (n) 162   (78%) 96  (76%) 66    (81%) 0.498 
Family History (n) 22     (11%) 14  (11%) 8      (10%) 0.822 
Dislipidemia (n) 146   (70%) 88  (69%) 58    (71%) 0.878 
Smoking (n) 89     (43%) 52  (41%) 37    (45%) 0.569 
Previous Thoracotomy (n) 74     (36%) 41  (33%) 33    (40%) 0.303 
NYHA class 4 (n) 6       (3%) 1    (1%) 5      (6%) 0.035 
LV Dysfunction (n) 29     (14%) 15  (12%) 14    (17%) 0.310 
PAH (n) 48     (23%) 33  (26%) 15    (18%) 0.239 
Previous CVA (n) 42     (20%) 20 (16%) 22    (27%) 0.055 
PVD (n) 59     (28%) 31  (24%) 28    (34%) 0.157 
COPD (n) 84     (40%) 50  (39%) 34    (42%) 0.774 
CKD (n) 85     (41%) 35  (28%) 50    (61%) <0.001 
Pre - existing Anaemia (n) 102   (49%) 54  (38%) 48    (59%) 0.033 
Previous Cancer (n) 63     (30%) 39  (31%) 24    (29%) 0.878 
Previous Radiation (n) 8       (4%) 5    (4%) 3      (4%) 1.000 
Logistic Euroscore  19.6 (18.1–21.2) 19.8 (17.7–21.8) 19.4 (17.1–21.8) 0.860 
STS Score 5.9 (5.5 – 6.4) 5.4 (5.0 – 5.9) 6.7 (5.7– 7.7) 0.009 
STS Score >8 36 (17%) 18 (14%) 18 (22%) 0.189 
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permanent pacemaker COAD = Chronic Obstructive Airways Disease, CVA = Cerebral 
Vascular Accident, GFR = Glomelular Filtration Rate, LVEF = Left Ventricular Ejection 
Fraction LVOT = left ventricular Outflow Tract dimension, NYHA = New York Heart 
Association classification, PVD = Peripheral Vascular Disease. CKD = chronic kidney 
disease, GORD = gastro-oesophageal reflux disease, CCF = Congestive cardiac failure) 
 
Table 7. 2 - Pre and post-procedure blood sample analysis of patients undergoing 
TAVI in this study. 
Item Overall No AKI AKI P-value 
Number of Patients (n) 209 127 82  
Creatinine Pre μmol/l 101.5 (95 - 108) 90.4 (85 - 95) 119 (105 -131) <0.001 
Creatinine Post μmol/l 140.2 (127 - 153) 98.1 (93 -104) 205 (179 -232) <0.001 
Creatinine Increase μmol/l 38.7 (30 - 48) 8 (5 - 11) 87 (69 - 104) <0.001 
GFR pre 58.9 (56 - 62) 63.9 (61 - 67) 51.1 (47 - 55) <0.001 
GFR post 48.0 (45 - 51) 59.4 (56 - 63) 30.4 (27 - 34) <0.001 
GFR Decrease 10.9 (9 - 13) 4.6 (3 - 6) 20.8 (18 - 23) <0.001 
Haemoglobin Pre (g/L) 
124.6  
(122-127) 
126.1 
(123-129) 
122.2 
(119-126) 
0.040 
Haemoglobin Post (g/L) 94.8 (93-97) 97.8 (95-100) 90.4 (87-94) <0.001 
Haemoglobin Decrease 
(g/L) 
29.5 (27.5-31.6) 28.4 (25.8-31.0) 31.2 (27.8-34.6) 0.194 
 
Footnote: Blood samples taken before and after TAVI procedure. Numbers in brackets 
indicate the 95% confidence interval or percentage of the population that exhibits that 
factor. (GFR = Glomerular filtration rate, CKD = chronic kidney disease, TAVI = Trans 
catheter aortic valve implant). 
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Table 7. 3– Procedure based Characteristics of patients undergoing TAVI in this 
study 
Item Overall No AKI AKI P-value 
Number of patients (n) 209 127 (61%) 82 (39%)  
Corevalve (n) 86   (41%) 49   (39%) 37 (45%) 0.389 
Edwards Valve (n) 104 (50%) 63   (50%) 41 (50%) 1.000 
Lotus Valve (n) 19   (9%) 15   (12%) 4   (5%) 0.138 
Surgical Approach (n) 62   (30%) 35   (28%) 27 (3%) 0.440 
Multiple Valves 
Implanted (n) 18   (9%) 8     (6%) 10 (12%) 0.205 
Valve Reposition (n) 7     (3%) 1     (1%) 6   (7%) 0.015 
Paravalvular AR >2 (n) 5     (2%) 3      (2%) 2   (2%) 1.000 
Rapid Burst Pacing (n) 186 (89%) 112  (88%) 74  (90%) 0.821 
Procedural Duration 
(mins) 82.4 (77-87) 81.0 (75-87) 85.2 (77-93) 0.425 
Contrast Media Volume 
(cc) 
228  
(217-239) 
227 
(213-240) 
231 
(212-250) 0.700 
Fluoroscopy Time 
(mins) 
19.4 
(18.1- 20.7) 
19.3  
(17.9-20.8) 
19.6 
(17.2-21.9) 0.875 
Liver Dysfunction Post 
(n) 12 (6%) 0 (0%) 12 (15%) <0.001  
Major Vascular Injury (n) 24 (12%) 15 (12%) 9 (11%) 1.000 
Procedural CVA (n) 8   (4%) 1   (1%) 7   (8%) 0.007 
Procedural MI (n) 3   (1%) 0   (0%) 3   (4%) 0.059 
Respiratory Failure (n) 16  (8%) 4   (3%) 12 (15%) 0.003 
Life threatening 
bleeding (n) 21  (10%) 9   (7%) 12 (15%) 0.099 
Transfusion Required 
(n) 51 (24%) 23 (18%) 28 (34%) 0.013 
New Need for Dialysis  5   (2%) 0   (0%) 5   (6%) 0.009 
72 Hour Mortality (n) 3   (1%) 2   (2%) 1   (1%) 1.000 
30 Day Mortality (n) 11 (5%) 4   (3%) 7   (9%) 0.115 
1 Year Mortality (n) 24 (11.5%) 13 (10%) 11 (13%) 0.511 
Mean ICU LOS (days) 4.1   (3.3-4.9) 3.2  (2.6-3.9) 5.6   (3.8-7.5) 0.004 
Mean Hospital LOS 
(days) 
9.2 
(8.2-10.2) 
7.5  
(6.9-8.2) 
11.7 
(9.6-13.9) <0.001 
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Footnote (Table 7.3): Procedural and post-procedural variables comparing those that 
suffered AKI and those that didn’t. Numbers in brackets indicate the 95% confidence 
interval or percentage of the population that exhibits that factor. (LBBB = left bundle 
branch block, ICU = intensive care unit, LOS = length of stay. CVA = Cerebral vascular 
accident (stroke). 
 
Table 7. 4 – Logistic regression analysis of key variables impacting on AKI 
Factor Odds Ratio 
          95% CI 
p value 
Lower Upper 
CKD 6.078 1.865 19.808 0.003 
Respiratory Failure 27.393 1.953 384.259 0.014 
Blood Transfusion 0.202 0.040 1.025 0.054 
Previous CVA 4.227 0.831 21.499 0.082 
Retrieval Reposition  8.244 0.754 90.106 0.084 
Procedural CVA 11.250 0.315 401.415 0.184 
NYHA Class 4 5.124 0.374 70.126 0.221 
Pre existing Anaemia 1.535 0.438 5.382 0.503 
 
Footnote: This table shows the key variables that demonstrated significance under 
univariate regression in a multivariate logistic model. It shows that respiratory failure and 
chronic kidney disease (CKD) are main predictors for AKI. (CVA = cerebral vascular 
accident, NYHA = New York heart association). 
 
After stepwise removal of non-significant variables, CKD (OR=3.98 (2.14-7.42) p=<0.001), 
respiratory failure (OR=5.77 (1.68-19.83) p=0.005) previous CVA (OR=2.16 (1.01-4.61) 
p=0.047) and valve retrieval/ repositioning (OR=11.21 (1.25-100.58) p=0.031) were 
demonstrated as significant predictors for AKI from the multivariate model. There was an 
increased length of stay in intensive care for patients with AKI (mean 5.6 days vs 3.3 days 
p=0.004) and an increased length of overall hospital stay (mean 11.7 vs 7.5 days 
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p<0.001). There was an insignificant difference in the average volume of ICM used 
between the AKI and non-AKI groups: 227cc (213-240) vs 231cc (212-250) p=0.700). The 
difference in average contrast media volume between each of the AKI groups was also 
insignificant:  Stage 0 = 226.8cc (213.3 - 240.2), stage 1 = 234.6cc (212.9 – 256.3), stage 
2 = 212.8cc (160.5 – 265.1) and stage 3 = 224.4cc (132.7– 316.1, p=0.864). 
Seven patients (4%) were highlighted as requiring the device to be repositioned or 
retrieved, with six of these developing AKI. Six of the seven were Core valves and one 
was an Edwards valve via the trans-apical route. None had died within 30 days or one 
year.  
Five patients (2.4%) required dialysis post TAVI. All five had chronic kidney disease (CKD) 
and had serum creatinine levels over 100 μmol/l prior to TAVI. All five had developed AKI 
levels 2 or 3. Two had died within 30 days and the remaining three were still alive at one 
year.   
Overall, three patients (1.4%) died within 72 hours of their TAVI procedure, with one of 
these having AKI. Eleven patients (5.3%) had died at 30 days, with seven of these 
developing AKI. Twenty four patients (11.5%) had died at 12 months, with 11 of these 
suffering AKI. Mortality did not reach significance at 72 hours, 30 days or at 12 months 
between those patients that suffered AKI and those that did not. However, mortality 
increased with AKI severity. Four of the 127 (3%) that had no AKI, two of the 65 (3%) 
patients that suffered stage 1 AKI, two of the nine (22%) patients that suffered stage 2 AKI 
and 3 of the 8 (37.5%) of patients that suffered stage 3 AKI had died at 30 days (p<0.001). 
No more patients with stages two or three AKI had died at one year than at 30 days post 
TAVI. The mortality for the different stages of AKI is demonstrated through Kaplan-Meier 
curves in figure 7.2. 
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Figure 7. 2  - Kaplan-Meier one year survival for different stages of AKI 
Legend: The Kaplan Meier curves demonstrates the survival for patients that suffered AKI 
in this study. Patients with stage 2 and 3 AKI have a 22% and 38% mortality rate in 
comparison to the 3% mortality of those that suffered either stage 0 or stage 1 AKI. 
 
Discussion 
The 39% overall incidence of AKI in this cohort was higher than some of the literature, 
(206-208) but similar to the 41.7% seen in others (198). This high incidence may be due to 
AKI being defined in this study with all 3 stages of the VARC 2 criteria included (113). Only 
17 (8%) of the 209 patient cohort suffered either stage 2 or 3 AKI and is consistent with the 
8.3% occurrence quoted in another study observing AKI stages 2 and 3 (208). The reason 
for the high overall incidence is unknown, but AKI has traditionally been linked to ICM 
usage and CIN and the 228 cc mean volume seen in this cohort is higher than some of the 
literature (90-219cc) (115,116,205). ICM is associated with AKI as it causes intense and 
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prolonged vasoconstriction and is toxic to the kidney tubules (14). A large study of 16,248 
patients who were administered ICM for radiological examinations demonstrated that the 
risk of death was 5 times higher for patients who developed AKI (212), which is similar to 
the experience in TAVI cohorts with AKI (115,204). Importantly, the study by Levy et al 
demonstrated that renal failure increased the risk of developing fatal non-renal 
complications. Their study suggested that ICM is strongly linked to AKI (212). However, 
Bagur et al demonstrated that surgical treatment of aortic stenosis carried a higher 
incidence of AKI in patients with CKD and that ICM volume was not associated with AKI in 
their TAVI cohort (115). This finding is echoed in other TAVI studies (204,206-210) and it 
is seen here in this present study where there was also no significant difference in ICM 
usage between the AKI groups, indicating that the severity of AKI is not associated with 
ICM. 
Both univariate and multivariate analysis highlighted the existence of CKD as the most 
significant baseline characteristic in predicting AKI. This finding is echoed in a recent 
publication of a large TAVI cohort multi-centre registry where the severity of CKD was 
strongly associated with AKI and patient outcomes (213). In this present study, patients 
with a high SC prior to TAVI were more likely to suffer AKI post TAVI. These patients had 
a higher ICU time and a longer hospital stay which has implications for funding in patients 
suffering AKI post TAVI (116). Also, patients that go on to require dialysis are at a much 
higher risk of developing CKD (214), which may impact on any future procedures or 
examinations. Of the five that required dialysis in this study, all presented with CKD, 
perhaps indicating that the requirement for new dialysis in patients with healthy kidneys is 
rare. The risk of mortality and renal failure post TAVI has previously been demonstrated to 
be higher in high risk patients (STS score >8%) (215) and although there was a significant 
difference in STS scores between the two groups in this present study, this did not 
correspond to a significant difference in numbers of patients with STS scores of >8%. 
In the univariate analysis, baseline haemoglobin and pre existing anaemia were also 
potential predictors of AKI. Other studies have found baseline haemoglobin not to be a 
significant predictor (207) but many have noted a fall in haemoglobin post-procedure, 
which may require blood transfusion (112,115,208). Procedural and post-procedural 
bleeding and the requirement for blood transfusions are seen as predictors of AKI in this 
study but this did not seem to impact on mortality, even though in other studies it has 
(210). 
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In terms of procedural and post-procedural variables, there was no significant difference 
between the surgical and femoral TAVI implantation methods in terms of AKI, even though 
the surgical access route for TAVI has previously been associated with a higher incidence 
of AKI (112,198,206,207). There was also no significant difference between the TAVI 
prosthesis types with regard to AKI.  
Procedural and post-procedural respiratory failure was seen in 16 patients and under 
multivariate analysis was highlighted as a significant factor in predicting AKI. In patients 
with COPD, acute respiratory failure has been highlighted as a major cause of death (216). 
Acute respiratory failure from COPD increases hypoxia and arterial carbon dioxide levels 
and may reduce renal blood flow, glomerular filtration and neurohormonal activation 
(115,217). Although not seen here, COPD has been highlighted as a key factor in 
predicting AKI (115,204) and COPD has also been previously highlighted as a major 
predictor of late mortality in TAVI (218).  
Repositioning or retrieval of the TAVI prosthesis is demonstrated here to be another 
predictor for AKI. This is the first time that this variable has been demonstrated to 
contribute to AKI. This presents another important variable that can impact on AKI. The 
mechanism for AKI through repositioning is unknown but showering of emboli, causing 
renal ischemia as the device moves is certainly a possibility. It may be influenced by other 
factors such as prolonged hypotension from more rapid burst pacing and longer overall 
procedure time.  
In this study, AKI as a whole did not lead to a significant increase in mortality, either in the 
short term or at 1 year. Mortality in this cohort was low: 5.3% at 30 days and 11.5% at 1 
year. However, of those patients that suffered AKI, 20.7% developed stage 2 or 3 AKI and 
their mortality rate was 22% and 37.5% respectively. This is more in line with other studies 
(115,204), suggesting that AKI impacts on mortality only if the patient suffers stage 2 or 3 
AKI. Acute kidney injury has been linked to an increase in mortality in other procedures, 
including thoracic percutaneous endo-vascular aortic repair (TEVAR) (219), suggesting 
that it is not be the valve implant per-se but the invasive nature of these endo-vascular 
procedures and the associated patient comorbidities. 
 
Conclusion 
This study demonstrated that AKI is a common complication of TAVI and that the severity 
of AKI is important in determining mortality. Acute kidney injury does not appear to be 
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dependent on ICM volume. Pre-existing chronic kidney disease, respiratory failure, 
previous stroke and blood tranfusion were highlighted as important predictors for AKI. 
Transcatheter aortic valve implant device repositioning or retrieval was also identified as a 
new risk factor impacting on AKI. 
 
Limitations 
This was an observational study with all the inherent weaknesses that exist with such. The 
number of patients was not large and therefore the number of patients was relatively small 
with respect to the investigation of mortality, though the results clearly demonstrate an 
increased risk of mortality with severity of AKI. Larger, multi-centre studies should be 
performed to demonstrate whether these findings are relevant in a larger population. In 
addition, the study was performed on the first 209 patients undertaken when the TAVI 
procedure was relatively new and the techniques were still being learnt. This would have 
an impact on contrast media use and patient outcomes.  
 
Current implications 
This study was one of the first studies to publish procedural outcomes for patients 
undergoing TAVI in Australia. Though it concentrated on AKI, the data collection was 
substantial and this allowed the detailed procedural outcome investigation and multivariate 
analysis to be performed. A further publication focused the overall patient outcomes in this 
cohort, demonstrated good outcomes and mortality compared to other international 
registries.(220)  It is worth noting that there is a learning curve associated with the TAVI 
procedure. One multi-centre study demonstrated that as centres become more 
experienced with TAVI, there is an improvement with patient outcomes, with decreased 
death, and major bleeding. In addition, one study found that contrast media volumes 
decrease with increased procedural volumes, though in that study there was no difference 
in the requirement for new dialysis and AKI was not reported.(221) A second study found 
similar findings with trans-aortic TAVI procedures, where contrast media volumes 
decreased with increased experience but AKI did not change with increased experience 
(222) 
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Details of my contribution to authorship: 
I performed a literature review of all relevant, previously published material and reviewed 
current guidelines. I had input into sections of the research protocol before ethical 
committee approval was obtained. I led the collection of relevant data. 
I analysed the data obtained, performed calculations and statistical analysis with 
assistance from Dr Jinlin Fu. I continued consultation with local experts in the field (co-
authors) and as lead author, wrote up the findings before sending out the manuscript for 
critical review by the co-authors. I liaised with the relevant journals for publication as 
corresponding author and made suggested changes in line with peer review. 
 
Prologue 
The previous chapter demonstrates the impact of acute kidney injury on the TAVI patient. 
Every effort should be made to reduce kidney injury in these patients and reducing the 
volume of iodinated contrast media is important in that regard. Chapter 8 investigates the 
potential for rotational angiography (DynaCT) to image the ilio-femoral arterial system in 
much the same way as traditional multi-slice computed tomography (MSCT), but with 
lower contrast media volumes. It investigates the ability of this imaging modality in 
comparison to MSCT in this assessment and any advantages and disadvantages that this 
modality may have. 
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Using DynaCT for the Assessment of Ilio-Femoral Arterial Calibre, Calcification and 
Tortuosity Index in Patients Selected For Trans-catheter Aortic Valve Implant 
 
Introduction 
Adequate vascular access for the delivery catheter is fundamental to procedural success 
in femoral approach Trans Catheter Aortic Valve Implant (TAVI).  Vascular access 
complications are likely to be influenced by the femoral delivery sheath size and patient 
anatomy(3,201). Patient suitability for trans-femoral AVR will depend on ilio-femoral vessel 
calibre, the degree of tortuosity and the extent of calcification. If the ilio-femoral access is 
inadequate, a patient may be considered for trans apical or more currently a trans aortic 
approach. 
Femoral and iliac angiography is well established at providing accurate measurements of 
the arterial lumen, as is multi-slice computed tomography (MSCT). MSCT also has the 
benefit of assessing tortuosity and calcification. It is therefore recommended that as a 
minimum, both femoral angiography and MSCT be performed for patients to be considered 
for TAVI by the femoral route. Magnetic resonance imaging (MRI) can also perform this 
role well but it still remains difficult to access in many centres due to the limited number of 
MRI systems being available.  
DynaCT (performing a CT scan using the Cath lab C-arm) has already been proven to be 
of benefit in TAVI procedures when imaging the aortic root for optimization of fluoroscopic 
implant angles(137). DynaCT of the ilio-femoral region would require a direct arterial 
injection and it could easily be performed at the coronary angiography phase of the 
patient’s work-up. It could provide 3D images, as well as a full assessment of vessel 
calibre, calcification and tortuosity. This cannot be achieved with 2D angiography. A 
patient who has demonstrable inadequacy of the ilio-femoral arteries (in terms of calibre or 
tortuosity) with Dyna CT may not require MSCT of the abdomen and pelvis at all, with the 
potential savings in contrast and radiation. However, DynaCT should be effective in 
providing vessel calibre measurements, assessing tortuosity and calcification and should 
match MSCT, arguably the gold standard in this area. 
The aim of this study was to scrutinise DynaCT in it’s assessment of vessel calibre, 
tortuosity and calcification of the ilio-femoral tree by direct comparison to the existing 
imaging methods readily available (angiography and MSCT). Contrast and radiation doses 
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would also be compared. This was to be performed in the clinical setting, in patients 
selected for TAVI. 
 
Material and Method 
15 patients who were to undergo trans-catheter aortic valve implant at the Prince Charles 
Hospital, Brisbane, Australia in late 2011 were selected for this study.  Prior to the 
procedure, the patients had coronary angiography, ilio-femoral angiography, contrast 
MSCT of the chest/abdomen/ pelvis and echocardiography performed as part of their 
routine work-up for their TAVI procedure. In addition to this, the cohort was to undergo a 
DynaCT of the ilio-femoral arteries at the time of the procedure. The inclusion criteria 
included suitable renal function with serum creatinine <100µmol/l and suitable body 
habitus with a BMI of < 30. 
Ethics committee approval was sought and granted for this study by the research 
committee at the Prince Charles Hospital. 
Prospective data was collected of the calibre of the vessels from angiography, MSCT and 
DynaCT. Pre-determined reference points of the left and right common iliac, external iliac 
and common femoral arteries were used. These points were:   
 
 Common iliac artery point – 30mm distal to the bifurcation of abdominal aorta. 
 External iliac artery point– 30 mm proximal to the mid femoral head. 
 Common femoral artery point – at the level of the mid femoral head. 
 
Contrast and radiation dose were also documented and were included in the study for 
comparison. 
 
Image Acquisition parameters: 
Angiography 
The angiogram was performed using a Siemens Axiom Artis dBc (Siemens Healthcare 
Erlangen Germany), at 15 frames per second, using a 5Fr pigtail catheter with 10mm 
markers. 20mls of Ultravist 370mg/ml contrast media was injected at a rate of 15mls per 
second into the abdominal aorta just prior to the bifurcation of the common iliac arteries. 
The unsubtracted image was panned to visualise the length of the ilio-femoral arteries. 
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The number of injections and volume of contrast media required to visulaise the entire ilio-
femoral tree was recorded. Measurements were taken at the reference points and 
documented. 
MSCT 
All MSCT scans were performed on the same Siemens Somatom Definition 64slice Dual 
Source CT scanner Scan parameters were 120kVp, 100-200mAs, 0.5 second rotation time 
and 0.75mm slice thickness and a 0.5mm table increment. Axial images were 
reconstructed with a slice thickness of 3mm with an increment of 3mm. The chest, 
abdomen and pelvis were scanned using 150 mls of intravenous injection (100ml of 
Optiray 350mg/ml and 50ml of Sodium Chloride) at a rate of 4 ml/s. 
DynaCT 
The DynaCT was performed using a Siemens Artis Zee dTa with a 30cm x 40cm detector. 
A 6Fr pigtailed catheter was inserted into the abdominal aorta, proximal to the bifurcation 
into the left and right common iliac arteries. 33mls of Ultravist 370mg/ml contrast media 
was diluted with 67 mls of 0.9% Sodium chloride and the 100mls was injected at a rate of 
12 ml/second. Rotational angiography was performed using the 8 second DynaCT protocol 
in which a 200o rotation acquires 397 images in 8 seconds.  
Image Reconstruction: 
In the MSCT and Dyna CT studies, multi planar reconstructions (MPRs) were created on a 
Siemens Syngo Leonardo workstation that gave a true cross-sectional image of the 
arteries at the 3 reference points. This is demonstrated in figure 8.1. Automatic calibration 
was achieved through the software of the workstation.  Measurements were taken at the 
reference points using the cross sectional planar images created at each reference point. 
Examples are demonstrated in figure 8.2. The measurements were documented by 2 
independent blinded observers. 
For the angiogram, measurements were taken from the images acquired at the specified 
reference points. The pigtail catheter with markers was used for calibration. 
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Figure 8. 1 - Screen shot of the MPR creation 
Legend:. Image demonstrating production of multi planar, true cross-sectional images of 
the iliacarteries. In this case, a cross section image is being created 30 mm below the level 
of the bifurcation (MPR multi-planar reconstruction) 
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Tortuosity:  
A novel but simple method of calculating the overall tortuosity of the ilio-femoral artery was 
developed and utilised in this study. A 3D volume rendered image was created from the 
MSCT and DynaCT acquisitions using the Leonardo workstation and the Inspace program 
(figure 8.3). First, the point to point distance was measured from the bifurcation of the iliac 
arteries to the femoral artery at the level of the mid femoral head. Then the total distance 
taken by the iliac artery between these points was measured using the AX vessel analysis 
tool on the workstation. This tool gives the length of an artery through its curves and 
bends. The difference between these two lengths is expressed as a ratio or a ‘Tortuosity 
Index’. This was performed for both the MSCT scan and DynaCT scan. The 2D angiogram 
was eliminated from this part of the study as the true tortuosity can only be assessed with 
three planar imaging.  
 
Calcification: 
Calcification was scored using a previously established technique(138).The most calcified 
section of the ilio-femoral tree was recorded on both the DynaCT and MSCT images by 
two independent, blinded observers and was scored as follows: 0 = no calcification seen, 1 
= scanty, 2 = half circumference, 3 = circumferential. For the calcification scores, the mean 
of the two observers was used to compare MSCT against DynaCT. 
Figure 8. 2 Example images taken of the right femoral artery using MSCT (left) and 
the respective DynaCT image (right) in the same patient. 
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Figure 8. 3 - 3D volume rendered image using DynaCT 
Legend: Example of 3D volume rendered Image acquired through DynaCT, 
demonstrating tortuosity and the difference between the direct distance and the distance 
taken by the artery. This was used for the tortuosity index calculation. 
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Radiation Dose Calculations: 
Angiography 
The effective dose a patient receives for the angiogram section of the study was estimated 
using PCXMC software (PCXMC Dose Calculations, Version 2.0 Copyright STUK 2008. 
STUK - Radiation and Nuclear Safety Authority, Helsinki, Finland).  This is a Monte Carlo-
based dose simulation software. Data collected for this was section the KVp, mAs, 
radiation dose per pulse, copper filtration, dose area product (DAP), skin entrance surface 
dose, distance of the patient from the source, distance of the source to the detector and 
the detector field size. 
MSCT 
MSCT effective dose was calculated by referring to ICRP 102 (223), using the appropriate 
conversion coefficients. The conversion coefficients presented in ICRP 102 are with 
reference to an adult with a standard physique so that the values are estimations only, 
even though procedure Dose Length Product (DLP) values are exact. 
DynaCT 
Using the milliamps (mA) and milliseconds (ms) of exposure output by the X-ray system, 
an effective mAs was determined. This was used in conjunction with the nominal tube 
output of 40 µGy/mAs which was then corrected for the dose one would receive at 1 m 
from the source. This value was then scaled to reflect the appropriate field size, then 
multiplied by the number of total frames, resulting in a DAP that accounted for the mAs of 
each frame. Once this revised total DAP had been acquired, it was divided into the number 
of individual projections that that would be considered as part of the simulation as 
conducted with the use of PCXMC. Once individual effective doses had been calculated 
for each projection, all effective doses were summed to result in the total effective dose.  
Statistical Analysis: 
The mean value of the measurements taken at the various anatomical points by the two 
independent observers for the three imaging methods was used for analysis. 
The calibre measurements were compared against one another using concordance 
correlation coefficients (CCC), and Bland Altman tests. Linear regression was performed 
for the calibre measurements in the same way as for CCC. 
 A receiver operator coefficient curve (ROC curve) was used to compare DynaCT against 
the gold standard, MSCT. In this, a cut-off diameter of 7mm was selected as this was the 
pre-determined arterial diameter required for access for the 23mm Edwards Sapien valve 
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and is in line with the SOURCE registry criteria (224). A measurement above 7mm was 
determined as suitable, a measurement below 7mm, determined unsuitable.  
The inter-observer variability was compared using correlation coefficients (CC). The 
tortuosity indices were compared for DynaCT and MSCT using a student t-test. 
Calcification scores between DynaCT and MSCT was assessed using CC. Inter-observer 
variability for calcification was assessed with a Kappa test. Analysis of the statistical data 
for these patients was performed using SPSS V16.0. 
 
Results 
Patient baseline characteristics and risk scores are outlined in table 8.1. 
Successful valve implantation was achieved in 14 of the 15 patients, with success being 
measured as a successful implant without conversion to surgery or death. One of the 15 
patients proceeded to a successful aortic valvuloplasty only, without TAVI.  
Of the 14 patients that proceeded to TAVI, 5 had Edwards valves implanted and 4 had 
Corevalves implanted via the femoral approach. The remaining 5 patients had Edwards 
valves implanted via the trans apical approach. 
Mean TAVI procedural fluoroscopy time was 18.7 (± 7.9) minutes. Mean DAP was 23181 
(± 9412) uGym2 and mean contrast media volume was 291 (± 72.7) mls. 
 
Vessel Calibre 
The mean values of the measurements taken for each anatomical area and how they 
compare between modalities is given in table 8.2.  CCC for angiography and MSCT gave 
a coefficient of 0.96 (95% CI 0.94 to 0.97). In comparison, the CCC comparing 
angiography to DynaCT was 0.94, (95% CI 0.91 to 0.96). When comparing the two CT 
methods, DynaCT and MSCT, the CCC was 0.95 with (95% CI 0.92 to 0.97).  
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Table 8. 1 – Baseline Characteristics of patients 
Baseline Characteristics Value SD Median 
Age 82.13 6.04 83 
Male 5       (33%)   
Height 167.27 14.42 165 
Weight 75.33 9.17 79 
CAD (n) 10     (66%)   
COAD (n) 4       (27%)   
Sternotomy (n) 6       (40%)   
Previous CVA (n) 3       (20%)   
PVD (n) 6       (60%)   
NYHA 2.8 0.56 3 
GFR <60 3       (20%)   
LVEF % 63.33 13.05 68 
 
Aortic stenosis Indicies 
   
AVA (cm²) 0.78 0.15 0.75 
Mean Gradient (mmHg) 52.82 19.12 50 
Peak Gradient (mmHg) 86.81 30.10 85.6 
LVOT (mm) 22.2 1.86 22 
 
Footnote: Baseline statistics for the patients involved in this study. All were patients being 
worked up for re-valving procedures. AVA = aortic valve area,  CAD = Coronary Artery 
Disease, COAD = Chronic Obstructive Airways Disease, CVA = Cerebral Vascular 
Accident, GFR = Glomelular Filtration Rate, LVEF = Left Ventricular Ejection Fraction 
LVOT = left ventricular Outflow Tract dimension, NYHA = New York Heart Association 
classification, PVD = Peripheral Vascular Disease. 
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Table 8. 2 – Difference in measurements across all groups with standard deviation. 
 
Anatomical Area Angio ± MSCT ± Dyna CT ± P value 
Right Common Iliac 9.31 ±1.55 9.53 ±1.72 9.47 ±1.66 0.9309 
Left Common Iliac 9.38 ±1.63 9.50 ±1.64 9.19 ±1.84 0.8763 
Right External Iliac  7.57 ±1.20 7.60 ±1.22 7.30 ±1.04 0.7385 
Left External Iliac 7.65 ±1.17 7.47 ±1.03 7.22 ±0.95 0.5447 
Right Common Femoral 7.10 ±1.20 7.26 ±1.10 7.00 ±0.99 0.8040 
Left Common femoral 6.92 ±1.05 6.94 ±0.94 6.93 ±0.97 0.9978 
 
Notes: Arterial measurements were taken at predefined points. This table demonstrates 
the mean value for each imaging modality and the p value obtained across all three 
methods. MSCT - Multi-slice Computed Tomography 
 
 
Bland-Altman tests indicate a mean difference (±1.96 standard deviation) between the 
angiogram and the MSCT of 0.06mm (+0.97, -1.42). The mean difference between the 
angiogram and DynaCT was 0.13mm, (+1.00, -0.87) and the mean difference between the 
DynaCT and the MSCT was 0.2mm, (+1.15, -0.76).  
Linear regression was performed, where MSCT was determined as the independent 
variable and DynaCT was determined as the dependent variable, giving R = 0.96 
(p<0.001). When angiography (dependent) was assessed against MSCT (independent), R 
= 0.96 (p<0.001). When DynaCT (dependent) was compared to angiography 
(independent), R = 0.94 (p<0.001). The Bland Altman and linear regression results are 
demonstrated graphically in figure 8.4. 
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Figure 8. 4 - Bland-Altman and linear regression plots for measurements in mm 
between Angio, MSCT and DynaCT. 
Legend: Bland-Altman plots (top row): where the mean arterial calibre measurements 
taken with DynaCT are compared to those taken with MSCT and angiography. The small 
dotted lines demonstrate the mean difference between the modalities compared and the 
large dotted lines demonstrate 1.95 standard deviations. Linear regression plots (bottom 
row), demonstrate the arterial calibre measurements for DynaCT in comparison to those 
taken with MSCT and angiography. (CT = Multi-slice Computed Tomography, Dyna = 
DynaCT, Angio = Angiography). 
 
The ROC curve demonstrated that with a cut-off of 7mm diameter, 27 of the 90 
measurements taken with MSCT were determined unsuitable. When DynaCT was 
compared against this, 33 of the 90 measurements were deemed unsuitable. The area 
under the curve was 0.96 (95% CI 0.92 to 0.99) p<0.001. The ROC curve is demonstrated 
in figure 8.5. 
When investigating the inter-observer variability for the calibre measurements, correlation 
was demonstrated between the two operators by Pearson correlation coefficient (CC). The 
overall CC between the two users was 0.75 (p<0.001). The results were then further split 
into the separate modalities. Angiography demonstrated a CC of 0.96 (p<0.001) MSCT 
demonstrated a CC of 0.89 (p<0.001) and Dyna CT, a CC of 0.90 (p<0.001). 
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Figure 8. 5 – ROC curve for arterial calibre MSCT and DynaCT 
Legend: Receiver Operator Coefficient (ROC) curve for the assessment of vessel calibre 
using DynaCT when compared against the gold standard: MSCT (MSCT = Multi-slice 
Computed Tomography). 
 
Tortuosity indicies 
 The tortuosity of DynaCT and MSCT for both left and right ilio femoral arteries are 
demonstrated in Table 7.3. The results give an overall median tortuosity index of  1.21 
(1.19 - 1.25) for DynaCT and 1.31 (1.25 - 1.35) for MSCT (p=0.009). With the catheter in 
situ, the median tortuosity index was 1.23 (1.17 - 1.26) for DynaCT and 1.33 (1.26 - 1.40) 
for MSCT (p=0.008). With the catheter absent, the median tortuosity indicies were similar, 
1.23 (1.17 - 1.27) for DynaCT and 1.29 (1.03 - 1.31) for MSCT (p=0.472). 
 
Calcification 
The average calcification scores of the two observers for DynaCT and MSCT gave a 
correlation coefficient of 0.245 (p=0.378), Figure 8.6. 
The calcification scores demonstrated an agreement between the observers of 0.44 ± 
0.156 for DynaCT and 0.674 ± 0.179 for MSCT using a Kappa test for inter-observer 
variability.  
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Table 8. 3 – Median Tortuosity measurements and Indices summarised - numbers in 
brackets 95% confidence. 
 Dyna CT MSCT P value 
Overall    
Median Direct Distance 145.35 (138.59 149.25) 146.50 (140.21 151.60) 0.605 
Median Arterial Length 174.45 (169.27 179.58) 189.50 (180.83 195.97) 
 
0.003 
Tortuosity Index 1.21 (1.19 1.25) 1.31 (1.25 1.35) 0.009 
Catheter In situ    
Median Direct Distance 146.75 (135.95 150.36) 146.05 (138.49 153.97) 0.541 
Median Arterial Length 172.65 (165.98 180.16) 191.00 (183.5 202.5) 0.001 
Tortuosity Index 1.23 (1.17 1.26) 1.33 (1.26 1.40) 0.008 
Catheter Absent    
Median Direct Distance 144.85 (139.95 154.26) 146.6 (135.61 155.22) 0.960  
Median Arterial Length 177.65 (167.90 185.00) 179.5 (168.28 155.22) 0.489 
Tortuosity Index 1.23 (1.17 1.27) 1.29 (1.03 1.31) 0.472 
 
Notes: Median measurements obtained from 3D images using Syngo AX vessel analysis 
tool. MSCT -  Multi-slice Computed Tomography. 
 
 
Radiation and Contrast 
Mean effective radiation doses calculated were: 0.57 ± 0.72 mSv (angiography), 7.15 ±  
2.58 mSv (MSCT) and 3.63 ± 0.65 mSv (DynaCT).  
The median number of acquisitions taken to visualise the ilio-femoral tree using 
angiography was 2 (95%CI 1.64 - 2.36). The median total contrast volume was 40mls 
(32.88 - 47.12). This compares to the protocol volumes of 100mls for MSCT and 33mls for 
DynaCT. 
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Figure 8. 6 - Correlation of mean calcification scores for MSCT and DynaCT 
Legend: Chart demonstrating the correlation of the mean calcification fixed value scores 
for MSCT and DynaCT. (MSCT = Multi-slice Computed Tomography). 
 
Discussion 
In this study, angiography, DynaCT and MSCT values for vessel calibre differ very little 
using the Bland Altman test, CCC and the linear regression. The strong correlation 
demonstrates that the measurements of the artery increase at the same rate in any 
modality and the measurements are accurate in any modality through a range of arterial 
size.  
A femoral arterial calibre of 7mm was desired for implantation of the Edwards Sapien valve 
in this study, in line with the SOURCE registry criteria (224). The ROC curve analysis 
demonstrates that when DynaCT is compared to MSCT (the gold standard) for 
determining arterial calibre, it accurately determined whether an artery was either suitable 
or unsuitable. 
The correlation between the two independent observers for the arterial calibre 
measurements is strong. These results indicate that the measurements of all modalities 
are reliably repeatable. This is noteworthy; particularly when one considers that the 
measurement accuracy is down to 0.1 or 0.2mm. This is confirmed by Norden et al, who 
also found no gross inter-observer variability in their assessment of DynaCT (138). 
R=0.24
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The two CT modalities in this study (MSCT and DynaCT) offer the added benefit of 
assessing the tortuosity in three dimensions as volume rendered images can easily be 
created. The tortuosity index outlined in this study was developed to give a numerical 
value to the tortuosity. To our knowledge, this is the first time a numerical value has been 
given to tortuosity of the ilio-femoral arterial system, though other more complicated 
systems have been developed for other body areas (225). The results indicate that the 
catheter within the vessel has an effect on the tortuosity of the vessel due to its stiffness. 
The tortuosity index calculations indicate that there is no statistical difference between the 
MSCT and DynaCT in assessing tortuosity with the catheter absent. MSCT is the only 
modality that demonstrates the vessels in their natural state. This may not be seen as a 
disadvantage of DynaCT, as the tortuosity of the vessels can be assessed for the 
practicality of visualising tortuosity with a catheter or sheath in situ. A radial pigtail catheter 
approach for the DynaCT may be of benefit in future studies as this would demonstrate the 
femoral arteries in their natural state. 
With the calcification scores, the results indicate that there are significant differences 
between the two modalities in assessing calcification. The calcification was much harder to 
see with DynaCT than MSCT and this is in line with the study by Nordon et al (138). 
DynaCT requires more image manipulation (windowing) to visualise the calcium and in 
many cases was not visible at all. Also, the inter-observer variability was poorly correlated, 
indicating that the scoring was not easily repeatable. Overall, the results demonstrate that 
it is not practical to use DynaCT to assess calcification with the methodology used. The 
contrast/saline ratio may have been too concentrated, causing partial volume artefact, 
obliterating the delineation of the calcification. Further assessment of DynaCT with lower 
contrast concentration or without contrast media for calcification assessment may be 
warranted. The 2D angiogram was not involved in the assessment of calcification because 
it cannot assess calcification in 3 dimensions and therefore would not fit the methodology 
used.  
The detrimental effect of contrast loading on renal function is well documented (226,227). 
In our study, the DynaCT was performed with 33 mls, as opposed to a median of 40mls for 
the angiogram and 100mls for the MSCT. Every effort to reduce contrast loading is 
important in this patient cohort, in whom the incidence of renal impairment is high. 
Anything that can reduce contrast load is beneficial (115), particularly if performed 
immediately prior to surgery (228).  A previous study has tried to address this issue with a 
direct arterial injection during MSCT (134). Our study demonstrates that DynaCT may be 
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able to perform this role without the requirement of transferring the patient to the CT 
scanner, sheath in situ. 
Radiation dose to the patient is also a consideration in these procedures. The calculated 
effective radiation dose for the patient using DynaCT from this study is lower than the 
MSCT but much higher than the angiogram and this agrees with a previous assessment of 
DynaCT (229). However, it should be noted that the MSCT covers the whole of the aorta 
and not just the pelvis. It can be used as a screening tool for TAVI patients during their 
work-up. Other non cardiac related pathology can be detected; with one study 
demonstrating significant non-cardiac findings in 22.6% of cardiac MSCT scans (230).   
A significant difference between the MSCT, DynaCT and angiography is that the latter two 
are invasive techniques, with the associated risks of arterial puncture (231-233). They also 
require a direct injection into the abdominal aorta in comparison to the intravenous 
injection of the MSCT. This is a disadvantage of these modalities, although no 
complication from arterial puncture was noted in this study.  
With DynaCT, the real benefit is its ease of use and the real time processing of the 3D 
images during the work-up coronary angiogram. It allows a better assessment of the 
anatomy when compared to 2D angiography in the same setting. On systems with the 
capability, DynaCT can add useful additional information and may be used instead of 2D 
ilio-femoral angiography. 
 
Limitations 
This is a small study with limited patient numbers. The results for assessing vessel calibre 
and tortuosity with DynaCT are encouraging. Further studies would be beneficial, 
particularly with regard to the assessment of calcification. 
 
Conclusion 
In patients selected for TAVI, DynaCT correlates very well to MSCT and angiography in 
the assessment of ilio-femoral arterial calibre. Like MSCT, it can produce 3D volume 
rendered images, providing valuable information on arterial tortuosity. However, in this 
study, DynaCT was deemed to be inadequate in the assessment of arterial calcification 
and inferior to MSCT in this regard. 
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Current Implications 
Rotational angiography or DynaCT is relatively easy to use. The study did, however, 
demonstrate that the identification of calcification was a weakness of the technology. This 
is in line with another study investigating the use of DynaCT in assessing the aorta. That 
study demonstrated that the calcification was not identified as readily and that DynaCT 
consistently undersized the aortic neck.(138) Since publication, MSCT has become the 
standard method of anatomical assessment for TAVI as it can image the aortic valve in 
addition to the femoral arteries in the same examination. In addition, ECG gating is used to 
avoid artefact of the valve and MSCT can also assess other alternate access routes at the 
same time. The MSCT is particularly important in assessing vessel size and the degree of 
calcification.(234) For this reason, there has been no further development of DynaCT in 
this setting. 
 
 
 
 
  
 177 
 
Crowhurst Thesis 2018  177 
 
Chapter 9 –  
J. Crowhurst, K. Poon, D. Murdoch, A. Incani, O.C. Raffel, A. Liddicoat, D. Walters. The 
Effect of X-ray Beam Distortion on the Edwards Sapien XT™ Trans-catheter Aortic Valve 
Replacement Prosthesis. J Med. Radiat. Sci.; 2015 Dec; 62(4) 239-245 
 
Details of my contribution to authorship: 
I performed a literature review of all relevant, previously published material and reviewed 
current guidelines. I designed the study protocol in consultation with relevant experts in the 
field (co-authors). 
I performed the imaging tests, collected the data and analysed the data obtained. I 
performed calculations and statistical analysis. I continued consultation with local experts 
in the field (co-authors) and as lead author, wrote up the findings before sending out the 
manuscript for critical review by the co-authors. I liaised with the relevant journal for 
publication as corresponding author and made suggested changes in line with peer 
review. 
 
Prologue 
The previous chapter investigates a new imaging modality in the assessment of patients 
for TAVI. In this next chapter, the opposite end of the technology spectrum is investigated 
with regard to TAVI procedures. Chapter 9 investigates the effect of basic X-ray beam 
distortion on TAVI devices. X-ray beam distortion is a known phenomenon that impacts on 
all radiographic imaging, including fluoroscopy and is well understood in plain film 
radiography of larger body parts. During some of these new and complex fluoroscopy 
procedures, such as TAVI, X-ray production basics may be forgotten, or not deemed as 
significant. However, as detailed in Chapter 9, the effect of X-ray beam distortion can be 
significant and should be taken into consideration during these procedures. 
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The effect of X-ray beam distortion on the Edwards Sapien XTTM trans-catheter 
aortic valve replacement prosthesis 
 
Introduction 
Patients who present with severe aortic stenosis and who are deemed too high risk for 
conventional open heart surgery can now be offered aortic valve replacement 
percutaneously.(3,200) Trans-catheter aortic valve implantation (TAVI) is a relatively new 
procedure which utilises fluoroscopy to percutaneously implant a new aortic heart valve. 
This is performed without the requirement of open heart surgery and was first described in 
2002.(235) Implantation of the Edwards Sapien (Edwards Lifesciences Irvine, CA, USA) 
trans-catheter aortic valve requires it to be accurately positioned in relation to the aortic 
valve annulus.(236) Inaccurate positioning can lead to paravalvular regurgitation post 
implant or even embolisation of the device into the left ventricular outflow tract or 
ascending aorta.(237) These complications can lead to conversion to open heart surgery, 
with the associated negative impact on patient outcome.(238)  
When implanting the TAVI device, a coaxial or perpendicular X-ray C-arm angle ensures 
that the three coronary sinuses are aligned in one plane under fluoroscopy and the depth 
of valve implantation in relation to the annulus can be accurately assessed (Figure 9.1). 
Ideal positioning is one-third to one-half of the valve above the mid-level of the aortic 
annulus.(236) With a coaxial angle, the upper and lower stent struts of the implanted valve 
appear superimposed on the image post implant (Figure 9.2).  
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Figure 9. 1 -  Pre-implant angiography of the aortic valve. 
Legend: This image demonstrates how the three sinuses of the aortic valve are aligned in 
one plane when the C-arm angle is optimal. The yellow line indicates the coaxial image 
plane and the level of the aortic annulus, which divides the aorta from the left ventricular 
outflow tract. 
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Figure 9. 2  - The trans-catheter aortic valve implant (TAVI) device in the aortic 
annulus. 
Legend: This figure depicts the Edwards Sapien XTTM TAVI device pre- and post-
deployment. In this case the appearance of the deployed valve is termed excellent as the 
anterior and posterior stent struts are almost totally superimposed. It also highlights how 
good image quality and coaxial valve imaging is important pre deployment to achieve a 
good prosthesis position. 
 
Previous studies have demonstrated the importance of co-axial imaging. Pre-operative 
multislice computed tomography (MSCT) or peri-operative cone beam computed 
tomography (also known as C-arm CT, angiographic CT, and flat-panel CT(135) or 3 
dimensional (3D) angiography(136)) can accurately determine the best C-arm angle to 
achieve coaxial imaging.(136,137,239) Optimising coaxial imaging has also been linked to 
a decrease in paravalvular regurgitation.(137,240) X-ray equipment vendors have even 
released specialist software to aid the alignment of the valve sinuses, such is the 
importance of this phase of the procedure.(137) 
The X-ray beam used in cardiovascular imaging systems, is emitted in a cone shaped 
beam, determined by the small focal spot size and is described as a divergent beam. If an 
object is not placed in the centre of the image, distortion of the object on the image may 
occur. This is a well-recognised phenomenon in all radiographic procedures(143) and it is 
most evident in radiographs using short object film distances and a large field of view 
(FOV). An example is the antero-posterior projection of the femur, where centring on the 
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mid femur will mean that the knee joint is exposed to divergent rays and the joint space will 
appear distorted. In such cases, a second projection would be required to optimally 
visualise the joint.(241) Distortion is just as relevant during fluoroscopy procedures and in 
the case of TAVI procedures, which are performed under fluoroscopy, the appearance of 
the aortic valve could change due to distortion. The valve sinuses may not appear coaxial 
if the valve is not positioned in the centre of the image, even though the C-arm angle is 
optimal. This would make the aortic valve appear more oblique and therefore could affect 
the TAVI device final implant position. The degree of distortion would be demonstrated by 
a change in the appearance of the TAVI prosthesis’ framework post implant. This study 
aimed to investigate the effect of X-ray beam distortion on the TAVI prosthesis. 
 
Methods 
Equipment 
Bench-top imaging was carried out on the three currently available Edwards Sapien XTTM 
Valve sizes: 23mm, 26mm and 29mm, using a modern, fluoroscopic system with a flat 
detector (Siemens Artis Zee, Siemens Healthcare, Erlangen Germany). This X-ray system 
has annual compliance testing performed by a medical physicist to ensure X-ray beam 
quality. This is an advanced cardiovascular image system with 3D capability and as such, 
the manufacturer specifies that the accuracy of C-arm anglulations are to within 0.1 
degrees. 
Image capture 
To investigate distortion, each valve was positioned toward the bottom third of the image 
field and the C-arm was moved to produce an image where the superior borders of the 
valve prosthesis frame are superimposed (Figure 9.3a). The X-ray table was then moved 
or ‘panned’ to position the valve in the upper third of the image field (Figure 9.3b). A 
calibrated sphere measuring exactly 30.00mm was placed in the image field for 
measurement tool calibration purposes and an image was stored. The C-arm was then 
rotated with the valve in its new position to once again produce an image where the 
superior borders of the valve prosthesis frame are superimposed and the number of 
degrees that the C-arm rotated through to achieve this (as displayed on the X-ray systems 
data display) was recorded. This was performed to demonstrate the equivalent number of 
C-arm degrees that the distortion creates. 
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Figure 9. 3 - Change in appearance of the trans-catheter aortic valve implant (TAVI) 
device as it is moved from the bottom to the top of the image. 
Legend: This figure demonstrates how the TAVI device can change in appearance as it is 
moved from the bottom of the image to the top. (A and B) In this case, a 29 mm valve in a 
32 cm field of view (FOV) and its change from excellent in (A) to satisfactory in (B). (C and 
D) Describes how the TAVI device changes its appearance on the image due to the 
divergent nature of the X-ray beam and the resultant distortion. 
 
Effect of magnification 
In an effort to establish whether any change in appearance was affected by magnification, 
the above methodology was repeated with the X-ray table height lowered by three 10cm 
increments from the isocentre (0cm, -10cm and -20cm) and also with the image detector 
raised in three 10cm increments to change the source to image distance (SID) from 100cm 
to 110cm and then to 120cm. The above methodology was performed at both a 22cm FOV 
and a 32cm FOV.  
 
Image analysis  
Using a previously published three tier classification tool, one can classify the success of 
the implant angle, using visual clues from the frame and struts of the newly implanted 
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valve. Excellent refers to perfectly aligned superior struts, where the anterior strut is up to 
half the height of a cell different to the posterior struts. Satisfactory refers to where the 
superior struts are from half the height of a cell to a whole cell different. Poor refers to 
where the superior struts are more than a whole cell different.(239) These criteria were 
used to assess any change in the valve appearance due to distortion. Examples of the 
appearance in the clinical setting are demonstrated in Figure 9.4. 
 
 
 
Figure 9. 4 - Clinical examples of the valves appearance using the 3 tier 
classification tool. 
Legend: This figure demonstrates examples of the appearance of the Edwards Sapien 
valve against the three criteria used in this and other studies. The white lines mark the 
anterior and posterior upper borders of the valve prosthesis. 
 
 
The change in appearance and the distance between the superior struts was assessed 
independently by two cardiac radiographers, with 7 and 19 years of experience 
respectively. These observers used the X-ray systems measurement tool to numerically 
quantify any change in appearance. Calibration of the measurement tool was performed 
against the 30.00mm sphere. Correlation of the observers measurements were assessed 
using a Pearson’s correlation coefficient. This study was a bench-top study and did not 
involve human subjects. Human research ethics approval was therefore not required. 
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Results 
Overall, the distortion was not sufficient to change the appearance from excellent to 
satisfactory on any valve size at any magnification when using a 22cm FOV. However, 
when a 32cm FOV was used, the distortion was sufficient to change the appearance from 
excellent to satisfactory in certain conditions. The detail of the results of the benchtop 
testing is shown in Tables 9.1 and 9.2. The two observers scored the valves appearance 
against the 3 tier classification tool with 92.3% agreement. The Pearson’s correlation 
coefficient showed good agreement between the observers for the numerical 
measurement of the distorted prosthesis appearance: R=0.96, P<0.001. 
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Table 9. 1 – The results of benchtop testing with the Edwards Sapien XT valve 
imaged in a 32cm field of view and the effect of distortion. 
Valve 
Size 
(mm) 
FOV 
(cm) 
SID 
(cm) 
Table 
Height 
(cm) 
Distance Table is 
moved to position 
valve from 
bottom to top of 
image (cm) 
Appearance 
score 
Mean Distance 
between 
superior stent 
struts as 
measured on 
the image (mm) 
Equivalent  
C-arm 
Angulation  
(degrees) 
29 32 100 0 16 Satisfactory 5.1 10 
  100 -10 14 Satisfactory 5.4 10 
  100 -20 11 Satisfactory 4.7 8 
  110 0 14 Satisfactory 4.3 10 
  110 -10 12 Satisfactory 4.4 9 
  110 -20 10 Satisfactory 4.5 7 
  120 0 14 Satisfactory 4.0 8 
  120 -10 12 Satisfactory 4.4 9 
  120 -20 9 Sat/Ex 3.4 6 
        
26 32 100 0 15 Satisfactory 4.9 11 
  100 -10 14 Satisfactory 5.1 10 
  100 -20 11 Satisfactory 4.9 8 
  110 0 13 Sat/Ex 4.1 9 
  110 -10 11 Excellent 4.4 9 
  110 -20 10 Excellent 4.2 8 
  120 0 12 Sat/Ex 4.2 9 
  120 -10 10 Excellent 4.3 8 
  120 -20 9 Excellent 4.1 7 
        
23 32 100 0 16 Satisfactory 4.1 10 
  100 -10 14 Satisfactory 4.0 10 
  100 -20 12 Satisfactory 3.8 9 
  110 0 15 Sat/Ex 3.5 10 
  110 -10 14 Excellent 4.0 10 
  110 -20 11 Excellent 3.9 8 
  120 0 14 Excellent 3.2 10 
  120 -10 12 Excellent 3.3 9 
  120 -20 10 Excellent 3.2 8 
 
Footnote: The table demonstrates how each of the 3 Edwards Sapien valves changes its 
appearance due to the image distortion created by the divergent beam in a 32cm field of 
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view. The distance between the anterior and posterior struts is quantified and the 
angulation required to bring the valve back to a coaxial angle is demonstrated. 
Disagreement in appearance score between the observers is demonstrated by a combined 
score (e.g. Sat/Ex). (FOV = field of view, SID = source to image distance) 
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Table 9. 2 – The results of benchtop testing with the Edwards Sapien XT valve 
imaged in a 22cm field of view and the effect of distortion. 
Valve 
Size 
(mm) 
FOV 
(cm) 
SID 
(cm) 
Table 
Height 
(cm) 
Distance Table 
is moved to 
position valve 
from bottom to 
top of image 
(cm) 
Appearance 
score 
Mean distance 
between 
superior stent 
struts as 
measured on 
the image (mm) 
Equivalent  
C-arm 
Angulation  
(degrees) 
29 22 100 0 10 Excellent 3.7 7 
  100 -10 9 Excellent 3.0 6 
  100 -20 7 Excellent 3.1 5 
  110 0 9 Excellent 2.4 4 
  110 -10 8 Excellent 2.4 5 
  110 -20 7 Excellent 2.5 6 
  120 0 8 Excellent 2.3 4 
  120 -10 7 Excellent 2.2 5 
  120 -20 6 Excellent 2.8 5 
        
26 22 100 0 9 Excellent 2.8 6 
  100 -10 8 Excellent 2.5 6 
  100 -20 6 Excellent 2.5 4 
  110 0 9 Excellent 2.4 7 
  110 -10 8 Excellent 2.4 5 
  110 -20 6 Excellent 2.5 5 
  120 0 7 Excellent 2.0 6 
  120 -10 7 Excellent 2.2 5 
  120 -20 6 Excellent 1.7 3 
        
23 22 100 0 12 Excellent 2.7 8 
  100 -10 10 Excellent 2.5 7 
  100 -20 9 Excellent 2.3 6 
  110 0 10 Excellent 2.4 7 
  110 -10 8 Excellent 2.4 7 
  110 -20 8 Excellent 2.3 7 
  120 0 9 Excellent 2.5 7 
  120 -10 7 Excellent 2.2 6 
  120 -20 7 Excellent 2.2 5 
 
Footnote: The table demonstrates how each of the 3 Edwards Sapien valves changes its 
appearance due to the image distortion created by the divergent beam in a 22cm field of 
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view. The distance between the anterior and posterior struts is quantified and the 
angulation required to bring the valve back to a coaxial angle is demonstrated.  
(FOV = field of view, SID = source to image distance) 
 
Discussion 
The effect of distortion from beam divergence is well understood in radiography and the 
principles are described in radiographic imaging technique text books.(143,241) Specific 
tools have even been designed to cater for the change in appearance of lateral lumbar 
spine radiographs due to distortion.(242) However, the effect of beam distortion has not 
been discussed before in relation to TAVI procedures. The effect may be most relevant 
during transaortic TAVI procedures, where the TAVI device is inserted through the 
superior aspect of the ascending aorta. During these procedures, visualisation of the 
insertion sheath under fluoroscopy is required to ensure that it is perpendicular to the 
valves annular plane.(243) This scenario has the most potential to position the valve away 
from the centre of the image.  
In this study, the greatest distortion of the valve is seen when the FOV is large (32cm) and 
the magnification is low (detector low and table high). With this combination, the table can 
be moved further whilst still being able to visualize the valve in the image. This places the 
valve further from the photons that are travelling perpendicularly between the X-ray tube 
and detector, increasing the distorted appearance. With this scenario, the appearance of 
the valve changes to the equivalent to rotating the C-arm by up to 11 degrees. The cut off 
for the valve changing from excellent to satisfactory appears to be between 10 and 6 
degrees of equivalent C-arm rotation, depending on the FOV used and the valve size. 
The results also indicate that magnification does not greatly affect the degree of distortion 
visualized until the larger FOV is used. With this in mind, the 22cm FOV is normally used 
for the set-up aortogram and subsequent valve deployment. This configuration also 
electronically magnifies the image to better visualize the detail of the anatomy and 
prosthesis. However, it is noted from the results that under high geometric magnification, 
only small table movements or only a few degrees of C-arm angulation will distort the 
valve’s appearance This is problematic in clinical practice where a small deviation from the 
optimal C-arm angle or table position has a large effect on the appearance of the valve. 
Therefore geometric magnification should be avoided or minimized. This issue may be 
highlighted again during procedures with trans aortic access, where there may be a 
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tendency to increase the height of the detector away from the patient to enable better 
access and visualization of the access site by the surgeon. This will increase 
magnification. The valve size is also shown here to influence the degree of distortion, with 
the 29mm valve distorting more than the 23mm, under the same beam geometry. This is 
due to the fact that with the larger valve, the distance between the upper and lower stent 
struts is greater and are therefore projected further apart onto the detector.   
The appearance of implanted TAVI devices against the 3 tier classification tool used here 
was investigated in detail in the clinical setting in 2013. That study demonstrated that by 
using cone beam CT and specialist software to predict the best C-arm angle, an excellent 
appearance could be achieved in 84% of cases, compared to 42% without. It 
demonstrated that more aortograms and fluoroscopy were required to obtain the desired 
coaxial appearance in the group where cone beam CT was not used. The main finding in 
that study however, was that with an excellent appearance, paravalvular regurgitation 
(leakage around the valve) from non-optimal TAVI device position was significantly 
lower.(137) This is clinically important as even mild paravalvular regurgitation has been 
associated with increased mortality at 2 years post procedure.(113,149) In another study, 
low positioning of the TAVI device has also been associated with a greater incidence of 
ECG rhythm disturbances, again highlighting the importance of accurate positioning.(244) 
The results in this study demonstrate that, as expected, moving the TAVI device from the 
bottom to the top of the image distorts its appearance. The clinical application of these 
findings is that the set-up angiogram, with a co-axial valve sinus appearance and the 
subsequent deployment of the valve must be performed with the valve positioned in the 
centre of the fluoroscopic image. Maintaining the native valve in the centre of the image as 
the prosthesis is positioned is of the utmost importance. Performing the initial aortogram 
with the valve positioned in one part of the image and deploying the valve in another could 
lead to inaccurate positioning from distortion. The team performing TAVI procedures 
should be aware of the existence of beam distortion and its potential to impact on final 
valve positioning. Practical ways to avoid prosthesis malposition from distortion are 
summarized in Table 9.3. 
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Table 9. 3 – Practical ways to avoid valve prosthesis malposition from distortion. 
 
Practical ways to avoid valve prosthesis malposition from distortion 
Ensure that the initial aortogram is performed with the native valve in the centre of 
the image. 
Use pre-operative CT or peri procedural cone beam CT to predict the coaxial C-arm 
angle for better accuracy. 
Use a small field of view. 
Avoid excessive geometric magnification as small changes in C-arm/table 
movements will have a greater effect on distortion. 
Ensure that the valve prosthesis is deployed in the centre of the image. 
 
Limitations 
This study was a bench-top study with a theoretical conclusion that the distorted 
appearance could lead to device mal positioning. Future studies could investigate the 
effect of distortion and its impact on deployment position of TAVI devices into 3D aortic 
models. Also, while this study concentrated on the Edwards valve prosthesis, it is likely 
that the other prosthesis types would demonstrate similar results. 
 
Conclusion 
Much effort is spent achieving coaxial imaging to ensure accurate TAVI position in relation 
to the aortic valve annulus. However the basic radiographic effect of fluoroscopic beam 
distortion has the potential to affect coaxial imaging and the final TAVI device position.  
 
Current Implications 
Since publication, there have been no further studies in the literature on the effect of beam 
distortion in TAVR from the C-arm as described here. This chapter remains a unique body 
of work and still remains relevant. 
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Chapter 10  - Discussion and Conclusions  
 
There is consistent growth in the number of cardiac angiography procedures performed 
each year(152) and the treatment options using percutaneous interventions continues to 
increase. This thesis contributes significantly to the evidence based practice model of 
advanced cardiac angiography. 
This thesis has covered the three main topics of angiography that would be relevant to the 
radiographer working in cardiac catheterisation laboratories. These items are: radiation 
dose and dose reduction to patients and staff, the impact of contrast media on kidney 
function and the assessment of imaging technology in new and developing types of 
procedures. This thesis pulls together these elements into a cohesive package and would 
be very relevant reading for radiographers and cardiologists undertaking contemporary 
and emerging procedures in cardiac catheterisation laboratories. 
Firstly, radiation dose in cardiac catheterisation laboratories was investigated. When 
investigating radiation dose, it is important to measure dose for the procedures performed 
and compare them to established benchmarks. However, the benchmarks that exist in the 
literature are from other countries. This may have implications as the workflow, regulations 
and licensing may be different from those in Queensland and Australia and this may 
impact on the reference level. Therefore, before investigating radiation dose at an 
individual facility, it is important to establish a local benchmark. As the international 
committee for radiation protection (ICRP) point out; diagnostic reference levels (DRLs) and 
benchmark levels for patients should be compared to national benchmarks.(7) As a result, 
the first part of this thesis was to establish a multicentre reference level for coronary 
angiography and intervention, given the paucity of data surrounding reference levels for 
radiation dose to patients undergoing cardiac angiography. Chapter 2 of this thesis 
demonstrated Australia’s first large scale multi-centre reference level study for both 
diagnostic and percutaneous coronary intervention procedures in Queensland public 
hospitals, something that has not been achieved to date in Australia. The levels observed 
are consistent with those published in the literature, as evidenced in tables 2.3 and 2.4 of 
this thesis. 
Once the reference levels are established, it is then a natural progression to investigate 
the factors that may impact on patient radiation dose. When considering the reference 
level, one should investigate locally the factors that would lead to doses above the DRL(7) 
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which is usually established as the third quartile value.(15,22,245) This has been 
encompassed within chapter 3. However, in addition to investigating patient dose, this 
study also investigates high radiation doses (>75th percentile) to the doctors (operators) 
performing these procedures. The operators stand close to the patient and as such are 
subjected to radiation that scatters backwards from the patient. Given some of the high 
profile publications of the effects of radiation on operators,(62-64) it is important to 
investigate this. The study outlined in chapter 3 is the largest study to date investigating 
high radiation doses to operators, with over 2500 observations. Again, the higher doses 
(>75th percentile) were investigated and using multivariate analysis, it was possible to 
demonstrate that in addition to biplane imaging and male patients, patient obesity was the 
factor with the highest predictive value to lead to a high dose in both patients and 
operators, after correcting for all other variables. Other studies in the literature on this topic 
are mostly of a small sample size and many only investigate the impact of changing one 
variable that impacts on radiation dose to the operator such as the arterial access 
route.(47) The authors study in chapter 3 investigated how embedding the use of the 
personal dosimeter into everyday practice, worn by each individual operator for each 
individual procedure, can give valuable detail when matched to a procedural database. 
The combined radiation exposure and procedural data obtained gives a comprehensive 
insight as to which procedures and variables within each procedure give the higher doses. 
This study is the most comprehensive to date on this important topic. It has shown that 
radiation dose is multi-factorial, and that patient obesity has the highest predictive value of 
a high radiation dose to both patients and staff.  
Once reference levels and the factors that lead to high doses are established, it is then a 
natural progression to reduce dose, which leads us to chapter 4. In chapter 4 I 
demonstrate that occupational radiation dose is not just a concern for the primary operator. 
Other staff members stand close to the patient during cardiac angiography and 
interventional procedures. Percutaneous intervention for structural pathology of the heart 
requires a larger team than for angiography, as the patient is often anaesthetised, 
requiring anaesthetic staff. In addition, adjunctive imaging is also often utilised, such as 
trans-oesophageal echocardiography (TOE). The TOE imaging operator is a cardiologist 
at the authors centre, and they stand close to the patient for the majority of the procedure 
whilst X-rays are being used. As the study in chapter 4 demonstrated, radiation dose to 
the TOE operator was the highest of the team, which led to an additional shield being 
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installed. The dose reduction from the use of the additional shielding  demonstrates the 
dramatic impact that additional shielding can have to TOE operator radiation dose.  
Given the high doses and the proven benefits of the shielding, the authors advocate the 
use of additional shielding like this in all catheter laboratories performing structural 
intervention requiring TOE guidance. This study is pivotal in radiation protection in the 
modern era and has the potential to alter radiation safety guidelines worldwide and dictate 
future catheter laboratory design. This chapter uncovers a previously unreported 
consequence in the percutaneous treatment of cardiovascular disease and the importance 
of this work is demonstrated by the Journal of the American College of Cardiology (JACC) 
accepting this paper for publication. Further, the editors chose this paper to be the 
continuous medical education (CME) article for the issue. For this, the journal editors 
invited this author to write a clinical scenario and a series of multiple choice questions that 
are related to the paper. The readers of the journal could then read the paper, answer the 
quiz and gain extra CME credits. This additional CME work is outlined in Appendix v of 
this thesis. An editorial was also published in the same issue of JACC, based on the paper 
in this thesis, written by Hirshfeld et al who congratulated this author and the team on the 
work.(246) 
Continuing the theme of dose reduction, chapter 5 was an editorial that this author was 
invited to write on the topic of radiation dose reduction in coronary angiography. The 
editorial was based on a paper by Badawy et al that reduced dose by lowering the 
fluoroscopy dose rate in conjunction with modifying the image processing protocol used by 
the X-ray system.(33) The editorial covered the reasons why radiation dose reduction 
should be considered and the methods that can be utilised to reduce dose in angiography. 
The editorial then concentrated on the publication of Badawy et al(33) and compared that 
study to others in the literature, in addition to expert commentary on the topic. It 
summarised that sensible reductions in fluoroscopy pulse rates can reduce overall 
radiation dose significantly and that this can benefit not only the patient but also the staff 
working in the room.  
The concept of dose reduction by reducing the fluoroscopy pulse rate in the Badawy et 
al(33) study is not a dissimilar methodology to that used in reducing radiation dose during 
electrophysiology procedures, highlighted in chapter 6 of this thesis. This paper was 
published in 2017 and demonstrated that using modern equipment, properly configured for 
low dose fluoroscopy can result in very low levels of radiation for electrophysiology 
procedures. Electrophysiology procedures were investigated because they have 
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previously been associated with high doses.(86) The X-ray system used for 
electrophysiology procedures at The Prince Charles Hospital was being replaced during 
the candidature period and was an excellent opportunity to investigate the impact of 
introducing a new system on radiation dose. The results are remarkable and they 
demonstrate that contemporary x-ray equipment can have a huge impact on radiation 
dose for these procedures. In that study, radiation doses to patients were reduced by 90% 
through the utilisation of modern, readily configurable equipment, when compared to 
equipment of a previous generation, without a reduction in fluoroscopy time. At the time of 
submission to the target journal, the doses seen from this low pulse rate, optimally 
configured system were the lowest published to date in the literature. However, by the time 
of actual publication, other studies emerged,(110) with slightly lower dose that were 
included in the authors eventual publication. However, where other studies have 
demonstrated low doses for only one procedure type,(105,192,247) the authors study is 
unique, as it that demonstrates extremely low doses can be obtained for all procedures 
performed in a modern contemporary EP laboratory. The doses seen from this system are 
extremely low and demonstrate what can be achieved with a contemporary, dose 
optimised X-ray system. 
 
We have seen from the work in chapter 4 that as contemporary complex structural 
procedures, such as TAVI gain momentum, one must be mindful of the risks to the patient 
and staff. These new procedures bring their own challenges, such as occupational 
radiation. However, radiation is not the only risk from angiography, iodinated contrast 
media (ICM) and the resulting acute kidney injury (AKI) are also significant problems for 
the patient. AKI is linked to ICM volume(14) and currently, this is particularly important 
because the patients undergoing the TAVI procedure are elderly and have multiple co-
morbidities. Chapter 7 investigates this problem and whether contrast media volume is 
linked to the incidence of AKI and whether patients suffering AKI post TAVI have a poorer 
outcome. The paper in Chapter 7 demonstrates that AKI severity is not necessarily due to 
an increased ICM volume administered but is due more to pre-existing co-morbidities such 
as chronic kidney disease and procedural factors such as device repositioning. In addition, 
it found that patients have a poorer outcome in terms of length of hospital stay and 30 day 
mortality in this study. These findings are consistent with others in the literature,(208) as 
were the predicting factors for AKI, such as chronic kidney disease(207) and the need for 
blood transfusions.(112) However, one new determining factor for AKI that was discovered 
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was that of device repositioning or retrieval. This was the first time that this procedural 
complication had been associated with AKI and is of great importance moving forward. 
The paper in this chapter was published using the initial data from an Australian TAVI 
program. As such, the procedural contrast media volume was higher than some others in 
the literature. It is worth noting that there is a learning curve associated with the TAVI 
procedure. One multi-centre study demonstrated that as centres become more 
experienced with TAVI, there is an improvement with patient outcomes, with decreased 
death, and major bleeding. In addition, contrast media volumes decrease with increased 
volumes, though in that study there was no difference in the requirement for new dialysis 
and AKI was not reported.(221) A second study found similar findings with trans-aortic 
TAVI procedures, where contrast media volumes decreased with increased experience but 
AKI did not change with increased experience.(222) 
 
TAVI is a relatively new procedure and it requires critical imaging assessment of both the 
valve anatomy and the arterial access.(248) Building on previous work in assessing c-arm 
CT (DynaCT) for imaging the aortic route for TAVI procedures,(137) advances in X-ray 
system c-arm capabilities in the assessment of the ilio-femoral arteries have been 
explored in chapter 8 of this thesis. The authors hypothesised that DynaCT could produce 
similar images of the ilio-femoral anatomy to MSCT by using the angiography c-arm and 
using much less ICM volume than MSCT. This could mean that patients may not have to 
have their ilio-femoral arteries imaged at all with MSCT, reducing the ICM load at the work-
up stage. The study in chapter 8 demonstrated that the fluoroscopy c-arm can create 
images similar to a conventional MSCT scan of the same area and that measurements of 
the anatomy are of a similar level of accuracy to 2D fluoroscopy and MSCT. In this study a 
new and novel method for calculating the tortuosity of the ilio-femoral arteries is described. 
This method was simple; it created a ratio of the distance taken by the artery between the 
femoral head and the aorto-iliac bifurcation compared to the direct distance. This was 
called the tortuosity index. The study did, however, demonstrate that the identification of 
calcification was a weakness of the technology, which is in line with previous studies.(138) 
It is therefore perceived that MSCT will remain the mainstay of pre-operative assessment 
for TAVI into the future. This technology demonstrates great potential and as computing 
power, image manipulation and artificial intelligence evolve, a greater utility of this and 
other similar techniques will undoubtedly emerge. 
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The final publication of this thesis demonstrates that even though we are in a new 
contemporary era of  percutaneous treatments, such as TAVI, these intervention devices 
can still be prone to basic X-ray beam distortion from the divergent nature of the beam. X-
ray beam distortion is well understood by radiographers and it is well described in 
undergraduate radiography text books.(143) As demonstrated in the paper Poon et 
al,(137) where implant angles were shown to impact on paravalvular leak, much effort is 
taken to implant the device in the optimal c-arm angle, so as to position the device 
correctly in the aortic annulus. The bench-top study in chapter 9 demonstrates that TAVI 
devices can appear oblique if implanted near the periphery of the image, even though the 
angle of the c-arm may be ideal. This study demonstrates  that it is extremely important to 
always position the aortic root in the centre of the image when performing angiography 
and also to always deploy the TAVI device in the centre of the beam. This is very 
important for optimal valve positioning and may help prevent paravalvular regurgitation, 
which affects patient outcomes. 
Ionising radiation will undoubtedly be used for years to come for diagnostic and 
interventional cardiac procedures. This thesis has investigated the areas of radiation dose, 
acute kidney injury and imaging techniques in a new era of increasing complexity and an 
ever-increasing range of options for percutaneous cardiac treatment under X-ray 
guidance. The use of angiography in cardiovascular disease continues to evolve and this 
thesis has highlighted some of the problems associated with this technology and some 
ways to combat those problems as we move forwards. 
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- Future Directions 
The study published in chapter 2 of this thesis was published in 2014. (166) One of the 
recommendations of that paper was that the diagnostic reference level (DRL) calculation 
should be repeated every five years. This is particularly relevant as technologically 
superior X-ray systems are developed and brought into clinical use. As technology 
improves, radiation doses from X-ray systems may lower the DRL. However, procedures 
are becoming more complex and lengthy and DRLs for different and new procedures 
should be created. The DRL study should be re-visited for cardiac angiography within 
Queensland public hospitals in the very near future. Additionally, it should be extended to 
include other procedures that are performed in high volumes at most centres, such as 
permanent pacemaker implants. 
Reduction in radiation dose outputs from X-ray systems will also affect the radiation doses 
to the staff in the room. There is a great need to continue to monitor radiation doses to 
staff to ensure that their doses reduce as time goes on. Additionally, interventional 
cardiologists should have benchmarked doses for procedures. These staff should know 
what radiation dose they will be exposed to for the procedures that they perform. If doses 
are monitored on a cases by case basis, for a sufficient period of time, we can build a 
picture of what doses cardiologists are being exposed to for a range of procedures. In 
effect, a DRL can then be created for operator dose. This would be readily achievable 
using the methodology outlined in chapter 3. 
In a similar manner to the methodology to that outlined in chapter 4,(171) other staff in the 
room should also be monitored. The assistant to the primary operator should have their 
doses evaluated on a case by case basis, as their doses have not been published to date, 
and may be different to that of the primary operator, with different influencing factors. This 
is a body of work that should be undertaken to better understand their doses and factors 
that may influence high doses and this is readily achievable. 
The results of chapter 7(249) demonstrated that contrast media volume did not appear to 
be associated with acute kidney injury in patients undergoing TAVI. This is an interesting 
topic and further work is required in trailing prophylactic methods to reduce the incidence 
of AKI in patients with pre-existing renal impairment. Further, the fact that contrast media 
volume has not been associated with AKI in numerous studies(112,115,249) suggests that 
a deeper understanding and further studies on contrast induced nephropathy in TAVI 
patients is required.  
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C-arm CT continues to evolve performing for procedures requiring computed tomography 
(CT) examinations peri-operatively. It is apparent, however, that there may need to be 
further developments in X-ray detector technology to improve the ability of c-arm CT 
systems to image vessel calcification. In addition, MSCT and has firmly positioned itself as 
an essential pre-requisite for anatomical assessment prior to TAVI procedures. 
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Appendix iv: Literature review searches. 
 
Search Terms in Pubmed: 
 
 Radiation dose and cardiac angiography and patient AND "last 10 years"[PDat] Not 
computed not CT  
 Radiation dose and cardiac angiography and operator AND "last 10 years"[PDat] 
 Radiation dose AND electrophysiology 
 Dyna CT) AND transcatheter aortic valve replacement) 
 ((computed tomography) AND femoral artery) AND transcatheter aortic valve 
replacement 
 ((rotational angiography) AND transcatheter aortic valve replacement) 
 ((acute kidney injury) AND transcatheter aortic valve replacement) AND contrast 
media 
 (((contrast media) AND transcatheter aortic valve replacement) NOT computed 
tomography) NOT CT 
 ((parallax) AND radiology) NOT computed tomography 
 ((divergent beam) AND radiology) NOT computed tomography 
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Literature review methodology flow diagram 
 
 
Total results from Pubmed search 
 n = 494   
Other studies included 
 (Existing library, related links etc) 
n = 53  
Total 
n = 547 
Full-text articles 
excluded,  
n =  42 
Articles included in literature review 
n =  153 
Full-text articles 
screened 
n = 195   
Studies excluded after 
reviewing abstracts  
n = 287   
Abstracts screened 
n =  482 
Studies appearing in both 
searches  
n = 65 
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Appendix v: Continuous Medical Education – JACC 
In 2018 I was invited to write a continuous medical education (CME) supplement for the 
Journal of the American College of Cardiology based on the paper outlined in chapter 5 of 
this thesis that was accepted to their journal. The work completed is outlined below: 
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